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Abstract 
The concept of animal cloning was first introduced to the public’s attention in 1996 with 
the birth of “Dolly the Sheep,” the first mammal to be cloned.  Now, after more than a decade the 
technology has reached a point of feasibility on a commercial scale.  With the publication of the 
U.S. Food and Drug Administration risk assessment on animal cloning in 2008, a report that 
concluded that the technology was safe and posed no risk to consumers, the issue has received 
renewed attention.  
 In this thesis I use survey data to examine attitudes to the use of cloning in animal food 
production among samples of college students in the U.S., Ireland, France, Honduras, and China.  
Stated likelihood of consuming meat products from cloned animals is correlated with individual 
characteristics including socio-demographic variables (gender, and farming background) and 
attitudinal variables measuring concern about various food technologies.  In addition, using 
ordered logit modeling, we examine how respondents might change their probability of 
consuming cloned products after being provided with information about scientific assessments 
about the safety of cloning and possible price reductions for cloned products. 
The analysis shows that: a) respondents in the U.S. and Honduras were more likely than 
those in other countries to indicate that they would consume cloned products, b) on average, 
respondents in all countries increased their stated likelihood of consuming cloned products when 
informed that the U.S. Food and Drug Administration and the European Food Safety Authority 
had assessed cloned foods as safe for human consumption, and c) individuals who were opposed 
to cloning on moral grounds were significantly less likely to consume cloned product and 
furthermore were less likely to respond positively to information about the safety of cloning. 
 
Key Words: animal cloning, cloned products, biotechnology, food safety, consumer perception, 
food issues. 
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1 Introduction 
In the years since the birth of the first cloned mammal, “Dolly the Sheep”, in 1996, the 
technology of animal cloning has made significant progress to the point where its use is 
becoming viable in commercial livestock production.  The potential for using cloned animals in 
food production was further enhanced with assessments by the U.S. Food and Drug 
Administration (FDA) and European Food Safety Administration (EFSA) that foods derived 
from cloned animals or their progeny were safe for human consumption.   Uncertainty remains 
however, about how consumers in domestic and international markets will react to the 
availability of foods from cloned animals, and about how their reactions will be influenced by 
media coverage and other information about cloning.    
The primary advantage cloning offers for food production is the ability to exactly 
replicate animals with superior production characteristics.  By duplicating a superior bull for 
example, cloning effectively extends the longevity of a genetically high-quality animal.  
Replicating superior animals in this way has the potential to significantly enhance, or at least 
accelerate the ongoing enhancement of overall herd genetics and productivity.  The resulting 
increase in animal productivity has the potential to benefit both producers – through lower 
production costs – and consumers – either through lower retail prices or improved product 
quality and uniformity.  Given the United Nations (2009) estimate that “food production will 
need to double by mid-century to meet demand from a growing world population” the production 
enhancing benefits of cloning become more appealing.   
At about the same time that cloning technology was being developed,  the world saw the 
introduction and widespread commercial adoption, particularly in the U.S. but also in many other 
countries, of genetic modification of plants in commercial agriculture, and to a lesser extent the 
adoption of bovine somatotropin (rBST) in commercial milk production.  Concurrently however, 
active and well-organized consumer groups helped to implement stringent labeling laws on GM 
ingredients in both food for human consumption and animal feed in Europe, Japan and other 
countries.  In the US, consumers still appear to be broadly unconcerned about GM ingredients 
but consumer opposition has resulted in a shift away from the use of rBST .  
The objective of this thesis is to assess the likelihood of consuming products derived 
from cloned animals or from the progeny of cloned animals.  Attitudes toward the use of cloning 
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in animal food production among samples of US, European, Asian, and Central American 
college students are examined.  We compare expressed levels of concern about cloning to 
concerns about other food production technologies, issues, and production practices (genetic 
modification, bacterial contamination, packaging, etc).  Furthermore we attempt to correlate 
attitudes toward cloning and willingness to purchase cloned products to individual characteristics 
including not only socio-demographic variables (gender, household income, farming 
background) but also attitudinal variables measuring political disposition – such as whether the 
individual tends to lean conservative or liberal on social and economic issues.  While the data 
collection is restricted to undergraduate student samples, we believe the comparison across 
locations will provide interesting findings about this global issue.  
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2 Literature Review 
Since the early 1990’s, the topic of genetically modified (GM) foods has received 
considerable attention in the media.  And while cloning is distinctly different from genetic 
modification – in that it involves replication of existing genotypes and not the modification 
thereof - the technology is often part of the same public debate.  Indeed, some studies have found 
the media is at fault for confusing the two topics when discussing agro-biotechnology (Marks et 
al. 2003).  And Storey (2006) reported that 59% of survey respondents believed that cloning 
involved genetic modification.  But since the topics are related, many consumer surveys eliciting 
views about cloning typically do so in conjunction with the eliciting of views on genetic 
modification. More recently though, and particularly in the years immediately before and after 
the 2008 risk assessment from the FDA, a number of surveys have focused specifically on 
attitudes about animal cloning as a distinctly separate issue from biotechnology. 
Early surveys focused on consumers’ initial reaction to cloning animals, not on whether 
they would accept it as a viable source of food.  Later surveys began to ask about the likelihood 
of consuming products derived from cloned animals or their offspring – what we will refer to as 
‘cloned products’ – and about who consumers trust to provide information about such products.   
This review focuses on four different questions that have been addressed in consumer studies, 
including: 
 
a) level of familiarity with biotechnology and/or cloning 
b) likelihood of purchasing/consuming ‘cloned products,’ 
c) specific concerns about cloning, and 
d) who consumers trust to provide information about the technology. 
 
Most of the consumer studies on cloning, plus a number of other studies on acceptance of 
genetic modification of food, are summarized in table 2-1 below.  Most of the work reviewed is 
relatively recent, within the past 12 years or so, and most has been with samples of US 
consumers.  For each study, table 2-1 provides the author, source and year, the sample size if 
available and the questions that the study addresses (using the lettering system a – b – c – d 
above).  
2-4 
 
Table 2-1: Surveys on Cloning and Biotechnology  
Author Source Year Country Sample 
Size 
Main 
Focus 
Questions 
Addressed 
a b c d 
Hoban Food Technology 1999 Japan 
USA 
1000 
Not stated 
Biotech X  X  
Marchant European 
Molecular Biology 
Organization 
(EMBO) 
2001 16 European 
Countries 
16,000 Biotech 
X    
Hoban North Carolina 
State University 
(NCSU) 
2003 Various Various Biotech 
X    
Hallman, Hebden, 
Aquino, Cuite, 
and Lang 
Food Policy 
Institute (FPI) 
2001 
2003 
USA 1,200 
1,200 
Biotech 
X X   
Sosin and 
Richards 
KRC Research 2005 USA 1,005 Cloning  X X X 
The Mellman 
Group, Inc. 
Pew Charitable 
Trust 
2001 
2002 
2003 
2004 
2005 
2006 
USA 1,000 
1,000 
1,000 
1,000 
1,000 
1,000 
Biotech & 
Cloning 
X X X X 
Storey Center for Food, 
Nutrition, and 
Agriculture Policy 
(CFNAP) 
2006 USA 1,040 Cloning 
 X X X 
 International Food 
Information 
Council (IFIC) 
2005 
2006 
2007 
2008 
USA 1,000 
1,000 
1,000 
1,000 
Biotech & 
Cloning X X X X 
 Gallup Poll Inc 2001 - 
2009 
USA Not stated Cloning   X  
Huang, Qiu, Bai, 
Pray 
Elsevier 2006 China 1,671 Biotech X X   
Knight AgBioForum 2005 USA 432 Biotech X X   
Lusk USDA 2008 USA 2,120 Cloning X X X X 
Nonis, Hudson, 
Hunt 
 2010 USA 145 Cloning X X X X 
The Gallup 
Organization 
Eurobarometer 2008 Europe 25,000 Cloning X X X X 
 
 
2.1 Familiarity with biotechnology and cloning 
Hoban (2001) concluded that not many consumers have a direct connection with 
agriculture and food production which limits their literacy about developments in food 
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biotechnology.  But during the 1990’s, perhaps because of publicity given to trade disputes 
between the US and the EU on issues such as hormone use in animals and genetic modification 
of plants, more people became aware of biotechnology.  Between 1992 and 2000, Hoban (2004) 
found that about 38% of American consumers had some familiarity with biotechnology, with a 
range of 29% to 53%.  Perhaps because the issue has received less media attention in recent 
years, a study conducted for the Pew Charitable Trust found that awareness of genetically 
modified food declined from 44% in 2001 to 40% in 2006 (The Mellman Group, Inc 2006). The 
same study found that about 65% of respondents had heard of animal cloning.   
The more information consumers have about a given food technology, the more 
accepting of the technology they appear to be.  For example, Lusk (2008) found that respondents 
who were provided with a half-page of information about cloning expressed less concern about 
the technology than those who were provided just a two sentence definition.  But it can be 
difficult to assess exactly what consumers “know” about an issue.  Knight (2005) makes the 
distinction between what respondents know and what they think they know putting it this way -  
“perception of knowledge measures the level of knowledge a consumer thinks he or she has, 
while objective knowledge measures actual knowledge about a particular phenomenon.”  He 
goes on to state that while many consumers may not have an understanding of the science itself, 
it does not mean that they are not following the public debate.  
Studies indicate that while most American consumers have likely heard of cloning, they 
tend to know relatively little about its applications.  Sosin and Richards (2005), found that just 
one in four had heard about applying biotechnology to farm animals, and when asked to list food 
safety concerns, cloning was not mentioned.  However, when asked about cloning, 64% assumed 
that it would be used by farmers at some point in the future.  Storey (2006) reported that only 
half her sample believed it was possible to clone farm animals.  Lusk (2008) found that 
respondents had a higher level of awareness about cloning compared to other reproductive 
technologies such as artificial insemination. 
Since most survey respondents are not very familiar with cloning it seems likely that 
stated purchase intentions regarding cloned products will be influenced by the information 
provided in a survey, or by how a survey question is worded.  For example, in a 2004 study for 
the Pew Initiative, the Mellman Group reported a significant increase in perceived safety of GM 
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foods as a result of informing respondents about the prevalence of GM ingredients in everyday 
foods.   
 
 
2.2 Acceptance of biotech/cloned products 
While it can be misleading to generalize, by and large the evidence to date suggests that 
European consumers are mostly opposed to new biotech products, Americans are split on the 
issue – even though they uncomplainingly consume hundreds of food products derived from GM 
corn and soybeans – and Asian consumers are generally accepting of plant genetic modification 
technologies.  Illustrating those general tendencies, Environics (2001) found that a net 66% of 
Chinese consumers would continue to buy GM foods if they were more nutritious (where net = 
percent continuing to consume minus percent not continuing), a net 25% of Americans would 
continue to buy, but for German and UK consumers the net figures were -5% and -7% indicating 
that more would discontinue buying the product than would continue.    
While most Americans are aware that cloning could be used as a form of reproduction for 
farm animals, acceptance of the process is low.  Sosin and Richards (2005) asked respondents 
about their likelihood of continuing to buy meat or milk products if they learned they were 
derived from the offspring of cloned animals, given that the FDA ruled such products safe to eat.  
Responses indicated that one third of the sample would continue to buy the product, one third 
would consider it if they found out more about it, and one third would never buy it.  Responses 
were statistically indistinguishable for meat and milk products.  Given similar information (i.e., 
respondents told to assume that FDA considered the products safe), Storey (2006) reported 
almost identical results with purchase intent evenly split among those who would continue 
purchasing product derived from the offspring of cloned animals (32%), those who would 
consider it (32%), and those who would never buy it again (35%).  As in the previous study, 
responses were almost identical when consumers were asked about meat or milk products. 
In survey research for the International Food Information Council (IFIC, 2005), 43% of 
respondents indicated they would be “not at all likely to buy” products derived from clones, with 
a combined 34% indicating they would be “likely” or “somewhat likely.” When questioned 
about product derived from clone offspring, the results were largely similar with 37% “not at all 
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likely to buy” and a combined 39% either “likely” or “somewhat likely.” Later IFIC studies 
found slightly higher levels of acceptance of product from clone offspring – at 41% in 2006, and 
49% in 2007.  
The data reported by the International Food Information Council also showed an increase 
in the percentage of respondents with a favorable impression of cloning – up from 17% in 2005 
to 23% in 2008.  In contrast however, studies conducted for the Pew Charitable Trust (Mellman 
Group, 2005, 2006) found only a slight decrease in opposition to animal cloning between 2005 
and 2006 (from 66% to 64%).   
Lusk (2008), like Sosin and Richards (2005) and Storey (2006), found respondents about 
equally split between those who considered animal cloning acceptable (34%), unacceptable 
(32%) or were neutral on the issue (34%). As in those earlier studies, acceptance was virtually 
identical for meat or milk products with about 31% of respondents willing to eat meat or drink 
milk from a cloned animal, and 43% unwilling.  As in the earlier IFIC study (IFIC, 2005) results 
were very similar when respondents were asked about products derived from clones or products 
from the offspring of clones.   
Consumers are more likely to view cloning favorably if it provides a benefit.  The 2008 
IFIC report found that 50% of consumers who were very likely to purchase biotech foods were 
willing to do so because they would provide healthful properties such as more beneficial fats, 
reduced saturated fats, reduced pesticide use, or taste better and fresher.  The same report found 
that regardless of their acceptance of cloning, consumers agreed that it was important to find 
more sustainable production practices, grow more food to feed a growing world population, and 
reduce pesticide use.  Sosin and Richards (2005) found that cloning would be acceptable to 
consumers if it improved animal health or bred animals immune to disease, or if it improved the 
nutrition of milk or meat. 
 
 
2.3 Consumer concerns about cloning 
Storey (2006) reported that two thirds of respondents were “mostly uncomfortable” about 
the use of cloning in animals, with significantly more women (78%) than men (54%) indicating 
discomfort.  Similarly, the Pew surveys (Mellman Group, 2006) found that a majority of 
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respondents were uncomfortable with the technology – 61% among those who had heard of 
cloning and 68% among those who had not.  The Pew (2006) survey also found a gender gap – 
with discomfort among men at 58% compared to 69% for women. Comfort level with cloning 
was higher among more educated respondents, but was lower among those who attended 
religious services more frequently.  Lusk (2008) also found that males and respondents with 
higher levels of education were more accepting of cloning.  
A number of surveys have tried to identify the specific reasons for this discomfort and 
most lean toward finding that the concerns are less about food safety than about ethical/moral 
issues.  Storey (2006) found that there was no single dominant reason chosen by those who 
expressed discomfort.  The most commonly cited reason was that cloning was morally wrong 
(32%) followed by uncertainty about food safety (26%), the fear that animal cloning might lead 
to human cloning (23%), and concerns for animal welfare (14%).  
The Pew surveys found that religion and ethics top the list of concerns among those who 
are uncomfortable with cloning (Mellman Group 2005).  Ongoing Gallup polls from 2001 to 
2009 show that the proportion of respondents who believe animal cloning is morally 
unacceptable has hovered at about 30% with little deviation (Gallup, Inc. 2009).  Roberts (2008) 
found that many consumers are concerned that animal cloning may be a slippery slope toward 
human cloning.  In a similar vein, Lusk (2008) found that people are relatively unconcerned with 
the safety of products derived from cloned animals, but that their major objection is to the 
‘unnaturalness’ of the process, and the idea that animal cloning might lead to human cloning.   
 
 
2.4 Who do consumers trust on cloning 
According to Martineau (2001), much of the “food fight” about genetically modified 
foods could be averted if the public was provided with hard facts about tests that support the 
safety of GM foods for both human consumption and the environment.  However, the facts are 
typically buried in scientific publications, distributed by agencies that lack trust, or are not 
conveyed accurately by the media or consumer organizations. It is understood that when factual 
information is provided to consumers about a specific technology, their overall acceptance level 
tends to increase (Hoban 1999).  Knowing which source has the most credibility with consumers 
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is useful in terms of understanding (or influencing) consumer opinion.  Because of this, a number 
of surveys have tried to ascertain who consumers trust in terms of providing information about 
technologies such as cloning.  The results from those studies have been mixed.  
Sosin and Richards (2005) asked respondents to rate their trust in different sources of 
information about cloning.  The top rated sources were USDA (69% approval rating), 
veterinarians and physicians (67%), FDA (66%), Department of Health and Human Services 
(63%), the Environmental Protection Agency (59%), the World Health Organization (55%), and 
universities (53%).  Lower trust ratings were given to consumer protection agencies and animal 
rights groups such as People for the Ethical Treatment of Animals (36%), and the Sierra Club 
(24%).  Lusk found a lower level of trust in government, with less than 30% expressing trust in 
information about cloning from agencies like the USDA and FDA.  But even when consumers do 
express trust in government, they still indicate unwillingness to consume clone product even if 
its safety is affirmed by those agencies. As noted above, Sosin and Richards (2005) found that 
43% of respondents were “not at all likely to buy” clone product, even if FDA had ruled it safe 
for consumption.   
Government agencies in the EU have lost a significant amount of public trust in the wake 
of high publicized events such as mad cow disease and dioxin contamination of animal feed in 
Belgium (1999), Ireland (2008), and more recently in Germany (2011).  Europeans generally 
have low trust in their governments (Hoban 2001). In the 2000 EMBO report, the Eurobarometer 
survey showed that fewer than half (45%) of Europeans gave governments positive ratings in 
regulating biotechnology.   
Since the release of FDA’s risk assessment on cloning in 2008, consumers may have 
educated themselves more about the subject, or have heard about and trusted the FDA’s findings.   
The IFIC continuing surveys showed that in 2008, 65% of US consumers were “somewhat or 
very likely” to purchase products derived from clone offspring if FDA determined them to be 
safe, up from 61% in 2007 and 57% in 2006. When the same respondents were told that USDA 
and FDA had determined meat from cloned animals to be safe, 48% stated they would buy 
cloned product.   
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3 Policy Review 
While the science of cloning has made considerable technological advances, it has also 
attracted some controversy.  In 1996, when Dolly was born most people viewed the event as a 
scientific sensation with little or no implications for the food industry.  Later, after the initial 
media attention had subsided, the realization that the ability to clone food animals had very real 
implications for industry struck political leaders and consumers alike. 
 
 
3.1 Bans on human cloning 
The first major hurdle for politicians was banning the use of cloning for humans.  In 
1997, one hundred sixty eight member nations of the United Nations Educational, Scientific, and 
Cultural Organization (UNESCO) signed the Declaration on the Human Genome and Human 
Rights.  The declaration described the human genome as, in a symbolic sense, the “heritage of 
humanity” and stated in Article 4 that it should not “give rise to financial gains.”  The UNESCO 
declaration preempted bans on human gene and cloning therapies in several countries 
(Bonnickson 2001).  Also in 1997, President Clinton, on the recommendation of his National 
Bioethics Advisory Commission, proposed a five year moratorium on federal and privately 
funded human cloning research, citing its potential to threaten “the sacred family bonds at the 
very core of our ideals and society” (Marshall 1997).   
The subject of human cloning is complex in that it involves two distinct types: a) 
reproductive cloning – in which the objective is to produce a cloned human, and b) therapeutic 
cloning – in which the objective is not to produce a human being but may for example be to 
produce stem cells which could lead to the production of a replacement organ. While the 
objectives are different both processes share common steps such as the harvesting of DNA, 
replacement of DNA in a female egg cell, and the subsequent growth of a human embryo.  
Efforts to ban human cloning have faced opposition from those who support embryonic stem cell 
research and therapeutic cloning.   
By 2004, human reproductive cloning had either been banned completely or allowed only 
with limited research application in Australia, China, South Africa, Canada, and most of the E.U 
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(Australian Government 2002, Republic of South Africa 2003, Government of Canada 2004, 
Peoples Republic of China 2003, European Communities 2000).  Bills restricting or banning 
human cloning have been repeatedly introduced in the US Congress, but to date, none have been 
signed into law.  In July 2001, the U.S. House of Representatives passed HR2505 – the Human 
Cloning Prohibition Act introduced by Reps. Weldon (R-FL) and Stupak (D-MI) which would 
ban both reproductive and therapeutic human cloning – by a vote of 265 for and 162 against.  At 
the same time, the House defeated a bill that would have banned only reproductive cloning. In 
January 2002, a companion bill to HR2505, Senate Bill 1899, was introduced by Sen. 
Brownback (R-Kansas) and later sponsored by Sen. Landrieu (D-LA) in the US Senate. That bill 
was stalled in committee and was never brought to a vote in the Senate.  The same fate befell 
other bills introduced by Sen. Feinstein (D- CA, S. 1758) and Sen. Harkin (D-IA, S. 1893) that 
would have banned only reproductive cloning (technically the bills would ban implantation of a 
cloned embryo).   
In 2003, HR 534, introduced by Rep. Weldon, passed the Republican controlled House 
by a 241-155 vote but again failed to receive a vote in the US Senate.  Senate Bill S303 – the 
Human Cloning Ban and Stem Cell Research Protection Act - introduced by Sen. Hatch (R-UT) 
also failed to receive a Senate vote.  Similar fates befell similar bills reintroduced in subsequent 
years.  
As of 2006, 13 states had banned reproductive cloning, and of those six also prohibited 
therapeutic cloning (Johnson and Williams 2006). At the federal level, the so called Dickey 
Amendment prohibits the Department of Health and Human Services from funding research in 
which human embryos are destroyed.  The Dickey Amendment is, technically, a rider attached to 
the appropriations act funding the Departments of Labor, Health & Human Services, and 
Education, and has been included in each such bill since 1995.  Also potentially related to human 
cloning, the Science, Justice and Commerce Appropriations Act, 2006 (P.L. 109-108) prohibits 
the granting of patents “directed to or encompassing a human organism,” a restriction that 
potentially deters research on human cloning since researchers would be unable to patent their 
discoveries (CRS, 2006).  
The only human cloning regulation signed into law has been a prohibition on the use of 
private funds for research and exclusively reserving human embryo research to government 
funding (Wright 2004). 
3-12 
 
After years of deliberation, the United Nations adopted a non-binding declaration on 
human cloning in which member states were called on to adopt “all measures necessary to 
prohibit all forms of human cloning inasmuch as they are incompatible with human dignity and 
the protection of human life” (United Nations 2005).  While this declaration did not end the 
debate on human cloning, it did quell the controversy long enough to redirect attention to animal 
cloning.  In the intervening years, animal cloning technology had made significant advances, and 
by 2005 nearly a dozen animal species had been cloned.  Even at prices as high as $20,000 to 
$50,000 per animal, the process was seen to have potential for application in production 
agriculture. 
 
 
3.2 Regulations governing animal cloning    
While no country has yet passed legislation regulating the use of animal cloning for food 
production, risk assessments have been carried out by government agencies in the U.S., E.U., 
Japan, Canada, Australia, and New Zealand (Food and Drug Administration 2008, EFSA 2010, 
Japanese Research Institute 2002, R. F. Seamark 2003, Canadian Food Inspection Agency 2010).  
These assessments have concluded that food derived from cloned animals is safe for human 
consumption.   
In 2001, the US Food and Drug Administration (FDA) undertook an assessment of the 
safety of foods derived from clones, and at the same time requested the livestock industry to 
refrain from introducing meat or milk from clones or clone offspring into the food supply.  A 
first draft of the FDA risk assessment was released in December 2006. The final risk assessment, 
a risk management plan, and guidance for industry were issued in January 2008 (FDA 2008).  
FDA concluded that meat and milk from clones of cattle, swine, and goats, and the offspring of 
clones from any species traditionally consumed as food (including sheep), were as safe to eat as 
food from conventionally bred animals. This conclusion was in agreement with that of an earlier 
report by the National Academy of Sciences (NAS 2002). 
The FDA had insufficient information for a recommendation on the safety of food from 
clones of sheep or other species. The final risk assessment did not call for any labeling of foods 
derived from clones or their offspring on the grounds that those foods were effectively 
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indistinguishable from products derived from conventionally bred animals. The opinion 
effectively cleared the way for meat and milk products from cloned animals to enter the market, 
but the guidance for industry document issued with the risk assessment recommended that 
products from clones of animals other than cattle, swine or goat (i.e. sheep) should continue to be 
kept out of the human food supply.  FDA also noted that the ethical concerns related to cloning 
were not within the purview of the risk assessment.   
At the same time as FDA’s January 2008 risk assessment, the European Food Safety 
Authority (EFSA), following a request from the European Commission, issued a draft scientific 
opinion on the safety of foods derived from clones (EFSA 2010).  While the EFSA opinion 
emphasized uncertainties in the risk assessment due to the limited number of studies available, 
and found that the health and welfare of a significant proportion of clones was adversely 
affected, it also concluded that it was very unlikely that there were any differences in terms of 
food safety between products derived from clones and clone offspring and foods derived from 
conventionally bred animals.  Following review of public comments, the EFSA opinion was 
adopted in July 2008, and reaffirmed in statements issued in 2009 and 2010 (EFSA Journal 
2010).   
Concurrent with the EFSA opinion, the European Group on Ethics in Science and New 
Technologies (EGE) issued an opinion on the ethical aspects of animal cloning (EGE 2008, 
EFSA 2010).  The EGE report, citing health problems of clones and surrogate dams, questioned 
whether animal cloning for food production was ethically justified and proposed that additional 
requirements be met before cloning could be deemed safe.  These included: a) that safety of food 
products be guaranteed as a precondition for marketing, b) that the “five animal freedoms” 
including freedom from hunger, thirst and malnutrition; freedom from fear and distress; freedom 
from physical and thermal discomfort; freedom from pain, injury and disease ; and freedom to 
express normal patterns of behavior as recommended by the Organization for Animal Health 
(OIE) be met, c) enactment of legislation to ensure traceability for all cloned animals and their 
products, and d) the import of cloned animals, their offspring, and materials derived be 
documented (EGE 2008).   
At this time, special interest and consumer advocacy groups were pressuring members of 
the European Parliament to ban animal cloning. The Novel Foods legislation of 1997 (Regulation 
EC 258/97) required that any food or ingredient not used for human consumption within the EU 
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prior to 1997 must undergo a safety assessment before being placed on the market. That law 
provided a framework for regulating genetically modified organisms, but GMO’s were 
subsequently regulated under separate legislations (Directive 2001/18/EC – on the release into 
the environment of genetically modified organisms; Regulation (EC) 1829/2003 and 1830/2003 
on the traceability and labeling of genetically modified organisms).  In January 2008 the 
European Commission published proposals to replace the 1997 novel food legislation with the 
aim of streamlining the authorization process for new foods – particularly foods that had not 
traditionally been sold in the EU but that had a safe history of use in other countries (Jukes 
2011).  The Commission proposed a central authorization process for novel foods, including 
assessment by EFSA, rather than having initial assessments carried out by member states.  The 
proposal also included an updated definition of a novel food to clarify that use of new 
technologies such as nanotechnology and animal cloning would require a pre-market safety 
assessment. 
In March 2009, the European Parliament indicated support for the Commission’s 
proposal on novel foods, but adopted a report requesting that the Commission prohibit the 
marketing of any foods derived from cloned animals or their offspring.  In June 2009, the 
Council of the European Union (the EU’s main decision making body) approved a draft 
regulation on novel foods but required, over the objection of the Commission, that the scope of 
the regulation would extend to foods derived from the offspring of cloned animals.  The Council 
adopted a first reading of the proposed regulation in March 2010, again with the Commission not 
in agreement that the law should extend to offspring of clones.  In May 2010, the European 
Parliament Environment committee voted in favor of proposals to centralize the authorization of 
novel foods, but opposed any approval of foods derived from clones or their offspring and asked 
the Commission to create a separate proposal to ban such foods.  On July 7, 2010, the Parliament 
supported a call for legislation, separate from the novel food proposal, which would ban foods 
derived from clones or their offspring.  By voting to exclude foods derived from clones from the 
novel food rules, the Parliament was in opposition to the position of both the Commission and 
the Council.  Until a law on cloned foods could be adopted, the Parliament requested an 
immediate moratorium on the sale of foods derived from clones or their offspring.  
On July 29, 2010, the New York Times reported that “breeders in Switzerland, Britain 
and possibly other countries had imported semen and embryos from cloned animals or their 
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progeny from the United States” (Kanter 2010).  In August, the UK Food Standards Agency 
(FSA) reported that meat from three offspring of a cloned cow had entered the food chain 
without authorization.  The animals had been born in the UK from embryos taken from a cloned 
cow in the US.  In its statement (FSA, 2010) the Agency noted “While there is no evidence that 
consuming products from healthy clones, or their offspring, poses a food safety risk, meat and 
products from clones and their offspring are considered novel foods and would therefore need to 
be authorized before being placed on the market." The news about clone offspring entering the 
food chain generated plenty of media attention with coverage focusing on the potential risks, or 
lack thereof, associated with cloning and on the apparent lack of enforcement of various 
regulations.   
On October 11, 2010 the European Commission issued its opinion on amendments to the 
novel food regulation proposed by the European Parliament (European Commission 2010).  The 
Commission rejected amendments pertaining to cloning that would require an immediate 
moratorium on food derived from clones and clone offspring, and that would require the 
introduction of legislation to ban those foods.  The Commission argued in part that the novel 
food regulation was not the appropriate legal framework for addressing the cloning issue since 
products other than foods (e.g., semen, embryos) did not fall within its purview.   
In October 2010, the European Commission announced a temporary five-year ban on the 
use of animal cloning for food production in the EU (Europa 2010, European Commission 2010).  
The ban was justified on animal welfare grounds, but, contrary to the wishes of the EU 
Parliament, did not include a ban on imports of foods derived from clone offspring. The 
Commission argued that such an import ban was: a) unnecessary since food from cloned animals 
is safe, and b) difficult to enforce since products derived from clones were indistinguishable 
from those from conventionally bred animals.   
In December 2010, the European Council rejected the Parliaments proposed amendments 
to the novel food draft proposal.  The rejection by the Council set the stage for a conciliation 
procedure.  As of March 2011 the different EU legislative bodies were still debating the 
amendments to the novel foods regulation, and the main sticking point still appeared to be the 
issue of animal cloning. Views on the proposed ban differed primarily between members of the 
European Parliament who sought a strict ban on products derived from clones and their 
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offspring, and member states governments (via the Parliament) who would agree to a ban on 
products derived from clones but favored allowing products derived from clone offspring.   
In the U.S., Representative Rosa DeLauro (D-Connecticut) introduced H.R. 6325 - the 
Consumer Right to Know Food Labeling Act of 2010.  The bill was referred to the House 
Agriculture Subcommittee on Livestock, Dairy, and Poultry in September 2010, but did not 
come to a vote before the end of the 2010 Congress.  The bill would have required any food 
product derived from advanced agro-biotechnology, including cloning, to be labeled as such. In 
arguing for the legislation, Congresswoman DeLauro referenced studies showing that consumers 
“actively oppose the cloning process, and are very suspicious of genetically-modified foods” 
(Richards 2010).   
 
 
3.3 Arguments for and against cloning for food production 
Proponents of animal cloning tout its potential economic benefits in livestock production.  
Opponents articulate concerns about human and animal health, welfare, ethics, agro-biodiversity, 
and sustainability.  Below, each position and their advocates are discussed.  While the arguments 
are basically the same, cloning opponents appear to be better organized in Europe than they are 
in America. 
 
3.3.1 The arguments for cloning 
Advocates for animal cloning focus on its potential impact on efficiency in livestock 
production, and the resulting impact on the human food supply.  The claim is that cloning can 
accelerate the production of genetically superior animals and allow them to stay in production 
longer.  Cloning advocates are diverse and include university scientists, research science 
associations, leaders in production agriculture, non-government associations (NGO’s), 
biotechnology and pharmaceutical companies, some religions, and legislators who advocate for 
technological advancement.  Advocates argue that they support advanced technology that will 
sustain and enhance human life, benefit the environment and enhance economic development.  
Their arguments emphasize the following points: 
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a) Food safety: Foods derived from clones and clone offspring are identical to those derived 
from conventionally produced animals and have been found safe for human consumption. 
 
b) Production efficiency: Cloning accelerates the reproduction of genetically superior 
animals and thus enhances the efficiency of livestock production.  Within any herd, 
production animals can vary widely in genetic merit. For example, consider a dairy herd 
with 100 cows in which the best animal is 20% more productive than the herd average.  
For simplicity, assume average production is 10,000 kg and the best cow produces 12,000 
kg.  Total production for the herd is 1 million kg (i.e., 100 x 10,000).  If all animals were 
as productive as the best cow, total production would be 20% higher at 1.2 million kg. 
Conventional breeding techniques cannot exactly replicate that best animal, but cloning 
can.  Given constraints on the amount of land that can be used for food production, gains 
in food production efficiency are needed to feed a growing world population.  
 
c) Replicating desirable attributes:  While the illustration above emphasizes a production 
attribute, the benefits of replicating the “best cow” also applies to attributes such as 
resistance to disease, efficiency in feed conversion, etc.  The Biotechnology Industry 
Organization (2010) suggests that cloning could reduce the use of antibiotics, growth 
hormones and other chemicals. 
 
d) Environmental benefits: If cloning can enhance animal productivity and reduce the use 
of antibiotics and other chemicals, an ancillary benefit would be a reduction in the 
environmental impact (carbon footprint) of animal agriculture.  Looking at the example 
above in another way, if all cows were as good as the best cow, the same total level of 
production, 1 million kg, could be produced with 84 (10^6 / 12,000 = 83.3) instead of 
100 animals. At a 2010 European Commission hearing on animal cloning, Keith 
Campbell, one of the creators of Dolly, argued that cloning genetically superior animals 
could provide sufficient milk and food, but also meant there could be fewer animals and a 
reduced environmental impact (Campbell 2010). 
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e)  Consumer benefits:  Improvements in production efficiency lead to lower costs per unit 
output (see Suk et al, 2007) which in turn lead to lower prices for consumers. But 
consumers can also benefit from improvements in product consistency. For example, 
attributes such as meat tenderness are influenced by genetics and can vary substantially 
across animals with similar (but not identical) genetics.  Cloning offers the potential to 
deliver more uniform products at lower cost. 
 
f) Producer’s rights:  Some advocates argue that producers should have the right to use a 
technology that is proven to be safe and effective and “allow the marketplace to decide 
their success or failure” (AMI 2010).  
 
Cloning remains an expensive proposition and its use remains limited to replicating 
premium sires and show animals. Until the embryo transfer patents held by the two largest U.S. 
cloning companies Viagen and Cyagra are opened to the public, cloning technology will 
continue to be expensive and most likely will not be used to produce commercial livestock 
(Lanza and West 2002, Gibori and Aurora 2010).   
 
3.3.2 The arguments against cloning 
Opponents of animal cloning have been aggressive in their position against the 
technology citing concerns about human health and animal health and welfare, ethical objections, 
and the potential risks for agro-biodiversity and sustainability.  Opponents represent a fairly 
homogenous group that includes animal and consumer activist groups such as The Humane 
Society of the United States and Europe’s Friends of the Earth.  Environmentally sensitive 
corporations such as Whole Foods and Ben & Jerry’s in the United States, and Tesco, Morison’s, 
and Marks & Spencer in Europe have publicized their opposition to the technology (Hisey 2007).   
Other food processors including Smithfield Foods Inc., Tyson Foods Inc., Kraft Foods Inc., and 
Wal-Mart Stores Inc. have indicated that they will not sell cloned products (Zhang and Jargon 
2008).  The arguments against cloning include: 
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a) Animal welfare:  The Humane Society emphasizes the admission by scientists that 
“cloning research reveals abnormalities and high failure rates” (HSUS 2010). Success 
rates are quite low ranging from 5% (Oback and Wells 2003) to upwards of 30% (Suk, 
et al. 2007), but have improved significantly since Dolly, whose birth represented one 
success following 276 failed attempts.  Opponents also point to high rates of fetal 
abnormalities (HSUS 2010, FOE n.d.).  According to the FDA, swine and goat clones 
are no more susceptible to abnormalities than their conventionally bred counterparts. 
However, in cattle and sheep some clone fetuses grow too large during pregnancy, and 
have serious birth defects – a set of abnormalities known as “large offspring syndrome” 
(FDA 2008).  But rates of this syndrome have decreased as the technology has 
improved, and most clones that are born with health problems appear to overcome 
them and are indistinguishable from conventional calves and lambs at around six 
months of age.  
 
b) Ethical concerns: From the moment Dolly was introduced to the world in 1996, 
ethical concerns about the technology have been at the forefront.  Once human cloning 
was set aside in 2005 (United Nations 2005), the discussion immediately turned to the 
ethics of animal cloning for human food consumption.  Cloning occurs in nature 
(identical twins are clones) and has been used in plant production (grafting), but 
opponents believe that when humans artificially facilitate asexual reproduction in the 
animal kingdom, it is akin to playing God (Cloer 2010).  The Catholic Church is not 
technically opposed to animal cloning.  They state “there is a place for research, 
including cloning, in the vegetable and animal kingdoms, wherever it answers a need 
or provides a significant benefit for man or for other living beings, provided that the 
rules for protecting the animal itself and the obligation to respect the biodiversity of 
species are observed” (Correa 1997).  Opponents of cloning believe that in their quest 
for knowledge, scientists make God obsolete by artificially giving life to animals and 
therefore surpassing the need for higher power.  Opponents also argue that misuse of 
animal cloning technology could have unforeseen negative consequences that humans 
would be unable to control (EGE 2008). 
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c) Inability to distinguish clones:  Opponents argue that cloned animals and their 
offspring, because they are indistinguishable from conventionally bred animals, need to 
be tracked and identified as such.  Failure to do so denies to consumers their right to 
know and choose how their food is produced.  As noted above, legislation that would 
requires such tracking and labeling was introduced to the US House of Representatives 
(but not passed) by Congresswoman DeLauro who explained that the Consumer Right 
to Know Food Labeling legislation would require “labeling of these products, both in 
supermarkets and restaurants, to alert American consumers to what they are eating and 
enable them to make informed purchase decisions” (Gabbett 2010).  During 
parliamentary arguments on the EU proposed ban on cloning, Anna Maria Corazza 
Bildt, member of the European Parliament from Sweden, expressed the concern that 
the inability to tell the difference between clone derived and non-clone derived 
products effectively eliminated the consumer’s right to choose products they preferred.  
 
 
3.4 Cloning and Trade 
The issue of animal cloning has the potential to disrupt trade in meat and other animal 
products depending on how different countries regulate the technology.  The treatment of 
products derived from clone offspring will be particularly important as such products will be far 
more plentiful than those derived from clones, and furthermore very difficult to track and 
identify.  As noted above, the EU Commission’s temporary ban on cloning does not, contrary to 
the wishes of the European Parliament, ban imports of foods derived from clone offspring.  Had 
it done so, it would likely have prevented imports of all meat and dairy products from the U.S. 
However, US exports of meat and dairy products are already restricted by EU rules on the use of 
growth promoting hormones, so any cloning related ban on trade with the EU would likely not 
be of particular concern to the US but certainly an added constraint.  In 2010, for example, US 
exports of red meat and dairy products were valued at over $12.8 billion, of which exports to the 
EU accounted for less than $300 million or about 2 percent (FAS 2010).  In terms of total 
exports, markets in North America (Mexico, Canada) and East Asia (Japan, South Korea) are 
much more important for the US livestock sector (FAS 2010) and it does not appear likely at this 
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time that those countries will restrict products from clone offspring given prior food safety 
protocols are reached (Health Canada 2003, Canadian Food Inspection Agency 2010, Japan Food 
Safety Commission 2009).  
World Trade Organization (WTO) rules governing trade in food products are included in 
the Agreement on Technical Barriers to Trade (TBT).  Agencies including the Sanitary and 
Phytosanitary Standards (SPS) Commission, the Codex Alimentarius Commission and the World 
Organization for Animal Health (OIE) require that import standards are derived from 
scientifically proven risk assessments. If a country cannot show that its import standards are 
science based, the WTO will typically rule against that country in a trade dispute.  For example, 
in the dispute between the US and EU over GMOs, the WTO ruled against the EU import 
restrictions (Europa 2006).   
Given that scientific assessments in both the US and EU have found products derived 
from clones to be safe for human consumption, it seems likely that any trade dispute would 
similarly end up in a ruling against the import restrictions. At the same time, the cloning issue 
involves the added dimension of animal welfare that was not a factor in previous trade disputes 
over hormones or GMOs.  Both the European Group on Ethics in Science and New Technologies 
(EGE) and the U.S. Council for Agriculture Science and Technology (CAST) have addressed the 
animal welfare issue (EGE 2008, Wall, et al. 2009).   It is possible that in arbitrating a trade 
dispute involving cloning that such an official finding on animal welfare could provide the 
necessary “scientific” basis to justify an import restriction on products from cloned animals.   
 
 
3.5 Conclusions 
As the science of cloning advances, political and economic policies regarding it will 
evolve, as will consumer perceptions and preferences.  It appears likely that the EU will, with the 
eventual passage of a new novel foods regulation, implement significant permanent restrictions 
on cloning but the extent to which those restrictions will impact trade remains to be seen. Current 
US policy does not restrict cloning for food production and, as costs decrease and benefits begin 
to be realized, it seems likely that the technology will be adopted by more producers.  Passage of 
any legislation that requires labeling of products from cloned animals however may significantly 
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restrict its adoption as consumers are unlikely to perceive much benefit from consuming 
products from clones and many would like to avoid them.    
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4 Data Collection and Survey Description 
Labeled products from cloned animals are not currently marketed so demand for those 
products cannot be estimated using market data.  Because animal clones are exact copies of 
parent donors, even if labeling laws were passed cloned product would be very difficult to track.  
For that reason the characteristics of market demand for cloned products can only be estimated 
using stated preference type data such as can be obtained from a survey, or perhaps from 
revealed preference data from a market experiment. For this study, data was collected from 
samples of undergraduate students on four continents using both an online and a printed version 
of a survey instrument.   
 
 
4.1 Acquiring Data  
Most of the data for this study came from an online survey using Survey Monkey and 
conducted using specific classes of undergraduates at different institutions in the United States, 
Europe, and Latin America.  Survey Monkey allows the user to design a survey instrument that is 
easy for a respondent to follow, and also includes a number of features that maintain the integrity 
and completeness of the responses.  These features include the ability to prevent the respondent 
from returning to earlier questions, restricting responses to one per question (when that feature is 
desired), or requiring that a question be answered in order to proceed with the survey.  The 
Chinese version was designed in Survey Monkey but submitted by hand on paper printouts.     
Respondents were not provided with any information about the subject prior to taking the 
survey. This ensured that subjects would not choose to participate or not participate based on the 
subject matter.  Subjects in the Kansas State classes were offered a small amount of extra credit 
to complete the survey. Subjects in all other samples were not provided any incentive to 
complete the survey.  
Each survey was translated into French, Spanish, and Chinese for the respective 
collectors in France, Honduras, and China.  Survey Monkey includes special controls for 
languages, which allows response buttons, descriptions, and important instructions to be 
automatically translated into the appropriate language.  These language features made Survey 
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Monkey an ideal platform for collecting data from an international sample.   Figures 5.1 to 5.3 
below show screen shots of one question from the survey instrument in English, French and 
Spanish.     
 
Figure 4-1: Survey Monkey Internet Price Screen English Version 
 
 
 
 
 
 
 
 
 
Figure 4-2: Survey Monkey Internet Print Screen French Version 
 
 
 
 
 
 
 
 
 
Figure 4-3: Survey Monkey Internet Print Screen Spanish Version 
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4.2 Data Sources 
Data was collected from samples of respondents in the United States, France, Ireland, 
Honduras, and China.  For all samples except China, an identity specific internet link was 
emailed to the respondent’s college email addresses.  The survey could be viewed using either 
Internet Explorer or Mozilla Firefox.  Once respondents were finished or had closed the survey 
window, their results were automatically updated in a data interface that was only accessible to 
the survey creator.   From that interface the data could be downloaded into excel files for 
analysis.  But the data interface itself also offered some basic statistical analysis, much of it in 
graphical form (pie charts, bar charts) that could be easily interpreted and manipulated.   
In total, surveying by each collector lasted approximately 2 months.  To keep the survey 
results as consistent as possible, the request of recruited surveyors was that the questionnaire 
respondents be limited to undergraduates only.  Admittedly, the student sample does have 
limitations because many students are not regular food purchasers and they have limited income; 
however, Lusk, et al. (2005) found that student samples were not different from more 
representative population samples in willingness to pay analysis for genetically modified food 
products.  In addition, the results from this particular age group are important, as they are the 
most likely to consume cloned product once it reaches the market on a wider level. Irrespective 
of the limitations from the sample, the cross continental comparison provides interesting insights.   
The total sample size was 714 of which 644 were complete and usable.  A brief description of 
the country subsamples follows.  
 
 United States: Data was collected from undergraduates in three classes – Agricultural 
Economics, Sociology, and English – at Kansas State University. The respective 
instructors were emailed an identity preserved link to the survey which they forwarded on 
to their class rosters.  A total of 166 students were sampled resulting in 141 complete 
responses – a response rate of eighty five percent.   
 
 France: Data were collected with the assistance of collaborators based at Purpan School 
of Agriculture, Toulouse, France.  The collaborators were emailed an identity preserved 
link to the translated survey; however information on the specific classes that were 
surveyed was unavailable.  The survey was forwarded to approximately 320 students in 
4-26 
 
the 3rd year of their program, resulting in 164 complete responses – an estimated response 
rate of fifty one percent.  The translation was done by French colleagues participating in 
an exchange program at the Agricultural Economics Department at Kansas State 
University.    
 
 Ireland:  Data was collected with the assistance of collaborators at University College 
Dublin, Ireland.  The collaborators were emailed an identity preserved link to the survey, 
but, as in France, information on the specific classes that were surveyed was unavailable. 
It is estimated that 584 students were sampled resulting in 119 complete surveys – a 
response rate of twenty percent.  
 
 Honduras: Data was collected with the assistance of collaborators at the Universidad de 
Zamorano of Tegucigalpa, Honduras.  The collaborators were emailed an identity 
preserved link to the survey which they forwarded to a university wide email list.   
Unfortunately this list included an undisclosed number of addresses and was not limited 
to just students.  It was estimated the email list included 2,000 recipients of which 134 
completed the survey.  Using responses to questions about age and income, an effort was 
made to limit responses to those believed to come from students by isolating based on 
high reported salaries or age groups outside the target area.  The final usable number was 
94 observations.  The translation and authenticity check was performed by several 
colleagues from Central and South America studying in the Agricultural Economics 
Department at Kansas State University. 
 
 China: Data was collected from a sample of students at the Beijing Vocational College of 
Agriculture, China with the assistance of collaborators based at the College.  The 
collaborators were emailed a PDF copy of the translated Chinese survey.  The translation 
and authenticity check was made possible by several colleagues from the Peoples 
Republic of China studying at the Agricultural Economics Department at Kansas State 
University.  The collaborators in China then made hard copies of the survey and passed 
them out in several classes.  On completion, the surveys were mailed back to the United 
States where the data was inputted by hand.  A total of 152 surveys were returned and 
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140 contained usable answers.  Human error with data entry is a potential concern with 
this dataset.  In addition, because the surveys were completed on hard copies, we did not 
have the same degree of control over the responses as with the electronic survey, and a 
number of response errors were detected and several surveys were incomplete.   
4.3 Variables and Hypothesis 
The survey data allowed for the construction of several variables which are listed in Table 
5-1 below.  Appendix A includes copies of each survey instrument used.   
 
Table 4-1: Description of Model Variables 
Variable Question # Variable Description Model Variable 
Respondent ID  Respondent ID number in Survey Monkey  respondentid 
Collector ID  Collector ID number in Survey Monkey  collectorid 
KSU Ag Econ  Collector name for AgEcon respondents at KSU agecon 
KSU English  Collector name for English class respondents at KSU english 
KSU Sociology  Collector name for Sociology class respondents at KSU sociology 
Ireland UCD   Collector name for University College Dublin respondents ireland 
France SAP  Collector name for  Purpan respondents france 
Honduras Zamorano  Collector name for Zamorano respondents zamorano 
China  Collector name for Beijing respondents china 
Meat Consumption 1 Weekly meat consumption frequency 
From 0 = Never, to 4 = Almost every day 
meatconsume 
Concern about Food 
Issues 
 Question 2 elicited levels of concern on a scale from 1 = 
Not concerned to 5 = Very Concerned  
 
     Packaging 2 Concern about product packaging packaging 
     Price 2 Concern about product pricing price 
     Food Handling 2 Concern about food handling and preparation foodhandlingpreparation 
     Ingredients 2 Concern about food ingredients ingredients 
     Food Borne      
     Pathogens 
2 Concern about food borne pathogens foodbornepathogens 
     Chemicals  
     Pesticides 
2 Concern about chemicals and pesticides chemicalspesticides 
     Hormones 2 Concern about the use of hormones in production useofhormones 
     Biotechnology 2 Concern about use of biotechnology in production biotechnology 
     Cloning 2 Concern about cloning technology in production cloning 
Attention to Labels 3 Attention paid to labels on meat packaging 
From 1 = Don’t know to 5 = A lot 
attention 
Knowledge of 
Technology 
4 Self-evaluated knowledge of biotech, cloning, genetic 
engineering.   
From 1 = nothing to 4 = A great deal 
knowtech 
Likely to consume 5 Likelihood of consuming meat from cloned animals  
From 1 = Not at all likely to 5 = Very likely 
likely1 
Reason for Discomfort 6 Question 6 elicited the main reason the respondent would 
be uncomfortable with meat from cloned animals.  
answerstoq7 
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     Reason Morally  
     Wrong 
6 Main reason for discomfort is moral objection morallywrong 
    Reason Food Safety 6 Main reason for discomfort is food safety concern foodsafety 
    Reason Human  
    Cloning 
6 Main reason for discomfort is possibility of human 
cloning  
humancloning 
    Reason Animal       
    Safety 
6 Main reason for discomfort is animal safety animalsafety 
    Reason Don’t Know 6 Do not know reason for discomfort dontknow 
    Reason Not       
    Uncomfortable 
6 Not uncomfortable with animal cloning notuncomfortable 
     Reason Don’t Care 6 Do not care about animal cloning dontcare 
Likely to consume 2 7 Likelihood of consuming meat from cloned animals after 
learning about FDA/EFSA safety assessment 
likely2 
Likely to consume 3 8 Likelihood  of consuming meat from cloned animals at a 
10% price reduction 
likely3 
Gender 9 Gender of respondent: = 1 if female female 
Religious Affiliation 10 Respondent has a religious affiliation:  
= 1 if yes, 0 if no or prefer not to answer  
religious 
Agriculture Background 11 Respondent has farm or ranch background 
= 1 if yes, 0 if no 
farm 
Political Affiliation 12 Respondents general political/social affiliation 
1 = conservative, 2 = moderate, 3 = liberal, 4 = no 
affiliation, 5 = liberal on some, conservative on other, 6 = 
other, 7 = prefer not to answer 
politics 
Age 13 Respondents age - from 1 = 20 or younger, 2 = 21-25, etc 
to 10 = 71 or older.  
age 
Education level 14 Respondents highest level of education, from 1 = some 
high school, to 5 = post graduate  (6 = other)  
education 
Income 15 Approximate 2008 household income before taxes. 
Categorical from 1 = < $20,000, 2 = $20,000 to $30,000, 
etc (with appropriate conversions for non-US 
respondents).  
income 
Household Residents 16 Number of people living in household household 
Children Under 6 17 Children under 6 living in household: 1 = yes, 0 = no. under6 
Children From 6 to18 17 Children between 6 – 18 living in household; 1 = yes, 0 = 
no. 
from6to18 
Food Tech Concern  2 Index of concern about food technology. Constructed as 
the average of concern about useofhormones and  
biotechnology from question 2 
FoodTechConcern  
 
Below is a list of the dependent and independent variables with a hypothesis summary of how 
the variable will behave with consideration to the major topic study:   
 
4.3.1 Dependent Variables 
Given the focus of the study, in order to understand consumer’s perception of animal cloning, 
it was important for us to ask about the respondent’s likelihood of consuming products derived 
from cloned animals.  However, a simple “yes” or “no” response would not allow for a precise 
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enough assessment of what consumers might be likely to do when provided with all the 
information they might have in the marketplace.  That information would include price, 
government approval, any information on the label, and the actual appearance of the products.  
The survey was designed to provide additional information about cloning as the respondent 
progressed through the instrument, and to assess the impact of that additional information on 
their likelihood of consuming a cloned product.  Thus, the question about likelihood of 
consuming a cloned product was asked three times, with information about safety and price 
interjected between the repeated questions.  Responses to those three questions, as described 
below, provide data on the dependent variable in a series of regression models.   
 
1. Question 5: Likelihood of consuming meat from cloned animals (Likely 1) 
How likely are you to buy and eat meat from cloned animals? 
 This question was designed to elicit the initial reaction on the likelihood of 
consuming cloned product. Answer options were on a Likert scale from 1= Not at 
all Likely, to 3 = Somewhat Likely, to 5 = Very Likely. 
Note that the question deals only with meat from cloned animals and not with 
meat from the offspring of clones.  This was a strategic decision made to keep the 
survey instrument as simple as possible.  A number of studies have found that 
respondents make little or no distinction between products from clones and those 
from clone offspring (Lusk 2008, Brooks and Lusk 2010, Sosin and Richards 
2005). However, our results pertain only to products derived from clones 
themselves.  
 
2. Question 7: Likelihood of consuming meat from cloned animals after being 
informed about EFSA/FDA safety assessments (Likely 2) 
 The question was worded as follows: “Both the United States Food & Drug 
Administration (FDA) and the European Food Safety Authority (EFSA) have 
determined that meat and dairy products from cloned animals and their offspring 
are no different from products derived from conventionally bred animals, and thus 
are safe for human consumption. Knowing this, if meat from cloned animals were 
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being sold in your local grocery stores, how likely would you be to buy and 
consume it?” 
  Responses were elicited using the same Likert scale used in question 5. 
Individual responses to this question allow us to investigate the effect of 
providing information about product safety (or, more accurately, assessments of 
product safety by government agencies) on the respondent’s likelihood of 
consuming cloned product.   
 Government has traditionally played a large role in regulating food products, 
including the technologies used in production and the steps necessary in ensuring 
food safety.  In 2008, both the FDA and the EFSA released statements which gave 
the green light to human consumption of products derived from cloning 
technology.  China, Japan, and New Zealand have all copied or referenced the 
2008 FDA assessment in their own regulations, indicating the international 
respect for the FDA opinion. Theoretically, given this additional piece of 
information, respondents should increase their stated likelihood of consuming 
cloned product.  However, it is expected that the degree of consumer trust in 
government will impact any change in their likelihood rating between question 5 
and question 7 (Sosin and Richards 2005, Lusk 2008).   
 
3. Question 8: Likelihood of consuming meat from cloned animals at a 10% price 
discount (Likely 3) 
  The question was worded as follows: “If the price of meat from cloned animals 
was 10 percent lower than meat from conventional animals, would you be likely 
to buy and consume meat from cloned animals?” 
 Responses were elicited using the same Likert scale used in question 5.  
Individual responses to this question allow us to investigate the effect of price 
reduction might have on the respondent’s likelihood of consuming cloned 
product.   
 Price is of universal importance to consumers worldwide.  For centuries science 
and technology has attempted to find ways of increasing production while at the 
same time decreasing cost.  Since the early 2000’s, cloning technology has made 
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significant advances and is out of the laboratory and instead currently being used 
in the mainstream beef industry, primarily for high valued breeding animals.  One 
potential benefit of cloning is enhanced production efficiency, which could lead to 
cost saving being passed onto the consumer.  It is expected that some respondents, 
those who are more price conscious, may increase their stated likelihood of 
consuming cloned product in a situation where the product price is more 
competitive.   
 
4.3.2 Independent Variables  
The survey collected information on several variables that might be related to an 
individual’s likelihood of consuming cloned product.  The questions used to collect that 
information are described below.   
 
1. Collector List  
Each subsample (or collector) in the study was identified using a dummy variable.  Collector 
dummy variables include those for the Kansas State University classes in Agricultural 
Economics, English, and Sociology, European collectors for University College Dublin, 
Ireland and Purpan School of Agriculture in France, a Latin American collector dummy 
variable for Universidad de Zamorano in Honduras, and an Asian collector dummy variable 
for the Beijing Vocational College of Agriculture 
 
a. Kansas State University 
Prior work has found that American consumers are more accepting of animal cloning 
(Hoban 1999)  At Kansas State University, it is likely that some students, particularly 
those in the College of Agriculture, are familiar with advanced agro-biotechnologies 
which could ease their concern about consuming cloned product  
i. Agriculture Economics – Likely originating from agriculture backgrounds, 
this subgroup is expected to be more accepting of animal cloning.  Because 
cloning has become more widely accepted by Americans (Hoban, 2001, 1999) 
(The Mellman Group, Inc 2006), and utilized by cattle producers in the United 
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States (Coover 2010), there is a chance that some of these students have either 
directly or indirectly been involved in animal cloning themselves.  
ii. English – Because undergraduate English is a required course in many majors, 
the students will come from a wide variety of backgrounds. Responses from 
this sub group may be more representative of the general student body 
population and perhaps more representative of US consumers in general.   
iii. Sociology – While Sociology is a required course for some majors, it is 
required by fewer than those majors that require English.  Because of this, it is 
probable that this class contains more students with a liberal arts interest who 
may be less accepting of animal cloning.  
 
b. University College Dublin of Ireland 
Europeans are known to be uncomfortable with biotechnology and animal cloning 
(Hoban 1999, 2001; Carlene 2007; European Commission 2008) and Ireland is no 
different. The 2008 Eurobarameter poll found that only 35% of Irish respondents 
were likely to consume products from cloned animals while 46% were not at all 
likely. Compared to the US agriculture students (Agricultural Economics), the 
expectation is that this sample of Irish undergraduate students in Agriculture will be 
less accepting of cloning.      
 
c. Purpan School of Agriculture of France 
The same 2008 Eurobarameter poll found that only 30% of French respondents were 
likely to consume cloned product, and 45% were not at all likely to consume 
(European Commission 2008).  In general, the French have been vehemently opposed 
to biotechnology for many years and are unlikely to have a favorable view of an 
American originated agricultural biotechnology.  The expectation is that the French 
agriculture students will be less accepting of cloning than their US counterparts (in 
Agricultural Economics).   
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d. Universidad de Zamorano of Honduras 
Very little research has been done on consumer perceptions of biotechnology in Latin 
American countries and therefore there is no established base of comparison between 
Latin America and the US.  The work that has been conducted shows that 
“biotechnology has had little effect on farmers or consumers in Latin American and 
the Caribbean” (Trigo, et al. 2002). Because many Latin American countries are low 
income, most people do not have the luxury of purchasing specialty foods but are 
more concerned about sustenance consumption.  The hypothesis for this study is that 
results will show strong opinions towards animal cloning because it is a survey 
conducted from educated students with backgrounds in agriculture production; 
however, those opinions will not affect consumption perceptions and therefore will be 
more lenient toward products derived from animal cloning.    
 
e. Beijing Vocational College of Agriculture in China 
Several studies have been done on Chinese consumer perceptions of advanced 
agricultural biotechnologies; however, the results from those are mixed (Huang, et al. 
2005, Li, et al. 2002).  For all its advances, China is still a developing country and 
many consumers base their diet choices on sustenance consumption.  Therefore they 
are less concerned with how the food is produced, but rather how it looks before it is 
consumed (Bieroth, Tucker and Anderson 2010). The hypothesis is similar to 
Honduras in that, there will be low overall perceptions of cloned product, but it may 
not affect likelihood to consume cloned product.  As with Honduras, no hypothesis is 
proposed regarding how assessments of cloning from this sample might compare to 
that of their US counterparts.  
 
2. Question 1: Consumption 
“Approximately how often does your household consume beef, chicken, or pork meat 
products?” 
 The question was designed to quantify meat consumption.  Answer options were: 1 = 
Almost every day, 2 = 3-4 times a week, 3 = About once a week, 4 = Less than once a 
week, 5 = Never – we have eliminated meat products from our diet.  These values 
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were reversed during data entry so that higher values would correspond to higher 
levels of meat consumption, i.e., 0 = never consume, up to 4 = almost every day.  
 The expectation is that higher levels of meat consumption would be correlated with a 
higher willingness to consume cloned meat product.  Individuals who consume meat 
less frequently may be more health conscious and may wish to avoid, for various 
reasons, products that involve use of new and “non-natural” technologies.  If 
individuals with higher levels of consumption are more likely to consume cloned 
product this suggests that there would be less of a negative impact on overall meat 
consumption if unlabeled cloned products were introduced to the market.   
 
3. Question 2: Meat Product Concern 
“With regard to meat products, how concerned are you about the issues listed below?” 
 The question was designed to evaluate concern about various issues related to food 
including cloning.  Answers were elicited on a five point Likert scale from 1 = Not 
concerned to 5 = Very concerned. Level of concern was elicited about the following 
nine issues: Packaging, Price, Food handling/preparation, Ingredients, Foodborne 
pathogens, Chemicals/Pesticides, Use of hormones, Biotechnology, and Cloning.  
Comparison of the stated levels of concern across the different issues allows an 
assessment about the relative degree of concern about cloning compared to other food 
issues. The stated level of concern about some of these issues is hypothesized to be 
related to the individual’s likeliness to consume cloned product.  
 
 Packaging 
Overall level of concern for packaging is expected to be low. It is unlikely to have a 
relationship with likelihood of consuming cloned product.   
 
 Price 
If consumers are more concerned about the price of their food, they may be less likely 
to be concerned about advanced production technologies such as cloning, which may 
be viewed as means of making production more efficient and thereby lowering price.   
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 Handling/Preparation 
As for packaging, concern about handling should be relatively low, particularly in 
higher income countries with advanced food safety protocols such as the US and 
Europe.  This factor is unlikely to be related to likelihood of consuming cloned 
product.  
 
 Ingredients 
The concern about ingredients would be expected to exceed that for packaging or 
handling.  While the internal makeup of products is often a concern for many 
consumers, this factor is unlikely to have a strong correlation with likelihood of 
consuming cloned product.  The reason being, consumers will be able to delineate 
that cloning is not an ingredient but rather a production process.  
 
 Foodborne Pathogens 
Foodborne pathogens such as E.coli and Salmonella have attracted significant media 
attention in the US in recent years.  Concern about this issue is expected to be 
relatively high in higher income countries.  If individuals perceive cloning as having 
negative implications for food safety, higher levels of concern about foodborne 
pathogens may be related to a lower likelihood of consuming cloned product, but that 
relationship is not expected to be strong.   
 
 Chemicals/Pesticides 
As for foodborne pathogens, the expressed level of concern is expected to be 
relatively high compared to other issues, but it is not expected to have a strong 
correlation with likelihood of consuming cloned product.    
 
 Use of Hormones 
The more concern the individual expresses about hormone use the less likely they 
may be to consume cloned product.  Many consumers are aware and concerned about 
the residues from additive hormones in food products (International Food Information 
Council 2008).  It has been a highly publicized topic that for many consumers 
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becomes a “perception filter causing bias between reality and scientific evidence on 
the one hand and consumer perception of this reality on the other hand” (Verbeke, et 
al. 2006).  In addition, the concern has been capitalized on in the form of an entirely 
new segment of the agriculture industry including organic and natural.  Because of 
this, many consumers, especially those in the developed nations and including China 
(Bieroth, Tucker and Anderson 2010), will have strong negative opinions about the 
issue.  The only group that may not be as concerned will be those from agricultural 
backgrounds.  
 
 Biotechnology 
The expectation is that the expressed level of concern about biotechnology will be 
highly correlated with that about use of hormones, and that both will be negatively 
correlated with likelihood of consuming cloned product.  To avoid multicollinearity 
issues, the average level of concern about hormones and biotechnology (a variable 
labeled ‘foodtechconcern’) will be included in models explaining variation in 
expressed likelihood of consuming cloned product.   
 
 Cloning 
Expressed level of concern about cloning will be compared to level of concerns about 
other issues, particularly foodborne pathogens, to ascertain the relative level of 
concern consumers have about the technology.  Expressed concern about cloning is, 
of course, expected to have a strong negative correlation with likelihood of 
consuming cloned product.  However, since both questions are essentially measuring 
the same thing, level of concern would effectively be a dominant variable in models 
explaining variation in likelihood of consumption, and for that reason will not be 
included in those models.   
 
4. Question 3: Attention to Labels 
“Other than the price, do you pay attention to marketing labels on meat packaging?” 
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 The question is designed to see how much attention is paid to marketing labels on 
product packages.  Answer options include: 1 = Don’t Know, 2 = Not At All, 3 = A 
Little, 4 = Some, 5 = A Lot.  
 Increased level of attention to labels is expected to be negatively correlated with 
likelihood of consuming cloned product, although that relationship may not be strong.  
Labeling products with specific types of information is a high stakes and often 
contentious discussion between policy makers, producers, and consumers.  Numerous 
studies have been published trying to weigh the objectivity between what consumers 
need to know for proper marketplace decision making compared to what information 
may alienate advanced production technologies (Nonis, Hudson and Hunt 2010, 
Gruere and Rao 2007, Raab and Grobe 2003).  If consumers pay attention to labels, 
they are either looking for product attributes they want to buy or attributes they want 
to avoid.   At present, the US Food and Drug Administration (FDA) consider products 
derived from clones to be identical to those from animals produced conventionally. 
For that reason, FDA does not require labeling of products derived from clones.  
However, it will treat on a case by case basis requests for approval of ‘negative 
labeling’ – i.e., labels indicating that product is not derived from cloning.  If such 
labels are introduced, consumers who pay more attention to labels will likely seek out 
those products.    
 
5. Question 4: Perceived Knowledge of Biotech 
“How much do you know about biotechnology, cloning, genetic engineering, or genetic 
modification?” 
 The question is designed to elicit the respondent’s perceived knowledge about 
advanced reproductive technologies.  Answer options are: 1 = Nothing, 2 = Very 
Little, 3 = A Fair Amount, 4 = A Great Deal.  
 Perceived knowledge may have an important influence on how a consumer will react 
to advanced reproductive technologies including cloning.  In general, consumer 
knowledge about cloning technology is low (Hoban 2001, International Food 
Information Council 2008, Lusk 2008, The Mellman Group, Inc 2006).    But as 
Knight (2005) discusses in his study on perceived versus objective consumer 
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knowledge, consumers “may be more likely to make purchase decisions based on 
their perceived level of knowledge even if that information is erroneous” (Knight 
2006).  While consumers are likely to exaggerate their level of knowledge (Knight 
2006), the hypothesis is that higher self-reported knowledge of technology will be 
positively correlated with likelihood of consuming cloned product.   
 
6. Question 6: Reasons for Discomfort with Cloning 
“Which one of the following is the main reason you would be uncomfortable with eating 
meat from cloned animals? Please choose one.” 
 This question tries to narrow down the primary reason for discomfort with animal 
cloning.  Respondents were allowed to choose one from a list of 7 responses 
including 1 = Animal cloning is morally wrong, 2 = Unsure of food safety from 
cloned animals, 3 = Animal cloning might lead to human cloning, 4 = Unsure that 
cloning is safe for animals, 5 = Don’t know, 6 = Not uncomfortable, and 7 = Don't 
care. In the web-based survey, respondents were prevented from choosing more than 
one of the 7 response options.  However, in the Chinese sample, where data was 
gathered on hard copies, several respondents chose more than one option from the 
list.  Dummy variables were created to identify individuals who opposed cloning for 
the different reasons presented.  These dummy variables will be included in models 
examining variability in the likelihood of consuming cloned product in an effort to 
ascertain the relative strength of opposition from individuals holding different 
objections to the process.  
 The more specific information available on why consumers are concerned about 
animal cloning, the easier it will be to target information designed to reassure them 
about the technology.  Based on numerous studies since early 2000, the most 
commonly cited objections to cloning have been the moral and ethical elements as 
well as overall uncertainty about the technology (Hoban 2001, Sosin and Richards 
2005, The Mellman Group, Inc 2006, The Mellman Group, Inc. 2005, International 
Food Information Council 2008, Gallup, Inc. 2009, Nonis, Hudson and Hunt 2010, 
Lusk 2008).  However, few surveys have narrowed down the actual reason why 
consumers, assuming they do, have a problem with animal cloning.   
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i. Animal Cloning is Morally Wrong – Nearly every survey done on animal 
cloning shows that some consumers have strong moral concerns about the 
technology (Hoban 2001, Sosin and Richards 2005, The Mellman Group, Inc 
2006 - 2005, International Food Information Council 2008, Gallup, Inc. 2009, 
Nonis, Hudson and Hunt 2010, Lusk 2008).  If respondents feel that cloning is 
morally wrong they are likely to be more adamant in their unwillingness to 
consume cloned product. 
ii. Unsure of food safety from cloned animals – Most surveys have mentioned 
food safety as a concern about animal cloning (Hoban 2001, Sosin and 
Richards 2005, The Mellman Group, Inc 2006- 2005, International Food 
Information Council 2008, Gallup, Inc. 2009, Nonis, Hudson and Hunt 2010, 
Lusk 2008).  As with those who consider cloning morally wrong, individuals 
who believe cloning is a food safety concern are likely to be less willing to 
consume cloned product.  However, reassurances about the safety of the 
technology may resonate with these individuals more than with those who 
believe the technology is morally wrong.   
iii. Animal cloning might lead to human cloning –The idea that animal cloning 
could lead to human cloning is frequently mentioned in newspaper articles 
and online blogs (Roberts 2008, Gallup, Inc. 2009).  Again, respondents who 
feel cloning is a slippery slope to human cloning or feel that human cloning 
criminal, will be less likely to consume cloned product.    
iv. Unsure that cloning is safe for animals – Many reports point out that while the 
technology of animal cloning is advancing, it still struggles with a low success 
rate.  The FDA and EFSA point out that there are safety concerns for both the 
surrogate female and the cloned animal during the process (Food and Drug 
Administration 2008, European Food Safety Authority 2009).  Anti-cloning 
activists draw attention to high animal mortality rates in hopes of swaying 
consumers and legislators against the technology (HSUS 2010).  The 
expectation is that respondents who believe cloning is unsafe for animals will 
be less likely to consume cloned product.    
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v.  Don’t Know, Not Uncomfortable, and Don't Care – These categories were 
included to provide as complete a set of response options as possible for 
respondents.  
 
7. Question 9: Gender 
“What gender are you?” 
 Response options, as coded by SurveyMonkey, were 1 = Male and 2 = Female.  
These were transformed into a dummy variable for Female gender, where the variable 
took a value of 1 for female respondents, and 0 otherwise.  
 Based on some results from the literature (Hoban 1999, Knight 2006, Albrecht 2003) 
females are expected to be less likely to consume cloned product.   
 
8. Question 10: Religious Affiliation 
“Do you have a religious affiliation?” 
 This question is aimed at identifying respondents with a religious preferences.  
Answer options included 1= Yes, 2 = No, and 3 = Prefer not to answer. These 
responses were transformed into a dummy variable (labeled Religious) which took a 
value of 1 for respondents indicating a religious affiliation, and 0 otherwise 
 One of the controversies surrounding animal cloning is the moral or ethical objection 
consumers have to the technology (Hoban 2001, Sosin and Richards 2005, The 
Mellman Group, Inc 2006 - 2005, International Food Information Council 2008, 
Gallup, Inc. 2009, Nonis, Hudson and Hunt 2010, Lusk 2008).  Several studies which 
have shown a negative relationship between acceptance of biotechnology and 
religious affiliation (Knight 2006, Biel and Nilsson 2005)  The theory is that 
consumers who hold religious values may be less supportive of cloning and 
biotechnology in general because the science changes the natural order of nature.  By 
modifying or manipulating the natural order, scientists are also modifying the creation 
of God (Biel and Nilsson 2005).   The expectation is that individuals with a religious 
affiliation will be less likely to consume cloned product.    
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9. Question 11: Farm Background 
“Are you from a farming or ranching background?” 
 Response options were 1 = Yes (agriculture background), or 2 = No, which again was 
transformed into a dummy variable for agricultural background ( 1 = yes, 0 = no). 
 While some of our subsamples targeted students in Agricultural programs, not all of 
those students will necessarily come from a farming background, and some in our 
other samples may come from that background.  Respondents from an agricultural 
background may be more familiar with and more accepting of new reproductive 
technologies (although there is a possibility that this variable may be correlated with 
one measuring self-reported knowledge of technology).   
 
10. Question 12: Social Issues 
“Considering sociopolitical issues, would you consider yourself more:” 
 This question is intended to find the political disposition of the respondent.  Response 
options included: 1= Conservative, 2 = Moderate, 3 = Liberal, 4 = No Affiliation, 5 = 
Liberal on some, Conservative on others, 6 = Other, 7 = Prefer not to answer.  
Responses were used to create dummy variables corresponding to the different 
response options.    
 While sociopolitical disposition is often used in sample descriptive statistics, it is 
rarely used in econometric modeling to explain, for example, consumer attitudes 
toward or perceptions of biotechnology.  Oftentimes liberals and conservatives tend 
to be at odds with one another; however, for animal cloning it seems they are at odds 
with one another for different reasons.  Surveys show that liberals tend to be more 
self-protective and therefore more skeptical about biotechnology and its unintended 
consequences on the environment (Hossain, Onyango and Adelaja, et al. 2002, 
Hossain and Onyango 2004).  However, conservatives tend to be more religious 
(Layman and Carmines 1997) and for that reason may also have a negative view of 
technologies such as cloning.  The dummy variables created from the responses to 
this question will allow for testing of various hypotheses such as “self identified 
liberals are less likely than others to consume cloned product.”  Given the potential 
offsetting effects mentioned, no hypotheses are put forward for the signs of these 
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effects, but it is expected that they would be relatively small after controlling for 
other covariates (knowledge of cloning, etc).   
 
11. Question 13: Age 
“Please select your age bracket” 
 Response options included 1 = 20 or younger, 2 = 21 – 25, 3 = 26 – 30, 4 = 30 – 35, 5 
= 35 – 40, 6 = 40 – 45, 7 = 46 – 50, 8 = 51 – 60, 9 = 61 – 70, 10 = 71 – older.   
 Given the targeted samples used in this study most respondents are likely to be of 
college age.  However, in some subsamples the survey may have been delivered to a 
broader group, perhaps including college faculty.  If that occurred, the responses to 
this question would allow for limiting the sample to the target group of 
undergraduates (note that the survey does not include a question about the 
respondents profession or employment status).   However, the main reason for 
including the question was to facilitate extension of the survey to other samples that 
might include adults.  Some studies have shown that respondent age is related to 
acceptance of cloning, but the effect is rarely significant (Knight 2006, Lusk 2008).  
Lusk 2008 found that age was negatively correlated to willingness to consume 
products from cloned animals.  
 
12. Question 14: Education 
“What is the highest level of education you have completed?” 
 Response options included 1 = Some high school, 2 = High school graduate, 3 = 
Some college, 4 = College graduate, 5 = Post graduate, 6 = Other. Similar to the 
question about age above, the main reason for including this question was to facilitate 
extending the survey to other samples in which responses would show more 
variability than in our targeted samples.   
 Surveys have found those with only high school diplomas are less supportive of 
eating product derived from cloned animals while those with bachelor degrees or 
higher are slightly more likely to consume, but still have low acceptance (Lusk 2008, 
Knight 2006, The Mellman Group, Inc 2006).  Our targeted respondents should all be 
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working toward a bachelor’s degree and therefore should have marked 2 or 3.  
However, some that may have marked 4 in anticipation of obtaining the degree.   
 
13. Question 15: Income 
“In order to evaluate if we are getting a cross section of all people, we would like to know 
your approximate 2008 household income before taxes?” 
 Answer options included 1= less than $20,000, 2 = $20,000 –30,000, 3 = $30,000 – 
$40,000, 4 = $40,000 – $50,000, 5 = $50,000 – $70,000, 6 = $70,000 – $100,000, 7 = 
$100,000 – $150,000, 8 = more than $150,000, 9 = Prefer not to answer.  .  For 
samples outside the US the currency values were converted to local values (European 
Union euro (€),Honduran lempiras (L), Chinese renminbi (¥)) that roughly 
corresponded to the values in the United States survey. For example, in the French 
and Irish surveys, response option 8 was “more than €110,000.”       
 Income is an important factor in demand and acceptance models because purchase 
behavior is, in theory, directly linked to the respondent’s disposable income.  
Interestingly, the literature is relatively sparse on findings relating income to 
consumer perceptions of animal cloning.   Respondents with higher incomes are 
generally more accepting of biotechnology in general (Albrecht 2003) and only 
marginally more accepting of animal cloning (Lusk 2008). In our sample however, 
the question is probably unnecessary.  The majority of respondents were college age 
whose own income would likely be in the lowest category.  However, some 
respondents may have reported their parent’s income, particularly if they still lived at 
home.  For those reason the models presented later will not include income as an 
explanatory variable.  
 
14. Question 16: People in Your Household 
“Including yourself, how many people live in your household?” 
 This question is designed to identify families and total number of mouths being fed in 
the house.  Answer options included 1 = 1 person, 2 = 2 people, 3 = 3 people, 4 = 4 
people, 5 = 5 people, 6 = more than 5.   
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 Again, this question was unnecessary given our target audience.  In a broader survey 
however, this question, in conjunction with household income would serve to help 
estimate the relative disposable income of different respondents.   
 
15. Question 17: Children living in the household 
“Are there any children living in your household?” 
 Answer options included 1 = Yes and 2 = No for both “Under age 6” and “Between 6 
and 18”. 
 In a broader sample, this could be an important variable. Families with young 
children are generally more concerned about the food they purchase.  Lusk (2008) 
found that respondents with children under the age of 12 were less likely to believe 
product derived from cloned animals was safe to eat.  But because this sample mainly 
includes college age students who likely do not have children, the variable will be 
unnecessary.    
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5 Describing Data 
Below are the descriptive statistics for the entire data set.  It is important to note that not 
every question had the total 644 observations, due to some non-responses to individual questions 
in the Chinese sample.  
 
Table 5-1: Descriptive Statistics 
Variable Total Observation Mean Std. Dev. Min Max 
Dependent Variables      
Likeliness to Consume (1) 644 2.188 1.227 1 5 
*Government Approval (2) 644 2.523 1.357 1 5 
**Price Reduction (3) 644 2.587 1.366 1 5 
Independent Variables      
meatconsume 644 3.244 0.995 0 4 
Concern about food       
packaging 642 2.804 1.326 1 5 
price 644 3.905 1.102 1 5 
foodhandlingpreparation  641 3.754 1.175 1 5 
ingredients 641 3.657 1.245 1 5 
foodbornepathogens 642 3.879 1.308 1 5 
chemicalspesticides 639 3.573 1.369 1 5 
useofhormones 641 3.399 1.464 1 5 
biotechnology 640 2.897 1.397 1 5 
cloning 640 2.98 1.513 1 5 
foodTechConcern***  639 3.15 1.302 1 5 
attention (to labels) 643 3.488 1.133 1 5 
knowtech 643 2.356 0.846 1 4 
Concern about cloning**** 696     
morallywrong 123 0.191 0.393 0 1 
foodsafety 232 0.36 0.48 0 1 
humancloning 74 0.115 0.319 0 1 
animalsafety 101 0.157 0.364 0 1 
dontknow 65 0.101 0.301 0 1 
notuncomfortable 51 0.079 0.27 0 1 
dontcare 50 0.078 0.268 0 1 
Demographic Variables      
female 644 0.452 0.498 0 1 
farm (background) 641 0.64 0.48 0 1 
Politics 639 3.562 1.73 1 7 
Liberal 644 0.14 0.347 0 1 
Moderate 644 0.517 0.5 0 1 
Conservative 644 0.134 0.34 0 1 
Other/No Affiliation 644 .0931 .291 0 1 
age 644 1.845 0.644 1 4 
education 644 3.632 0.866 1 6 
income 636 4.89 3.494 1 9 
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* Likelihood of consuming cloned meat after receiving information about government approval. 
** Likelihood of consuming cloned meat contingent on 10% price reduction 
*** FoodTechConcern is an average of useofhormones and biotechnology 
****Concern about cloning does not sum to 644 due to multiple responses from some Chinese respondents 
 
 
5.1 Response Rates and Timeline 
The online survey was conducted at four universities in four countries including Kansas 
State University, Manhattan, Kansas; University College Dublin, Dublin, Ireland; Ecole 
Superieure d’Agriclture de Purpan, Purpane, France; and Escuela Agricola Panamericana 
Zamorano, Honduras.  In China, the data was collected using hard copies distributed by hand.  
Table 5-2 provides detail about the samples and response rates.   
The total number of responses was 714.  However, a number of responses were dropped 
from the final sample either due to incomplete answers or because of incompatibility with the 
desired sample group.  A total of 429 responses were obtained from the online surveys with U.S., 
Irish and French respondents, from which 19 were dropped due to incomplete responses.  In 
these cases, the respondent would begin but fail to complete the survey.  In Honduras, the survey 
was made available to a much broader sample of respondents than was the case in any of the 
other online surveys.  The total number to which it was made available was estimated to be 2,000 
and the sample included not only undergraduate students but also staff and faculty at the 
University.  Using responses to the age and education questions, 40 of the 134 responses were 
dropped because they were clearly not from undergraduate respondents.  Because the Chinese 
respondents completed the survey using a paper copy, we had less control over how the survey 
was completed.  Due to incomplete responses, 11 of a total of 151 responses were dropped.  The 
final sample size was 644.   
  
household 638 3.378 1.521 1 6 
under6 575 0.08 0.272 0 1 
from6to18 574 0.22 0.414 0 1 
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Table 5-2: Survey Completion Summary 
 Sampled Total Received 
Total 
Completed 
Completed 
Response Rate 
Agricultural Economics (AgEcon) 70 61 59 84.29% 
English 53 46 46 86.79% 
Sociology          43          34          30     69.77% 
TOTAL USA 166 141 135 81.33% 
Ireland 584 123 112 19.18% 
France 320 165 163 50.94% 
Honduras 2000 134 94 4.70% 
China 152 151 140 92.11% 
TOTAL 3222 714 644 19.99% 
 
Understanding the survey timeline is important due to the potential influence media 
attention given to animal cloning could have on the respondents (Neeteson, et al. 1999, Hoban 
2001, Hoban 2004).  This data was collected over a period of approximately 10 months between 
December 2009 and October 2010.  During that period, there were few significant developments 
relative to cloning and relatively little media attention was given to the issue.  Data was first 
collected from the classes at Kansas State University in December 2009.  The survey was made 
available on 12/07/2009 with the majority of responses received by December 16, 2009.  In 
France and Ireland, the survey was made available in April 2010 (beginning 04/11/2010 in 
France, and 04/12/2010 in Ireland).  Responses were gathered for a period of about one month 
with collection shut off on 05/12/2010.  It is important to note that all responses from the USA, 
Ireland, and France were received prior to the renewed European debate on animal cloning in 
July 2010 (Novel Foods Act 2010).  In Honduras, the survey was made available for almost three 
months from 06/30/2010 until being shut off 09/05/2010.  The link was emailed twice to the 
sample in an effort to boost the response rate.  The majority of responses came in the second 
month of availability.  For the Chinese survey, the PDF file was emailed to the collaborator in 
Beijing in August 2010.  Copies of the survey were passed out in several classes then collected 
and posted in the mail back to the U.S. on 10/25/2010.   
 
 
5.2 Respondent Demographic Characteristics 
Given the final 644 respondents, the figures and tables below compare the demographic 
characteristics between each respondent group.  Note that the targeted population for this study 
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was students attending university. Figure 5.1 shows the gender composition of the sample. The 
final dataset contains a relatively even split of males at 45% and females at 55%. In the U.S. 
sample, there is a slight majority of male respondents but within the individual classes 
comprising the U.S. sample there is some variability with a majority of males in the AgEcon 
class and a majority of females in the English class. The Sociology class is more closely 
balanced. The Irish and French samples have slightly more females than males, while the 
opposite is true with the Honduran and Chinese samples.        
 
Figure 5-1: Gender Composition of the Sample 
 
  
Figure 6-2 shows the age distribution of the sample.  As already noted, the samples were 
selected to focus on undergraduate students and for that reason most respondents are under the 
age of 25.  It is interesting to note that only France and China included students primarily from 
the ages of 20 or younger and 21 – 25.  The data from the USA, Ireland, and Honduras included 
at least some respondents aged 26 or older. 
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Figure 5-2: Age Composition of the Sample 
 
 
Table 6-3 contains data on the other demographic information collected from 
respondents.  As expected 49% of respondents stated they had completed some college with an 
additional 28% indicating they were a college graduate. Income levels are also relatively uniform 
but, as expected, many respondents, 34% in total, chose the “prefer not to answer” response.  In 
the Chinese sample, over 70% chose that response.    
Responses to questions about household composition were very diverse as expected in a 
sample focused on students.  Forty-six percent indicated that they lived in households with either 
three or four people.  The French sample was notably different with over 37% indicating they 
lived in a single person household.  As expected for this sample, less than 10 percent indicated 
that the household included a child under the age of 6 years.  An exception was the Honduran 
sample, with over 30% from a household with a young child.  While it is not uncommon for 
college students to have young children, the Honduran data may reflect a greater societal 
tendency for extended family members to live together.   
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Table 5-3: Other Demographic Characteristics 
AgEcon  English Sociology Ireland France Honduras China Total
N  % Freq.  N  % Freq. N % Freq. N % Freq. N % Freq. N % Freq. N % Freq. N % Freq.
Total Number  59     46 30 112 163     94 140 644
         
Education Level          
Some High School  0  0.00%  0 0.00% 0 0.00% 0 0.00% 1  0.61% 0 0.00% 1 71.00% 2 0.31%
High School Graduate  4  6.78%  2 4.35% 0 0.00% 8 7.14% 2  1.23% 0 0.00% 6 4.29% 22 3.42%
Some College  54  91.53%  39 84.78% 23 76.67% 47 41.96% 19  11.66% 26 27.66% 109 77.86% 317 49.22%
College Graduate  1  1.69%  5 10.87% 7 23.33% 36 32.14% 70  42.94% 47 50.00% 15 10.71% 181 28.11%
Post Graduate  0  0.00%  0 0.00% 0 0.00% 20 17.86% 70  42.94% 21 22.34% 3 2.14% 114 17.70%
Other   0  0.00%  0 0.00% 0 0.00% 1 0.89% 1  0.61% 0 0.00% 6 4.29% 8 1.24%
         
Income          
less than $20,000  24  40.68  21 45.65 13 43.33% 7 6.25% 82  50.31% 46 48.94% 16 12.12% 209 32.45%
$20,000 ‐ $30,000  5  8.47  8 17.39 5 16.67% 11 9.82% 4  2.45% 12 12.77% 6 4.55% 51 7.92%
$30,000 ‐ $40,000  1  1.69  3 6.52 1 3.33% 10 8.93% 5  3.07% 6 6.38% 4 3.03% 30 4.66%
$40,000 ‐ $50,000  4  6.78  2 4.35 0 0.00% 18 16.07% 5  3.07% 0 0.00% 1 0.76% 30 4.66%
$50,000 ‐ $70,000  3  5.08  0 0.00% 2 6.67% 10 8.93% 3  1.84% 4 4.26% 5 3.79% 27 4.19%
$70,000 ‐ $100,000  6  10.17  4 8.7 1 3.33% 11 9.82% 2  1.23% 3 3.19% 0 0.00% 27 4.19%
$100,000 ‐ $150,000  5  8.47  2 4.35 2 6.67% 11 9.82% 1  0.61% 0 0.00% 3 2.27% 24 3.73%
more than $150,000  3  5.08  1 2.17 2 6.67% 4 3.57% 1  0.61% 3 3.19% 4 3.03% 18 2.80%
Prefer not to answer  8  13.56  5 10.87 4 13.33% 30 26.79% 60  36.81% 20 21.28% 93 70.45% 220 34.16%
         
People in Household          
1 person  11  18.64  6 13.04% 4 13.33% 7 6.25% 61  37.42% 6 6.38% 1 0.75 96 14.91%
2 people  6  10.17  8 17.39% 8 26.67% 17 15.18% 35  21.47% 14 14.89% 5 3.73 93 14.44%
3 people  10  16.95  10 21.74% 6 20% 16 14.29% 29  17.79% 10 10.64% 59 44.03 140 21.74%
4 people  20  33.9  15 32.61% 4 13.33% 22 19.64% 21  12.88% 21 22.34% 53 39.55 156 24.22%
5 people  8  13.56  3 6.52% 3 10% 27 24.11% 11  6.75% 30 31.91% 7 5.22 89 13.82%
more than 5 people  4  6.78  4 8.70% 5 16.67% 23 20.54% 6  3.68% 13 13.83% 9 6.72 64 9.94%
         
Children in 
Household                         
Under age 6 (Yes)  2  3.51%  4 9.09% 0 0.00% 5 5.10% 5  3.16% 25 31.25% 5 4.55% 46 7.14%
Between 6 & 18 (Yes)  13  22.81%  6 13.04% 4 13.33% 42 38.89% 24  15.19% 30 40.00% 7 7.00% 126 19.57%
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5.3 Respondent Other Characteristics 
Other characteristics that were measured in the survey were religious disposition, 
political disposition, and whether or not the respondent had an agricultural background.   
The question about religious disposition was included because it was hypothesized that it 
might have an impact on likeliness to consume cloned product.  Figure 5.3 shows the distribution 
of responses for the different subsamples for religious affiliation.  The samples from the United 
States and Honduras have the highest rates of religious affiliation at 71% and 76%, respectively.  
These countries have strong religious institutions that are supported by communities throughout 
the nation (CIA 2011).  The lowest level of religious affiliation was in the Chinese sample at 
24% - a level that might be surprisingly high for a nation that defines itself as atheist.  In France 
and Ireland, 45% and 42% respectively indicate a religious affiliation which might be 
surprisingly low for countries in which the populations are majority Roman Catholic - 87.4% in 
Ireland and 83% in France (CIA 2011).  Again however, our samples are focused on university 
age students, a group among which church affiliation might be expected to be much lower than 
in the general population.      
 
Figure 5-3: Religion: Response to “Do you have a religious affiliation?” 
 
 
Regarding political predisposition, a majority of respondents identified themselves as 
“moderate”.  But looking closer to the data there were some interesting comparisons across 
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groups.  For example, the AgEcon class at K-State had a majority of conservatives, with not even 
one respondent identifying themselves as “liberal.”  Meanwhile, the English and Sociology 
classes, more like the samples from Europe, China and Honduras, had a majority of respondents 
identifying themselves as either “moderate” or “liberal.”  In Ireland, France and Honduras, fewer 
than 10 percent identified themselves as “conservative.”   
 
Figure 5-4: Political Predisposition 
 
  
Regarding the respondent’s agricultural background, figure 5.5 shows that over sixty 
percent of respondents indicated that they came from a farming or ranching background with that 
percentage varying from a low of 17 percent in the English class at K-State to a high of 97 
percent in the French sample.   
  
55.00%
17.39%
30.00% 37.04%
5.36% 4.29% 4.26%
14.07% 13.35%
32.20%
52.17% 30.00%
38.52%
43.75%
61.96% 68.09% 49.63%
51.71%
0.00%
26.09%
23.33%
14.07%
16.96%
9.20%
18.09%
14.81% 13.98%
11.86% 4.35% 16.67% 10.37%
33.93%
24.54%
9.57%
21.48% 20.19%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
AgEcon English Sociology USA Total Ireland France Honduras China Total
Conservative Moderate Liberal No Affiliation/Other
5-53 
 
Figure 5-5: Agricultural Background 
 
 
 
 
5.4 Concern for Food Product Issues 
Using a 5 point Likert scale, question 2 elicited levels of concern about different food 
related issues.   Table 5-4 shows the average reported concern for the questions about packaging, 
price, foodhandlingpreparation, ingredients, foodbornepathogens, chemicalspesticides, 
useofhormones, biotechnology, and cloning.  Many of these variables were not used in the 
model, but could provide insight into individual’s general perceptions toward food related issues.  
The average response for each food issue was found using the entire dataset (figure 5.6) as well 
as broken down for each group individually (table 5.4).  Note that these questions were asked 
before the likeliness questions were presented which gave additional information about animal 
cloning.   
Figure 5-6 shows that the order of average level of concern from largest to smallest for 
the entire dataset was price, foodbornepathogens, foodhandlingpreparation, ingredients, 
chemicalspesticides, useofhormones, cloning, biotechnology, with the lowest being packaging.  
Table 5-4 shows average concern levels broken down by each group.  The highest average 
concern was 3.91 for price indicating that consumers are more than ‘slightly concerned’ about 
that issue.  This was followed by concern about foodborne pathogens (avg.=3.88) and food 
handling (avg.=3.75).  The average response for price tended to be ranked first, second, or third 
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for each group.  Interestingly, the highest level of concern was not in the price category but 
rather the foodborne pathogens category indicated by the Honduras group (avg. =4.72).  On the 
price issue, the highest level of concern was in the French sample (avg. =4.31).    
 
Figure 5-6: Average Response for Concern for Food Issues (Total Dataset) 
 
 
Packaging (avg. = 2.80) had the lowest average level of concern, followed by 
biotechnology (avg. =2.90) and animal cloning (avg. =2.98).   These values indicate that 
consumers are only ‘slightly concerned’ about biotechnology and animal cloning.  Two of the 
lowest average values were in the AgEcon group which reported a 1.98 average level of concern 
for both biotechnology and animal cloning.  The only lower group average was also in the 
AgEcon group which had a value of 1.97 for use of hormones.  Overall, the average concerns for 
both biotechnology and cloning tended to be among the lowest ranked (7th, 8th, or 9th) concern for 
each group.  The average biotechnology value for the total dataset was not significantly different 
(indicated by superscript ‘ab’) from Ireland, China, France, English, and Honduras.  The AgEcon 
and Sociology groups indicated average levels of concern that were significantly lower than the 
overall average.  For cloning, the average level of concern was significantly higher than the 
overall average for both France and Ireland, and significantly lower for the AgEcon group.  
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From these results, it is apparent that while price concerns were the most important, 
biotechnology and cloning were among the issue of least concern to respondents.  This is 
especially interesting for this study as it deals directly with a technology respondents are only 
‘slightly concerned’ about.  
Table 5-5 is the non-grouped correlation table which shows measureable relationships 
that exist between the variables.  The largest correlation coefficient is between biotechnology 
and cloning where the correlation is 0.74.  This indicates moderate correlation and shows there is 
a positive relationship between concern for biotechnology and cloning.  In addition 
biotechnology, cloning, and use of hormones are all slightly correlated where the correlation 
coefficients are 0.66 and 0.63 for correlations on use of hormones to biotechnology and cloning, 
respectively.  These correlations are not surprising as cloning and additive hormones are 
technological subsets of biotechnology and many studies have found that consumers also see 
them as closely connected (Hoban 2001).     
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Table 5-4: Food Concerns Likert Scale Mean Values (Question 2) 
 
packaging  price  
food handling 
preparation  ingredients 
foodborne 
pathogens 
chemicals 
pesticides 
use of 
hormones  biotechnology  cloning 
  Avg.   Std. 
Dev. 
Avg.   Std. 
Dev. 
Avg.  Std. 
Dev. 
Avg.  Std. 
Dev. 
Avg.  Std. 
Dev. 
Avg.   Std. 
Dev. 
Avg.  Std. 
Dev. 
Avg.  Std. 
Dev. 
Avg.  Std. 
Dev. 
AgEcon  2.59cde  1.27  3.37f  1.11  3.56cdef 1.15 2.83e 1.16 3.34de 1.32 2.64g  1.36 1.97e 1.26 1.98f 1.18 1.98d 1.15
English  2.76bd  1.37  3.96bc  1.01  3.98b 0.93 3.59bc 1.27 3.76bc 1.25 3.46bef  1.29 3.15bc 1.32 2.80ace 1.24 2.85b 1.35
Sociology  2.70be  1.02  4.07ab  0.94  3.70bf 1.12 3.37bcd 1.27 3.27de 1.17 3.03fg  1.16 2.67cd 1.24 2.50de 0.90 2.70bc 1.24
USA  2.67cde  1.25  3.73cdef  1.08  3.73be 1.08 3.21d 1.26 3.47ce 1.27 3.01g  1.34 2.53d 1.37 2.38e 1.20 2.44c 1.29
Ireland  2.68cde  1.20  3.81be  1.09  3.86bc 1.16 3.78ab 1.12 3.87b 1.19 3.63bc  1.20 3.82a 1.30 3.12a 1.37 3.34a 1.53
France  2.20f  1.09  4.31a  0.85  3.47f 1.11 3.71bc 1.18 3.60cd 1.43 3.48cde  1.44 3.91a 1.31 3.09a 1.37 3.29a 1.49
Honduras  3.94a  1.29  3.54f  1.09  4.48a 0.88 3.96a 1.12 4.72a 0.68 4.20a  1.06 3.66a 1.35 2.73bcd 1.48 2.87b 1.57
China  2.96b  1.28  3.93bd  1.26  3.54ef 1.31 3.73ac 1.38 4.05b 1.33 3.76b  1.42 3.14c 1.49 3.12a 1.46 2.91b 1.54
TOTAL  2.80bc  1.33  3.91b  1.10  3.75bd 1.17 3.66bc 1.25 3.88b 1.31 3.57bd  1.37 3.40b 1.46 2.90ab 1.40 2.98b 1.51
a,b,c,d,e,f,g numbers sharing the same superscript are not significantly different. 
 
Table 5-5: Correlation Table for Food Concerns (Question 2)  
 
packaging  price  food handling preparation  ingredients 
foodborne 
pathogens 
chemicals 
pesticides 
use of 
hormones  biotechnology  cloning 
       
packaging  1.0000     
price  0.0830  1.0000  
foodhandlingpreparation   0.4261  0.2198 1.0000  
ingredients  0.3101  0.2607 0.5454 1.0000  
foodborne pathogens  0.3664  0.1872 0.4638 0.4922 1.0000   
chemicalspesticides  0.3304  0.1644 0.4012 0.5301 0.6307  1.0000
useofhormones  0.1592  0.1994 0.3445 0.4754 0.4570  0.6293 1.0000
biotechnology  0.1365  0.2021 0.3193 0.4515 0.3678  0.5308 0.6567 1.0000
cloning  0.1075  0.1527 0.2400 0.3446 0.3354  0.4710 0.6288 0.7431 1.0000
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5.5 Likelihood of Consuming Cloned Product 
Each of the likeliness to consume questions used a five point Likert Scale with 1= very 
unlikely, 3=somewhat likely, and 5=very likely.  The data are reported in Tables 5-4 to 5-7 and 
in Figures 5.6.  The first question about likelihood of consuming cloned product was presented 
with little prior information given to respondents.  Prior to the 2nd question, respondents were 
informed about safety assessment by the U.S. Food and Drug Administration and the European 
Food Safety Authority.  The data shows an increase in the stated likelihood of consuming cloned 
product between the first and second assessments, which can be attributed to the influence of that 
information about product safety.  On the 5 point scale, the average likelihood of consuming 
increases from 2.19 to 2.52 between the first and second assessments, an increase that is 
statistically significant at the 1% level (p = 0.00).  Average likelihood of consuming increased 
for all subsamples, but the change was not statistically significant for the French or the Sociology 
class groups.  The third question about likelihood of consuming cloned product was based on a 
scenario in which the price of cloned product was 10 percent lower than meat from 
conventionally bred animals.  Again, the average likelihood of consumption increased, from 2.52 
to 2.59 on the Likert scale, but in this case the change was not statistically significant.  The 
change was positive for all subgroups except for the Honduran respondents where the average 
likelihood of consuming fell from 3.42 to 3.35.  However, none of the differences in each 
subgroup were significant at any level, likely due to the small average increase.  The greatest 
increase was in the Sociology group where likelihood of consuming increased from 2.53 to 2.80, 
but that change was not statistically significant.  Given the experimental design, we cannot claim 
that the effect of providing information about safety exceeded that of lowering price - to do so 
we would need to randomize the order in which those pieces of information were presented 
across respondents.   
Comparing likelihood of consuming cloned product across the different subgroups shows 
that the highest likelihood is found in the AgEcon subgroup, where the average score increases 
from 3.22 in the first question to 3.80 in the third.  Meanwhile the lowest level of acceptance is 
from the Chinese group, where the average response is 1.71 to the first question, increasing to 
1.96 for the third.  Across groups within the initial likeliness level, the value for the USA sample 
(indicated by superscript ‘b’) was significantly higher than those for Ireland, France, and China 
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but significantly lower than that for Honduras.  For the second likeliness level which shows 
reaction due to government approval, the value for the USA sample is again significantly higher 
than Ireland, France, and China but is not significantly different from Honduras.  The same 
pattern is found for the average values of the 3rd likelihood of consumption question. 
While the questions presented in this survey do not measure trust in government 
explicitly, the results do measure the change in consumption as a result of government approval.  
Therefore these results can be compared to current literature which has found similar outcomes.  
Sosin and Richards (2005) show that consumers trust government agencies (FDA, USDA) most 
as reliable sources of information about animal cloning.  In addition, Lusk (2008) found that 
people who had more trust in government agencies and were convinced of the safety of cloned 
animals because of government agencies, were also highly likely to consume product from 
cloned animals.  
 
Table 5-6: Likeliness to Consume Cloned Product Likert Scale Mean Values 
  Likeliness to 
Consume (1) 
Government
 Approval (2)    Price Reduction (3) 
 
  Mean  Std. Dev.  Mean  Std. Dev.  Diff. b/w (1) & (2)  Mean  Std. Dev. 
Diff. b/w 
(2) & (3) 
Diff. b/w 
(3) & (1) 
Ag Econ  3.22a  1.27  3.73a  1.26 0.51** 3.80a 1.35  0.07  0.58**
English  2.20ce  0.96  2.94cd  1.24 0.74*** 3.17bc 1.31  0.24  0.98***
Sociology  2.10cd  1.06  2.53de  1.25 0.43 2.80cdf 1.22  0.27  0.70**
USA  2.62b  1.23  3.19bc  1.33 0.57*** 3.36b 1.36  0.17  0.74***
Ireland  1.95de  1.11  2.31ef  1.36 0.37** 2.36e 1.30  0.04  0.41***
France  1.93d  0.94  2.10fg  1.09 0.17 2.20ef 1.30  0.10  0.28**
Honduras  3.01a  1.49  3.42ab  1.38 0.40* 3.35b 1.42  ‐0.06 0.34
China  1.71f  1.00  1.94g  1.06 0.23* 1.96g 1.06  0.01  0.24
TOTAL  2.19c  1.23  2.52e  1.36 0.34*** 2.59d 1.37  0.06  0.40***
Avg Change        0.43 .10  0.53
a,b,c,d,e,f,g numbers sharing the same superscript are not significantly different. 
*,**, and *** indicates statistical significance at the 10%, 5%, and 1% levels. 
  
Figure 5-6 shows how the distribution of responses for the entire sample changed from 
the first to the second to the third question about likelihood of consuming cloned product.  This 
same data broken down by group for Likeliness to Consume (1) is shown in table 5-5, 
Government Approval (2) shown in table 5-6, and Price Reduction (3) shown in table 5-7.  
Overall, the ‘not at all likely” category fell from 40% for the first question to 30% for the third 
question.  For the 2nd question (given information about product safety), about 1 in 3 respondents 
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indicated they would be ‘not at all likely’ to consume cloned product – a proportion that 
corresponds well with previous findings.  For example, Lusk (2008) and The Mellman Group 
(2006) found a general 1/3, 1/3, 1/3 breakdown between consumers who would purchase cloned 
product, who would not purchase, and those who were unsure.   
 
Figure 5-7: Likeliness to Consume Cloned Product (Total Data)  
 
 
A closer look at the distribution of likeliness between the first to the second to the third 
question about likelihood of consuming cloned product, creates a more specific picture of the 
breakdown across groups.  First, the majority of Chinese (63%) respondents and Ireland (50%) 
respondents were initially ‘not at all likely’ to consume while Honduras (25%) respondents and 
AgEcon (22%) respondents were ‘very likely’ to consume cloned product.  With the additional 
information about government approval, all groups notably decreased in their indication of ‘not 
at all likely’ and instead shifted toward the ‘very likely category’, except France which stayed at 
40% through the change.  China showed no increase in ‘very likely’ to consume staying at 1.43% 
after learning about government approval and instead increasing to nearly 40% in the ‘somewhat 
likely’ category.  In the final likeliness to consume category, all groups consistently shifted 
stated likeliness levels toward the ‘very likely’ category.  Honduras was the only group to break 
from the pattern and increase in the ‘not at all likely’ category to a total of 16% which was met 
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with a total 2% decrease in the in between ‘4’ category to 12%.  This is consistent with the 
negative average difference Honduras shows between price reduction and government approval.   
 
Table 5-7: Likeliness to Consume (1) 
  Not At All 
Likely ‐1  2 
Somewhat 
Likely ‐ 3  4  Very Likely ‐ 5 
Ag. Econ.  8.47%  23.73% 27.12% 18.64% 22.03%
English  23.91%  43.48% 23.91% 6.52% 2.17%
Sociology  33.33%  40.00% 10.00% 16.67% 0.00%
USA Total  19.26%  34.07% 22.22% 14.07% 10.37%
Ireland  48.21%  20.54% 23.21% 4.46% 3.57%
France  40.49%  31.90% 23.93% 1.84% 1.84%
Honduras  25.53%  8.51% 29.79% 11.70% 24.47%
China  62.86%  6.43% 28.57% 0.71% 1.43%
TOTAL  40.06%  21.43% 25.31% 6.06% 7.14%
 
Table 5-8: Likeliness to Consume – Government Approval (2) 
  Not At All 
Likely ‐1  2 
Somewhat 
Likely ‐ 3  4  Very Likely ‐ 5 
Ag. Econ.  5.08%  15.25% 18.64% 23.73% 37.29%
English  13.04%  26.09% 28.26% 19.57% 13.04%
Sociology  23.33%  30.00% 26.67% 10.00% 10.00%
USA Total  11.85%  22.22% 23.70% 19.26% 22.96%
Ireland  38.39%  25.00% 12.50% 15.18% 8.93%
France  39.26%  23.93% 27.61% 6.13% 3.07%
Honduras  13.83%  8.51% 31.91% 13.83% 31.91%
China  52.86%  4.29% 40.00% 1.43% 1.43%
TOTAL  32.61%  17.24% 27.48% 10.56% 12.11%
 
Table 5-9: Likeliness to Consume - Price Reduction (3) 
  Not At All 
Likely ‐1  2 
Somewhat 
Likely ‐ 3  4  Very Likely ‐ 5 
Ag. Econ.  8.47%  11.86% 15.25% 20.34% 44.07%
English  13.04%  17.39% 28.26% 21.74% 19.57%
Sociology  20.00%  13.33% 43.33% 13.33% 10.00%
USA Total  12.59%  14.07% 25.93% 19.26% 28.15%
Ireland  33.93%  25.00% 21.43% 10.71% 8.93%
France  33.74%  29.45% 25.15% 6.13% 5.52%
Honduras  15.96%  8.51% 31.91% 11.70% 31.91%
China  50.00%  7.86% 40.00% 0.71% 1.43%
TOTAL  30.28%  17.70% 28.88% 9.32% 13.82%
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6 Ordinary Least Squares Analysis of Likelihood to Consume 
Cloned Product. 
 
The data from the Likert Scales on likelihood to consume cloned product is treated as the 
dependent variable in an Ordinary Least Squares (OLS) regression model.  Separate models were 
estimated for each subsample, and for each of the three times the question about likelihood to 
consume cloned product was posed to respondents.  Regression modeling was done using 
Stata®10 software.  
 
 
6.1 OLS Theoretical Model 
OLS is used to find the marginal impacts independent variables have on dependent 
variables.  For the purpose of this study, three models were run using three separate assessments 
of the likelihood of consuming cloned product as the dependent variable - Likeliness to Consume 
(1), Government Approval (2), and Price Reduction (3) – where Government Approval and Price 
Reduction represent likelihood of consumption following the provision of information on 
product safety from government scientists, and contingent on a ten percent price reduction 
respectively.  The independent variables hypothesized to influence likelihood of consuming 
cloned product are meatconsume, price, foodtechconcern, attention, knowtech, morallywrong, 
foodsafety, humancloning, animalsafety, female, farm, and religiousyes.  These variables were 
chosen based on their theoretically plausibility to influence a consumer’s likeliness to consume 
cloned product (see discussion in Chapter 5) without causing multicollinearity concerns in the 
model.  Equation 1.1 below is the theoretical model where ݕ௜ is represented by one of the 
dependent variables ‘Likeliness to Consume (1)’, ‘Government Approval (2)’, and ‘Price 
Reduction (3)’ representing likelihood of consuming cloned product. 
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ݕ௜ ൌ ݂ሺ݉݁ܽݐܿ݋݊ݏݑ݉݁, ݌ݎ݅ܿ݁, ݂݋݋݀ݐ݄݁ܿܿ݋݊ܿ݁ݎ݊, ܽݐݐ݁݊ݐ݅݋݊,	 
݇݊݋ݓݐ݄݁ܿ,݉݋ݎ݈݈ܽݕݓݎ݋݊݃, ݂݋݋݀ݏ݂ܽ݁ݐݕ, ݄ݑ݈݉ܽ݊ܿ݋݊݅݊݃, 
݈ܽ݊݅݉ܽݏ݂ܽ݁ݐݕ, ݂݈݁݉ܽ݁, ݂ܽݎ݉, ݎ݈݁݅݃݅݋ݑݏݕ݁ݏሻ 
(6.1) 
 
OLS regression estimates coefficients that minimize the sum of squared residuals in the 
model (Studenmund 2001).  When a set of assumptions (the so called classical assumptions – see 
Studenmund) are met, OLS estimates are unbiased and have the lowest variance of any linear 
unbiased estimator.  The classical assumptions include a zero mean for the error term, error 
terms being uncorrelated with each other and with any independent variables in the model, errors 
being normally distributed and having constant variance, and no explanatory variable being a 
perfect linear function of other explanatory variables.  The dependent variable is assumed to be 
continuous.  
 Let X be a ݊	 ൈ ݇ matrix where we have n observations on k independent 
variables 
 Let y be a ݊	 ൈ 1 vector of observations on the dependent variable 
 Let ߳ be a ݊	 ൈ 1 vector of errors terms 
 Let ߚ be a ݇	 ൈ 1 vector of unknown population parameters which are estimated 
in the model 
 
The OLS model is represented by the following equation:  
 ݕ ൌ ܺߚ ൅ ߝ (6.2) 
By rearranging the equation, the vector of residuals e is given by:  
 ݁ ൌ ݕ െ ܺߚመ  (6.3) 
Therefore the sum of squared residuals is as follows:  
 
݁ᇱ݁ ൌ ൫ݕ െ ܺߚመ൯ᇱ൫ݕ െ ܺߚመ൯
ൌ ݕᇱݕ െ ߚመᇱܺᇱݕ െ ݕᇱܺߚመ ൅ ߚመᇱܺᇱܺߚመ	
	 ൌ ݕᇱݕ െ 2ߚመᇱܺᇱݕ ൅ ߚመ′ܺ′ܺߚመ  
(6.4) 
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 By taking the derivative of equation (7.3) with respect to ߚመ , this gives us the coefficient 
values for each variable which minimize the sum of squared residuals.  
 
߲݁′݁
߲ߚመ ൌ െ2ܺ
ᇱݕ ൅ 2ܺᇱܺߚመ ൌ 0 (6.5) 
To be sure this is the minimum, the second partial derivative of డ௘ᇱ௘"డఉ෡ᇱఉ෡ ൐ 0 would be taken 
to be sure that the coefficients are at a local minimum. Finally the identity matrix of ݇ ൈ ݇ is 
found giving us:  
 ߚመ ൌ ሺܺᇱܺሻିଵܺ′ݕ (6.6) 
 
 
6.2 Correlations among Independent Variables 
To avoid a potential problem with multicollinearity it is useful to analyze correlation 
values between the independent variables.   Correlation tables (see tables 6-1 to 6-8) were 
estimated for the complete dataset (n = 664) and for each of the subsamples: AgEcon, English, 
Sociology, Ireland, France, Honduras, and China.  None of the estimated correlation coefficients 
in any of the subsamples reach 0.80, the absolute value many textbooks cite as a level that would 
cause concern (Studenmund 2001).  The largest correlation coefficient is the AgEcon subsample 
- between foodtechconcern and price where the correlation is 0.62.  
 Note that the variables indicating the primary reason respondents were uncomfortable 
with cloning (morallywrong, food safety, humancloning, and animalsafety) are necessarily 
negatively correlated with each other – because respondents could only choose one of those 
reasons as their primary reason for discomfort.  However, in the Chinese sample the responses 
could not be restricted and respondents were able to indicate more than one reason for 
discomfort.  This led to some positive correlation, the largest being between morallywrong and 
humancloning at 0.31.   
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Table 6-1: Correlation Table for Total Data Set 
  meat 
consume 
price  foodtech
concern 
attention knowtech morally
wrong 
food
safety 
human
cloning 
Animal
safety 
female farm religious
yes 
meatconsume  1.0000       
price  ‐0.1322  1.0000     
foodtechconcer
n 
‐0.0717  0.2154  1.0000  
attention  0.0976  0.0376  0.1740 1.0000  
knowtech  0.2482  ‐0.1166  0.0373 0.3304 1.0000  
morallywrong  ‐0.0034  0.0417  0.0876 ‐0.0027 0.0348 1.0000  
foodsafety  ‐0.1257  0.0964  0.0657 0.0804 ‐0.0907 ‐0.3082 1.0000   
humancloning  ‐0.0065  0.0351  ‐0.0335 ‐0.0238 0.0380 ‐0.1020 ‐0.1972  1.0000
animalsafety  ‐0.1529  ‐0.0304  0.0518 0.0169 ‐0.1445 ‐0.1466 ‐0.1156  ‐0.0748 1.0000
female  ‐0.0031  0.0570  0.0883 0.0184 0.0070 0.0987 ‐0.0315  0.0591 ‐0.0371 1.0000
farm  0.1157  0.1077  ‐0.0099 0.1168 0.1218 0.1584 ‐0.0873  0.0736 ‐0.1011 ‐0.0941 1.0000
religiousyes  0.2271  ‐0.0389  ‐0.1046 0.0473 0.1676 ‐0.0279 ‐0.0099  0.0445 ‐0.0606 ‐0.0412 0.1086 1.0000
 
Table 6-2: Correlation Table for AgEcon 
  meat 
consume 
price  foodtech
concern 
attention knowtech morally
wrong 
food
safety 
human
cloning 
Animal
safety 
female farm religious
yes 
meatconsume  1.0000       
price  ‐0.1203  1.0000     
foodtechconcern  0.0087  0.6186  1.0000  
attention  0.1086  0.1360  0.0918 1.0000  
knowtech  0.0253  ‐0.3295  ‐0.4615 0.0843 1.0000  
morallywrong  0.0760  ‐0.0633  ‐0.0777 0.0485 ‐0.0381 1.0000  
foodsafety  0.0334  0.3097  0.3915 0.1099 ‐0.3989 ‐0.1341 1.0000   
humancloning  ‐0.1663  ‐0.0579  ‐0.1142 ‐0.0640 0.0802 ‐0.0795 ‐0.3038  1.0000
animalsafety  ‐0.0907  0.2015  0.4435 ‐0.0620 ‐0.1017 ‐0.0434 ‐0.1657  ‐0.0982 1.0000
female  ‐0.1897  0.2599  0.0796 ‐0.0521 ‐0.1560 ‐0.1192 0.2559  ‐0.0617 0.0231 1.0000
farm  0.0141  ‐0.1932  ‐0.2769 ‐0.0093 0.3128 0.0897 ‐0.2088  ‐0.0390 ‐0.2854 0.0163 1.0000
religiousyes  ‐0.1177  ‐0.0798  ‐0.0476 ‐0.2453 0.0216 0.0996 ‐0.2240  ‐0.0019 0.1230 ‐0.1132 0.1655 1.0000
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Table 6-3: Correlation Table for English 
  meat 
consume 
price  foodtech 
concern 
attention knowtech morally
wrong 
food 
safety 
human
cloning 
animal
safety 
female farm religious
yes 
meatconsume  1.0000       
price  ‐0.1126  1.0000     
foodtechconcern  ‐0.0471  0.2454  1.0000  
attention  0.0606  0.2076  0.3156 1.0000  
knowtech  ‐0.0109  ‐0.0724  0.4854 0.1707 1.0000  
morallywrong  0.2242  ‐0.0421  ‐0.2713 ‐0.0514 ‐0.0362 1.0000  
foodsafety  ‐0.3899  0.1273  0.0716 0.1323 0.1219 ‐0.3883 1.0000   
humancloning  0.0174  0.1160  0.1379 0.0733 0.1915 ‐0.0903 ‐0.1954  1.0000
animalsafety  0.1751  ‐0.1353  0.0317 ‐0.2109 ‐0.1718 ‐0.2233 ‐0.4830  ‐0.1124 1.0000
female  ‐0.3183  0.2482  ‐0.0515 ‐0.0450 ‐0.1635 0.2947 0.0789  0.1483 ‐0.0831 1.0000
farm  0.1812  0.0200  ‐0.1118 0.1043 ‐0.0267 0.2846 ‐0.3054  ‐0.0978 0.1753 0.1968 1.0000
religiousyes  0.1914  ‐0.0784  ‐0.1083 0.0928 ‐0.2397 0.1990 ‐0.2025  ‐0.0576 0.1851 ‐0.1483 0.1137 1.0000
 
Table 6-4: Correlation Table for Sociology 
  meat 
consume 
price  foodtech 
concern 
attention knowtech morally
wrong 
food
safety 
human
cloning 
animal
safety 
female farm religious
yes 
meatconsume  1.0000       
price  ‐0.2894  1.0000     
foodtechconcern  ‐0.2942  ‐0.2980  1.0000  
attention  0.0260  0.1324  0.0817 1.0000  
knowtech  0.1171  ‐0.0542  0.0440 ‐0.0020 1.0000  
morallywrong  0.0000  ‐0.1436  ‐0.0282 0.1258 0.2989 1.0000  
foodsafety  ‐0.0829  0.3550  ‐0.1585 ‐0.0448 ‐0.2396 ‐0.3563 1.0000   
humancloning  0.1657  ‐0.3070  ‐0.1585 ‐0.0112 ‐0.0126 ‐0.0891 ‐0.2857  1.0000
animalsafety  0.0000  ‐0.2154  0.4235 0.0838 0.0944 ‐0.1667 ‐0.5345  ‐0.1336 1.0000
female  ‐0.0829  ‐0.0048  0.2150 0.0392 ‐0.0505 0.3118 0.1964  ‐0.2857 ‐0.0334 1.0000
farm  0.0417  0.0821  ‐0.3475 0.0479 ‐0.2317 0.1570 0.0090  ‐0.2337 ‐0.1009 0.0090 1.0000
ReligiousYes  0.0000  0.2820  ‐0.4251 ‐0.1555 ‐0.2781 ‐0.0242 0.2624  ‐0.1166 ‐0.4001 ‐0.1750 0.1321 1.0000
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Table 6-5: Correlation Table for Ireland 
  meat 
consume 
price  foodtech 
concern 
attention knowtech morally
wrong 
food
safety 
human
cloning 
animal
safety 
female farm religious
yes 
meatconsume  1.0000       
price  0.1746  1.0000     
foodtechconcern  0.1248  0.1246  1.0000  
attention  0.0005  0.1435  0.2247 1.0000  
knowtech  ‐0.1252  ‐0.0420  0.1272 0.0294 1.0000  
morallywrong  ‐0.0172  ‐0.0494  0.1300 0.0519 0.2516 1.0000  
foodsafety  0.0926  0.0558  0.0959 0.0569 ‐0.0290 ‐0.3148 1.0000   
humancloning  0.1076  ‐0.1611  0.0411 ‐0.2495 ‐0.0039 ‐0.0987 ‐0.1505  1.0000
animalsafety  ‐0.0912  ‐0.0427  0.1161 0.0065 ‐0.1690 ‐0.2703 ‐0.4120  ‐0.1292 1.0000
female  ‐0.2482  ‐0.1717  ‐0.0608 ‐0.0226 0.1010 0.0362 ‐0.0198  ‐0.1245 0.1186 1.0000
farm  0.1390  0.1842  ‐0.0190 0.0439 ‐0.2044 ‐0.0061 0.1140  0.0064 ‐0.1658 ‐0.4252 1.0000
ReligiousYes  0.1865  0.0488  0.1866 ‐0.0251 ‐0.0681 ‐0.0749 0.1464  0.1526 ‐0.0850 ‐0.3016 0.2470 1.0000
 
Table 6-6: Correlation Table for France 
  meat 
consume 
price  foodtech 
concern 
attention knowtech morally
wrong 
food
safety 
human
cloning 
animal
safety 
female farm religious
yes 
meatconsume  1.0000       
price  ‐0.0512  1.0000     
foodtechconcern  ‐0.1034  ‐0.0504  1.0000  
attention  ‐0.0535  ‐0.0974  0.3010 1.0000  
knowtech  ‐0.0940  ‐0.1513  0.0949 0.0517 1.0000  
morallywrong  ‐0.1051  ‐0.0775  0.1217 ‐0.0683 ‐0.1034 1.0000  
foodsafety  ‐0.0404  0.0867  0.0629 0.0817 0.0899 ‐0.4392 1.0000   
humancloning  0.0511  0.1312  ‐0.0759 0.0024 0.0857 ‐0.4077 ‐0.2631  1.0000
animalsafety  ‐0.0123  ‐0.0224  0.0745 0.1287 0.0935 ‐0.1467 ‐0.0947  ‐0.0879 1.0000
female  ‐0.0699  0.2454  0.1574 0.1066 ‐0.0597 ‐0.0568 0.0501  0.1227 0.0128 1.0000
farm  0.0966  ‐0.0362  ‐0.0499 0.0104 0.0828 ‐0.1923 0.0844  0.0784 0.0282 ‐0.0594 1.0000
ReligiousYes  0.1374  ‐0.0905  ‐0.1787 ‐0.0633 0.0729 ‐0.0490 0.0228  0.0767 ‐0.0804 ‐0.0487 0.0556 1.0000
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Table 6-7: Correlation Table for Honduras 
  meat 
consume 
price  foodtech 
concern 
attention knowtech morally
wrong 
food 
safety 
human
cloning 
animal
safety 
female farm religious
yes 
meatconsume  1.0000       
price  ‐0.0792  1.0000     
foodtechconcern  ‐0.2028  0.1859  1.0000  
attention  ‐0.1357  ‐0.0333  0.0372 1.0000  
knowtech  ‐0.1564  0.0732  ‐0.0593 0.3661 1.0000  
morallywrong  0.0252  0.1272  0.0526 ‐0.1559 0.1008 1.0000  
foodsafety  ‐0.2107  0.0383  0.3359 0.1656 ‐0.0266 ‐0.2591 1.0000   
humancloning  0.0528  0.0261  ‐0.0079 ‐0.0352 ‐0.0132 ‐0.1011 ‐0.1768  1.0000
animalsafety  ‐0.0184  0.0665  0.0446 ‐0.0352 ‐0.0952 ‐0.1011 ‐0.1768  ‐0.0690 1.0000
female  ‐0.0664  ‐0.0322  0.0684 ‐0.0039 ‐0.0322 0.1644 ‐0.0438  0.2477 ‐0.0233 1.0000
farm  0.0700  0.1465  ‐0.1092 0.0956 ‐0.1493 0.1894 ‐0.1015  ‐0.0488 0.0402 ‐0.0767 1.0000
religiousyes  ‐0.0275  0.1119  0.0339 ‐0.1438 0.0678 0.0719 ‐0.0445  ‐0.0524 0.0491 0.1366 0.0812 1.0000
 
Table 6-8: Correlation Table for China 
  meat 
consume 
price  foodtech
concern 
attention knowtech morally 
wrong 
food
safety 
human
cloning 
animal
safety 
female farm religious
yes 
meatconsume  1.0000       
price  ‐0.2503  1.0000     
foodtechconcern  ‐0.0058  0.2692  1.0000  
attention  ‐0.1319  0.1156  0.0114 1.0000  
knowtech  ‐0.0240  0.0626  0.0199 0.3674 1.0000  
morallywrong  0.0176  ‐0.0599  ‐0.1685 ‐0.0299 0.0075 1.0000  
foodsafety  ‐0.0137  0.1177  ‐0.0423 0.3286 0.1792 ‐0.0157 1.0000   
humancloning  0.0272  0.0029  ‐0.0344 0.1137 0.1513 0.3083 ‐0.0854  1.0000
animalsafety  ‐0.1445  ‐0.0289  ‐0.1182 0.2809 0.0564 0.0878 0.0514  0.0352 1.0000
female  0.1254  ‐0.1709  0.0159 ‐0.0091 0.1916 0.0816 ‐0.2265  0.0773 ‐0.1422 1.0000
farm  ‐0.0055  0.0734  0.0896 0.1268 0.2105 0.0862 0.1574  0.0638 0.2198 ‐0.1561 1.0000
ReligiousYes  ‐0.0834  0.0874  ‐0.0164 0.1087 0.1338 0.0922 0.0450  0.2047 0.1169 0.1829 0.1314 1.0000
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6.3 Likely to Consume (1) 
Table 6-9 presents results from models using the initial responses to the likelihood of 
consumption question – the variable we identify as Likely to Consume (1).  This question was 
asked without providing any information about cloning. However, since the Chinese data was 
collected using a hard copy, it was possible for those respondents to read ahead and find the 
information about FDA/EFSA approval before responding to the question.   
 
Table 6-9: Likely to Consume (1) - Likelihood of Consuming Cloned Product 
Likely to Consume (1)  Ag Econ  English  Sociology  Ireland  France  Honduras  China 
Food Related Issues         
meatconsume  ‐0.0713  0.1604 ‐0.4883* 0.1139 0.0824 0.2771  ‐0.0524
price  0.2843**  0.1117 0.0513 0.0102 0.1289* 0.1773  ‐0.1470**
foodtechconcern  ‐0.4184***  ‐0.2811** ‐0.2838 ‐0.3636*** ‐0.1233** ‐0.3766***  ‐0.2059***
attention  0.2113*  ‐0.1783 ‐0.1563 ‐0.1065 ‐0.1459** 0.1777  0.0383
knowtech  0.2598  0.7906*** ‐0.1013 0.2287* 0.1882** 0.0970  0.1592
Reason for Concern         
      morallywrong  ‐2.0701***  ‐2.6721*** ‐0.2426 ‐1.1755*** ‐1.3418*** ‐1.3512***  0.0369
      foodsafety  ‐1.3661***  ‐1.6977*** ‐0.5271 ‐0.6338** ‐0.8920*** ‐1.2816***  0.2459
      humancloning  ‐1.1973***  ‐2.2426*** 0.8584 ‐0.7274 ‐0.8827*** ‐1.0152*  0.2398
      animalsafety  ‐0.6179  ‐1.2845*** ‐0.0543 ‐0.6392** ‐0.5621 ‐1.2950**  0.0907
Demographic Info.         
female  ‐0.3467  0.5433 ‐1.0052*** ‐0.0737 ‐0.0483 ‐0.1820  0.2350
farm  0.2121  ‐0.4526 ‐0.8324*** ‐0.2607 0.3825 ‐0.1388  0.0052
ReligiousYes  ‐0.5990**  0.1510 0.3548 0.1817 0.0185 0.0334  0.0525
_cons  3.1279**  2.2616** 6.0028*** 3.2734*** 2.1789*** 2.3133  2.3820***
Adjusted R‐Squared  0.556  0.347  0.665 0.297 0.323 0.348  0.127
Root MSE  0.849  0.774  0.615 0.928 0.773 1.200  0.930
Total Observations  59  46  30 111 163 93  132
DF  46  33  17 98 150 80  119
Prob > F  0.648  0.006  0.001 0.000 0.000 0.000  0.004
*,**, and *** indicates statistical significance at the 10%, 5%, and 1% levels. 
 
At first glance, the results indicate in table 6-9 that several variables are statistically 
significant and have the same sign in all or most subsample models.  Every model has at least 
three statistically significant coefficients, and adjusted R-squares values range from 0.127 
(China) to 0.665 (Sociology).   
  The meatconsume variable measures the respondents total meat consumption behaviors.  
Its coefficient has the expected positive sign in all models except AgEcon, Sociology, and China, 
but is only statistically significant at the 10% level for Sociology.  The Sociology coefficient 
6-69 
 
indicates that as meat consumption increases (on the 0 to 4 scale, 4 = almost every day) it is 
associated with a -.49 decrease (again on a 1 to 5 Likert scale) in likelihood of consuming cloned 
product.  The price variable measures the respondent’s level of concern about food prices.  Its 
coefficient has the expected positive sign in all models except that for the Chinese sample, but is 
statistically significant in only the AgEcon and French subsamples.  In the AgEcon sample, the 
coefficient indicates that a one-unit increase in concern about food prices (on the 1 to 5 Likert 
scale) is associated with a 0.28 unit increase (again on a 1 to 5 Likert scale) in likelihood of 
consuming cloned product.  
As expected, the variable foodtechconcern has a negative coefficient in all subsample 
models, and has a statistically significant impact in all but Sociology.  As described in section 5 
(Describing Data), this variable was created to measure the average concern consumers have for 
“Use of Hormones” and “Biotechnology”.  This variable has the largest impact in the AgEcon 
subsample where the coefficient value is -0.42.  The conclusion is that consumers who are 
concerned about advanced agro-biotechnologies will be less likely to consume cloned product.  
Because cloning is often confused with genetic modification (Marks, et al. 2003), it makes sense 
that consumers who are concerned about advanced agro-biotechnology will also be concerned 
about cloning technology.  
It was expected that the variable, attention, measuring attention to food labels would have 
a negative correlation with likelihood of consuming cloned product but, as shown in table 6-9, its 
effect is not consistent.  It has a statistically significant negative effect only in the French sample, 
and is in fact positive and significant in the AgEcon sample.  It was hypothesized that knowledge 
of technology, knowtech, would be correlated with a greater acceptance of cloned products and 
for the most part that appears to be the case.  The variable has a positive coefficient in all but the 
Sociology group, and it statistically significant in three models.  Its impact is strongest in the 
English class group, where a one unit increase in familiarity with technology (on a 4-point scale) 
is associated with a 0.79 unit increase in acceptance of cloned product.  
The variables with the greatest impact in these models are the dummy variables that 
identify respondents by the specific reason they are concerned about cloning, morallywrong, 
foodsafety, humancloning, animalsafety.  It is no surprise of course that these coefficients are all 
negative (they will be so almost by definition) – but what is of interest is their relative 
magnitude.  The distribution of responses to the question eliciting the primary concern about 
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cloning is shown in figure 6.1.  The China group has a large “Don’t Know” subsection because it 
includes the multiple responses where respondents could identify more than one “primary” cause 
for concern.  In all groups, over half the respondents identify with one of the four listed 
“concerns,” and the distribution (see also Table 6-10) shows that food safety is the primary 
concern for almost 1 in 3 respondents.  Note that these responses were elicited prior to providing 
information about official findings on the safety of cloned products.  
 
Figure 6-1: Answers to "Reasons Uncomfortable with Animal Cloning" (Question 7) 
 
 
However, even though food safety is the most commonly cited concern, the results in 
Table 6-9 indicate that the variable with the greatest impact on likelihood of consuming cloned 
product is that identifying respondents who believe that cloning is morally wrong.  The dummy 
variable for morallywrong is negative in the models for all subsamples except China, and is 
statistically significant at the 1% level in five of the other six models (all bar Sociology).  And in 
those five models, the magnitude of its coefficient exceeds that of any of the other coefficients 
identifying a specific cause for concern about cloning.  For example, in the AgEcon sample, the 
coefficient on morallywrong is -2.07, compared to -1.36 for respondents citing foodsafety as their 
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primary concern, -1.19 for those concerned that animal cloning will lead to human cloning, and -
0.62 for those concerned about animal safety.  
In the English class sample, the coefficient on morallywrong is -2.67, indicating that, 
compared to individuals who “don’t know,” “don’t care,” or who are “not uncomfortable” with 
cloning, those who believe it is morally wrong rate their likelihood of consumption 2.67 points 
lower on the 5 point Likert scale.  For comparison, the coefficient on foodsafety is -1.70, 
indicating that compared to those who have food safety concerns, those who believe the process 
is morally wrong rate their likelihood of consuming almost a full point lower on the Likert scale.  
A similar, if not quite so dramatic pattern is seen in the AgEcon, Irish and French samples.  In 
the Honduran samples, the coefficients on morallywrong and foodsafety are more similar in 
magnitude, with morallywrong only slightly more negative.   
The variable identifying respondents whose primary concern is humancloning (i.e., that 
animal cloning may lead to human cloning), is negative and significant in four of the seven 
models, while the variable identifying respondents whose primary concern is animalsafety is 
negative and significant in three.  In the Chinese sample, none of the four variables identifying a 
cause for concern are significant – in fact all are positive and small in magnitude compared to the 
effects found in most of the other samples.  This again may be due to the fact that data was 
collected on hard copies, where respondents could identify more than one “primary” cause for 
concern. These variables are also insignificant in the Sociology sample, a finding that is difficult 
to explain given the patterns in the other samples.        
 
Table 6-10: Data for "Reason Uncomfortable with Animal Cloning" (Question 7) 
 N % Freq. 
Food safety concerns 204 31.68% 
Morally wrong 115 17.86% 
Don’t Know 90 13.98% 
Animal safety concerns 75 11.65% 
Animal cloning lead to human cloning 64 9.94% 
Not Uncomfortable 48 7.45% 
Don’t Care 48 7.45% 
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It was hypothesized that females would be more concerned about consuming cloned 
product than males, but a statistically significant effect with the expected sign is found in only 
one of the seven samples – that for the Sociology class.  Likewise, a positive effect on 
acceptance of cloning was hypothesized for respondents from a farming or ranching background, 
but none of the estimated models had a positive and significant coefficient for that variable.  In 
the Sociology class sample, the effect of a farming background was in fact negative and 
significant.  Similarly but less surprising given the possibility that individuals with religious 
affiliations could arguably take either a positive or a negative perspective on the technology, the 
coefficient on religousyes is significant in only one of the seven models.  
This model was also run as an ordered logit model in order to constrain the dependent 
variable to the values indicated in the ‘Likeliness to Consume’ five point likert scale question.  
While the results are not shown in this thesis document, the signs, statistical significance, and 
integer value of the estimated coefficients generally replicated those from the OLS modeling 
which further supports these results.  
 
 
6.4 Likelihood of Consuming Cloned Product given information about Safety 
– Government Approval (2) 
Table 6-11 presents results from models using the second set of responses to the question 
about likelihood of consumption – the variable we identify as Government Approval (2).  These 
models are similar to the first in that they use the same set of independent variables, and the 
hypothesized effects of those variables are similar.  However, since acceptance (or likelihood to 
consume) is now measured following the provision of information about cloned product safety, 
we would expect the effect of the variable identifying respondents with food safety concerns to 
be diminished.  
Model fit as measured by the adjusted R-squared values are similar for the first set 
ranging from 0.145 for China up to 0.583 for the Sociology class.  Again, models for the 
different samples have at least three significant coefficient estimates, and by and large, the 
pattern of significant variables is similar to that in the first set of models.  In fact there are 35 
statistically significant coefficients which did not change from the previous model.   
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The variable measuring meat consumption level is nowhere significant, while that for 
concern about food prices again has the expected positive sign and is significant in the AgEcon 
and French samples.  The coefficient on foodtechconcern is in all cases negative, and significant 
in five of the seven models.  Attention to labels does not have a significant effect in any model, 
while familiarity with biotechnology (knowtech) has the expected positive sign and is significant 
in four models (compared to three in the earlier set).   
The variables identifying reasons for concern about animal cloning – morallywrong, 
foodsafety, humancloning, and animalsafety – have similar coefficients to those observed in the 
first set of models.  The coefficients on the morallywrong variable are negative and significant in 
all samples except China, and again this variable has the largest impact on the model.  
Consumers who question the morality of animal cloning continue to be the least likely to 
consume cloned product.   
 
Table 6-11: Government Approval (2) – Likelihood of Consuming Cloned Product given 
information about USDA/EFSA Approval 
  Ag Econ  English Sociology Ireland France Honduras  China
Food Related Issues         
meatconsume  0.0101  0.3555 ‐0.3899 0.1678 0.1335 ‐0.0176  ‐0.0135
price  0.3556**  0.1338 ‐0.0857 0.0886 0.1844** 0.0863  ‐0.1472*
foodtechconcern  ‐0.3768**  ‐0.2564 ‐0.3108 ‐0.3041*** ‐0.1252** ‐0.3360***  ‐0.1261*
attention  0.0996  ‐0.1151 ‐0.1184 ‐0.0654 ‐0.0774 0.1834  0.0182
knowtech  0.4779**  0.8400*** 0.0928 0.4776*** 0.1454 ‐0.1162  0.3029**
Reasons for 
Concern 
       
      morallywrong  ‐1.9078***  ‐3.5860*** ‐2.6471*** ‐1.8683*** ‐1.5193*** ‐1.1712***  0.0154
      foodsafety  ‐0.8231**  ‐1.9908*** ‐2.0147*** ‐0.5945* ‐0.6223*** ‐1.1173***  0.3711*
      humancloning  ‐1.4640***  ‐3.0153*** ‐1.6819* ‐1.3594** ‐0.7035*** ‐0.7978  0.4277
      animalsafety  ‐0.9876  ‐1.4617** ‐2.0941*** ‐0.7408** ‐0.5546 ‐0.4421  0.0576
Demographic Info         
female  ‐0.1480  0.7866 ‐0.9844** 0.0910 ‐0.1732 ‐0.4098  0.0818
farm  0.0612  ‐0.6314 ‐0.2142 ‐0.4330* 0.3518 ‐0.1217  0.3064
ReligiousYes  0.0189  0.2895 ‐0.0851 0.2946 ‐0.1252 0.0421  0.1822
_cons  2.2421  2.0017 7.8322*** 2.2688** 1.9490** 4.5912***  1.9441***
Adjusted R‐Squared  0.412  0.303  0.583 0.289 0.332 0.274  0.145
Root MSE  0.964  1.032  0.809 1.143 0.891 1.173  0.986
Total Observations  59  46  30 111 163 93  132
DF  46  33  17 98 150 80  119
Prob > F  0.000  0.014  0.003 0.000 0.000 0.000  0.002
*,**, and *** indicates statistical significance at the 10%, 5%, and 1% levels. 
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The variable identifying respondents with food safety concerns is negative and significant 
in six of the seven models.  While still consistently smaller in magnitude than the coefficients on 
the variable for morallywrong, the coefficient estimates are not consistently smaller in absolute 
value than those observed in the first set of models.  In the AgEcon sample, the coefficient on 
foodsafety has fallen from -1.37 to -0.82, while in the Sociology sample it has increased in 
absolute magnitude from -0.53 to -2.01.  This suggest that the information about government 
agencies finding cloned products safe did not have a uniformly reassuring effect for respondents 
whose primary concern was with foodsafety.  
The most notable change between these and the previous models occur with the 
Sociology class sample. In the earlier model, none of the variables identifying respondents with 
specific concerns about cloning were significant, whereas in this model all four variables have 
the expected negative sign and are significant.  Again, the pattern in the earlier model is difficult 
to explain.   
Regarding the remaining variables, there is little that is noteworthy.  The effect of gender 
is again only significant in the Sociology sample, while that of a farming background is only 
significant (with a negative sign) in the Irish sample.  The religiousyes variable is nowhere 
significant.   
 
 
6.5 Likelihood of Consuming Cloned Product at a 10% Reduced Price - Price 
Reduction (3) 
The third and final likeliness model uses the same independent variables used in the first 
and second model, but uses the third set of response to the question about likelihood of 
consumption – the variable identified as Price Reduction (3).  As before, the hypothesized effects 
on the independent variables are similar; however, since acceptance (or likelihood to consume) is 
now measured following the additional provision of information about a potential 10% price 
reduction, we expect the effect of price variable to become consistently positive throughout all 
groups.  
Overall model fit as measured by the adjusted R-squared values are consistently lower for 
every group except China and France.  Values range from 0.127 in China to 0.347 for Honduras.  
France and China were to the only adjusted R-squared values to increase, but only slightly.  
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Sociology experienced the greatest decrease from a value of 0.665 in the second (Government 
Approval (2)) model to 0.245 in this third model.  This model broke from the pattern the 
previous two models set in that it decreased to a total of 28 statistically significant variables. The 
total decrease was caused by the decrease in negative and significant variables down to 19, 
although there was an increase in total positive and significant variables (total of 9).  The greatest 
change occurred within the Sociology group which had at least two significant variables in the 
previous two models, but now has no significant variables across the entire model. 
 
Table 6-12: Likeliness to Consume Cloned Product Given 10% Price Reduction 
Price Reduction (3)  Ag Econ  English Sociology Ireland France Honduras  China
Food Related Issues         
Meatconsume  0.0361  0.1166 ‐0.0120 0.1143 0.1314 ‐0.1776  0.1135
Price  0.5256***  0.0068 0.1628 0.3284*** 0.3724*** 0.1373  0.1069
foodtechconcern  ‐0.5966***  ‐0.3546* ‐0.4198 ‐0.4321*** ‐0.1735***  ‐0.4073***  ‐0.2113***
Attention  0.0621  ‐0.2453 ‐0.0745 ‐0.0144 ‐0.0549 0.0751  0.1411*
Reasons for Concern         
      knowtech  0.2456  0.7190** 0.1455 0.3257** 0.2889*** ‐0.0905  ‐0.1600
      morallywrong  ‐1.1219  ‐4.1227*** ‐1.4200 ‐1.072*** ‐1.3705***  ‐1.1946***  ‐0.1686
      foodsafety  ‐0.9440**  ‐1.9753*** ‐1.1838 ‐0.3080 ‐0.5743** ‐1.3981***  ‐0.0999
      humancloning  ‐0.9281**  ‐3.1990*** ‐0.6302 ‐0.6447 ‐0.8237***  ‐0.8042  0.3616
Demographic Info         
animalsafety  ‐0.6433  ‐2.1778*** ‐1.2730 ‐0.0724 ‐0.4247 ‐0.3329  0.1974
female  ‐0.6014*  1.1632** ‐0.7641 0.1358 ‐0.1974 ‐0.3802  0.0251
farm  0.2062  ‐0.0782 ‐0.5924 ‐0.3731 0.2516 ‐0.0483  0.4192**
ReligiousYes  0.0371  06016 0.1558 0.3255 ‐0.0920 0.2850  ‐0.1348
_cons  2.7207  4.1873*** 5.0398 1.7252* 1.0413 5.3959***  1.5879***
Adjusted R‐Squared  0.3642  0.2811 0.2450 0.2637 0.3275 0.3799  0.0842
Root MSE  1.0757  1.1063 1.0556 1.1137 0.9344 1.1157  0.9915
Total Observations  59  46  30 111 163 93  132
DF  46  33  17 98 150 80  119
Prob > F  0.0005  0.0200 0.1339 0.0000 0.0000 0.0000  0.0295
*,**, and *** indicates statistical significance at the 10%, 5%, and 1% levels.  
 
The variables measuring meat consumption and attention to labels are nowhere 
significant.  The variable measuring familiarity with biotechnology (knowtech) continues to have 
the expected positive sign in five of the previous models, compared to the four in the second 
model and three in the first model. 
The variable measuring concern for food prices has the expected positive sign in every 
respondent group and is statistically significant at the 1% level (p=0.000) in the AgEcon, Irish, 
and French samples.  It is notable that the price variable became very statistically significant 
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(statistically significant at the 1% level) in the economically developed countries (USA, Ireland, 
France) where price is a leading factor in purchase intent as well as food related issue concern 
(average equals 3.37, 3.81, 4.31 respectively).  In addition, this variable increased in absolute 
value in nearly all groups from the first two original models except in the English, Honduran, 
and Chinese samples although it was not statistically significant.  This does give some indication 
that information on reduced price positively influences price conscience consumers and in fact 
increases stated likeliness to consume cloned product.  
The variable measuring concern for food biotechnology (foodtechconcern) continues to 
be negative in all groups.  However, it repeats the trend from the first model, which measures 
initial likeliness, and is significant in all groups except Sociology.  This variable indicates that 
those consumers who are concerned with advance food biotechnologies are unlikely to consume 
cloned product even if it is cheaper than conventional product.    
The variables identifying respondents concern about animal cloning –morallywrong,  
foodsafety, humancloning, and animalsafety – show the most interesting changes in coefficients 
observed from the previous two models.  All variables continue to be negative for each group 
except for humancloning and animalsafety in the Chinese sample.  However, each variable lost 
total significance across every group.  The coefficient on the variable morallywrong decreased in 
absolute value from the first and second models, but continues to have the largest impact on each 
model except for the Chinese and Honduran samples.  This suggests that the information about 
price decreased the impact for nearly every variable, but those consumers who have moral 
objection to the technology are still the least likely to consume cloned product.  
The variable foodsafety is negative and significant in four of the seven models.  The 
absolute value is consistently smaller than the morallywrong coefficients across all groups, 
except in the Honduran sample where foodsafety is -1.40 and morrallywrong is 1.19.  The 
variable humancloning is now only statistically significant in the AgEcon, English, and French 
samples.  The variable animalsafety changed the most of all the ‘concern’ variables, and is now 
only significant in the English sample.   
There is little that is noteworthy in the remaining variables.  The gender effect is now 
negative and significant in the AgEcon group where it indicates females are less likely to 
consume cloned product; however, conversely it is positive and significant in the English group 
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which indicates females are more likely to consume cloned product.  The religiousyes variable is 
nowhere significant.  
 
 
6.6 Summary – Influences on Likelihood of Consuming Cloned Product 
Now that all three models for likeliness to consume cloned product have been estimated, 
we can examine which variables have consistent effects.   
These models were estimated using variables that might be most likely to explain why 
consumers may or may not consume cloned product.  The variable which most consistently had a 
statistically significant impact throughout all twenty one models was ‘foodtechconcern’.  While 
this variable did not have the largest impact on any of the models, it was statistically significant 
seventeen times and negative all twenty one times.  It can be concluded from this that those 
consumers who are concerned with biotechnology and hormone use in food production are very 
unlikely to consume cloned products.   
Following foodtechconcern were the variables foodsafety and morallywrong which each 
had fifteen statistically significant and negative occurrences.  This is notable as morallywrong 
consistently had the greatest impact on each model in terms of the magnitude of its coefficient.  
This suggests that consumers who feel cloning is morally wrong are very unlikely to consume 
cloned product even if educated about the food safety issue.  
Very few coefficients were positive and statistically significant.  The variables knowtech 
and price had ten and seven statistically significant and positive coefficients respectively.  It is 
important to note that each of these variables also had some negative estimated coefficient 
values, and in addition, the coefficient on price was actually negative and significant in two 
models.  However, in general we can say that consumers who feel they have knowledge and 
understanding of cloning technology and biotechnology are more likely to consume product from 
cloned animals.  It is interesting to note that this particular variable was only positive and 
statistically significant in the higher income countries in the sample (US, Ireland, and France) 
where consumers likely have better opportunities to educate themselves.   
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Table 6-13: Total Significant Positive and Negative Coefficients by Variable 
  Likeliness to 
Consume (1) 
Government 
Approval (2)  Price Reduction (3)  TOTAL 
  Pos. & 
Sig. 
Neg. & 
Sig. 
Pos. &
Sig. 
Neg. & 
Sig. 
Pos. & 
Sig. 
Neg. & 
Sig. 
Pos. & 
Sig. 
Neg. & 
Sig. 
Food Related Issues       
meatconsume    1    1
price  2  1  2 1 3 7  2
foodtechconcern    6  5 6   17
attention  1  1  1 2  1
knowtech  3    4 3 10  0
Reasons for Concern       
      morallywrong    5  6 4   15
      foodsafety    5  1 6 4 1  15
      humancloning    4  5 3   12
      animalsafety    3  3 1   7
Demographic Info.       
female    1  1 1 1 1  3
farm    1  1 1 1  2
religiousyes    1    1
TOTAL  6  29  7 28 9 19 22  76
 
In total, the Ag Econ, English, and French models had the most statistically significant 
variables with a total of eighteen each.  English had the most negative and statistically significant 
variables at fourteen with Ag Econ and France close behind with thirteen at each.  Sociology had 
the most negative variables at thirty, but the least statistically significant variables at eight.  
China interestingly had the least negative and statistically significant variables out of all the 
respondent groups with just five in total.  This is less than half of most of the respondent groups 
except for Sociology.   
 
Table 6-14: Total Significant Positive and Negative Coefficients by Respondent Group 
  Likeliness to  
Consume (1) 
Government
 Approval (2) 
Price Reduction (3) Total
  Pos. & 
Sig. 
Neg. & 
Sig. 
Pos. & 
Sig. 
Neg. & 
Sig. 
Pos. & 
Sig. 
Neg. & 
Sig. 
Pos. & 
Sig. 
Neg. & 
Sig. 
Ag Econ  2  5  2 4 1 4 5  13
English  1  5  1 4 2 5 4  14
Sociology    3  5 0  8
Ireland  1  4  1 6 2 2 4  12
France  2  5  1 4 2 4 5  13
Honduras    5  3 3 0  11
China    2  2 2 2 1 4  5
Total  6  29  7 28 9 19 22  76
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7 Ordered Logit Analysis of Changes in Likelihood of Consuming 
Cloned Product 
In order to have a greater understanding of why respondents might have changed their 
likeliness to consume cloned product throughout the survey, an ordered multinomial logit model 
was used.  The ordered logit model was chosen because it allows for the probability in change of 
response to be measured against attributes of the respondent.  For example, a respondent might 
have a higher probability to change their likeliness to consume cloned product if they are female 
or because they were reassured of their knowledge of the science of animal cloning.  Marginal 
effects in the ordered logit model show the probability for consumers to either increase decrease, 
or maintain their likelihood of consumption level when an explanatory variables changes by one 
unit.  This allows a closer analysis of the directional changes consumers might make in their 
rating of consumption likelihood in response to some external change such as the provision of 
information or a reduction in price.  The sum of these marginal changes across categories equals 
zero because as the probability of an individual being in one category (e.g., increasing their 
likelihood of consumption) increases, their probability of being in another category (decreasing 
likelihood or same likelihood) must decrease.  This information can be very helpful to producers 
and policy makers because it can provide insights about what might influence respondents to 
change their perceptions and attitudes toward the technology.  
 
 
7.1 The Ordered Logit Model  
The ordered logit models predict probabilities that a dependent variable will fall in one of 
several ordered categories based on a set of independent variables.  These probabilities are used 
to study how the explanatory variables influence the changes in consumer’s likeliness to 
consume cloned product given new information. For the purpose of this study, three variables 
were created in order to quantify the change consumers had in their likeliness to consume levels 
after being given new information.  These change variables are: 
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ܱݎ݀݁ݎ݁݀	ܮ݋݃݅ݐ	ܸܽݎܾ݈݅ܽ݁ 1 ൌ ܩ݋ݒ݁ݎ݊݉݁݊ݐ ܣ݌݌ݎ݋ݒ݈ܽ ሺ2ሻ–	 
ܮ݈݅݇݁݅݊݁ݏݏ ݐ݋ ܥ݋݊ݏݑ݉݁ ሺ1ሻ 
(7.1) 
 
ܱݎ݀݁ݎ݁݀	݈݋݃݅ݐ ܸܽݎܾ݈݅ܽ݁ 2 ൌ ܲݎ݅ܿ݁ ܴ݁݀ݑܿݐ݅݋݊ ሺ3ሻ–	 
ܩ݋ݒ݁ݎ݊݉݁݊ݐ ܣ݌݌ݎ݋ݒ݈ܽ ሺ2ሻ 
(7.2) 
 
ܱݎ݀݁ݎ݁݀	ܮ݋݃݅ݐ ܸܽݎܾ݈݅ܽ݁ 3 ൌ ܲݎ݅ܿ݁ ܴ݁݀ݑܿݐ݅݋݊ ሺ3ሻ–	 
ܮ݈݅݇݁݅݊݁ݏݏ ݐ݋ ܥ݋݊ݏݑ݉݁ ሺ1ሻ 
(7.3) 
 
The independent variables which were chosen for the model include knowtech, Likely1, 
morallywrong, foodsafety, humancloning, animalsafety, and female.  These variables were 
chosen based on their theoretically plausibility to influence the probability that a consumer 
would change their likelihood of consumption after receiving new information.  Below is the 
theoretical model where ݕ௜ is the dependent variable representing Ordered Logit Variable (1), 
Ordered Logit Variable (2), and Ordered Logit Variable (3).  
 
 
ݕ௜ ൌ ݂ሺ݇݊݋ݓݐ݄݁ܿ, ݈݈݅݇݁ݕ1,݉݋ݎ݈݈ܽݕݓݎ݋݊݃, ݂݋݋݀ݏ݂ܽ݁ݐݕ, 
	݄ݑ݈݉ܽ݊ܿ݋݊݅݊݃, ݈ܽ݊݅݉ܽݏ݂ܽ݁ݐݕ, ݂݈݁݉ܽ݁ሻ 
(7.4) 
 
The ordered logit model obtains parameter estimates by maximizing the log of the 
likelihood function.   
The model is represented by the following equation; 
 ݕ௜∗ ൌ ݔ௜ᇱߚመ ൅ ߝ௜ (7.5) 
where ݔ௜ represent the independent variables and ߚመ  are the coefficients associated with the 
independent variables.  The ߝ௜ is the random error term.  The error term is assumed to have a 
standard logistic distribution with a mean of zero and a variance of Λ ൌ గమଷ  (Greene 1997, Crespi 
2010). The dependent variable, ݕ௜∗, is an unobserved latent variable. What can be observed are 
different categories of response.  Below, ݕ௜ are the changes in response between the three 
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likeliness questions included in the survey.  Per the model, since ݕ௜∗ is the latent variable, it is 
unobserved.  What is observed is, 
 
ݕ௜ ൌ െ1 ݂݅ ݕ௜∗ ൑ ߬ଵ
ݕ௜ ൌ 0					݂݅	߬ଵ ൏ ݕ௜∗ ൑ ߬ଶ	
ݕ௜ ൌ ൅1 ݂݅ ݕ௜∗ ൐ ߬ଶ 
(7.6) 
while ߬௜ are the unobserved thresholds parameters which are estimated along with the ߚ vector.  
Essentially these are the cut-off points for the dependent variables.  For this model, if a 
respondent decreases their likeliness to consume after given new information, then the observed 
ݕ௜ ൌ െ1.  If a respondent sustains their likeliness to consume cloned product after new 
information, the observed ݕ௜ ൌ 0 and if they increase their likeliness to consume the observed 
ݕ௜ ൌ ൅1.   
The probability of observing an outcome is provided in the equations below, where the Λ 
is the standard logistic distribution function.  
 
ܲݎ݋ܾሺݕ௜ ൌ െ1ሻ ൌ 1 െ ߉ሺݔ௜ᇱߚሻ ൌ ߉ሺെݔ௜ᇱߚሻ
ܲݎ݋ܾሺݕ௜ ൌ 0ሻ ൌ ߉ሺ߬ଵ െ ݔ௜ᇱߚሻ െ ߉ሺെݔ௜ᇱߚሻ	
ܲݎ݋ܾሺݕ௜ ൌ ൅1ሻ ൌ 1 െ ߉ሺ߬ଶ െ ݔ௜ᇱߚሻ 
(7.7) 
Given these probabilities marginal effects can be found by taking the first order derivative with 
respect to ݔ௜ thereby measuring the change on the independent variable. These marginal effects 
are as follows: 
 
߲ܲݎ݋ܾሺݕ௜ ൌ െ1ሻ
߲ݔ௜ ൌ െߣ൫െݔ௜
ᇱߚመ൯ߚመ
߲ܲݎ݋ܾሺݕ௜ ൌ 0ሻ
߲ݔ௜ ൌ ൣߣ൫െݔ௜
ᇱߚመ൯ െ ߣ൫߬ଵ െ ݔ௜ᇱߚመ൯൧ߚመ	
߲ܲݎ݋ܾሺݕ௜ ൌ ൅1ሻ
߲ݔ௜ ൌ ߣሺ߬ଶ െ ݔ௜
ᇱߚመሻߚመ  
(7.8) 
Where the ߣ	is the probability density function of the logistic distribution.  These derivatives tell 
how a one-unit change in the variable ݔ௜ affects the probabilities of consumers increasing, 
sustaining, or decreasing their likeliness to consume cloned product.  
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7.2 Variables for Ordered Logit Model 
In order to estimate the ordered logit model, the dependent variable had to be created and 
some observations had to be deleted as explained below.  
 
7.2.1 Dependent Variables  
Since the goal is to understand the change in the likeliness value from one assessment to 
another (i.e., following the provision of information), the first step in creating the dependent 
variable is to find the differences in responses.  Each of the likeliness to consume questions were 
based on a 5 point Likert scale from 1= Not at all Likely, 3 = Somewhat Likely, and 5= Very 
Likely.  The variable to be analyzed using the ordered logit model is the difference between the 
values obtained for the first two assessments of the likelihood of consumption – i.e. 
“Government Approval (2) – Likeliness to Consume (1).”  (Similar models were estimated for 
the changes represented by “Price Reduction (3) – Government Approval (2)”, and “Price 
Reduction (3) – Likeliness to Consume (1)” but, as shown below, there was very little change in 
the likelihood of purchase ratings between the 2nd and 3rd assessments and thus very little to be 
learned from analyzing those changes.)  If a consumer increased their likeliness of consuming 
they were assigned a “+1” value for the new dependent variable.  If they decreased their 
likeliness to consume (difference was a negative value), they were assigned a “-1” value.  A “0” 
value was given to consumers who did not change their likeliness level.   
Thus, the dependent variable is defined as: 
 ݕ௜ ൌ ቐ
െ1 	݂݅ 	ݕ∗ ݅ݏ ൏ 0
		0 	݂݅ 	ݕ∗ ݅ݏ ൌ 0
൅1 	݂݅ 	ݕ∗ ݅ݏ ൐ 0
 (7.9) 
 As a consequence of their initial likeliness to consume value, some respondents were 
constrained in their responses.  That is, respondents with extreme opinions may have wanted to 
increase or decrease their likelihood of consuming value, but were unable to do so because of the 
confines of the scaling.  Consider a respondent whose response to the first “likeliness to 
consume” question is a “5” indicating they are “Very likely” to consume cloned product.  If their 
opinion of cloned product is enhanced as a result of new information, they have no way to 
indicate that is the case and can only indicate again, by choosing response option “5” that they 
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would be “Very likely” to consume.  If such observations are included in the ordered logit 
model, they will be misclassified as respondents whose opinion on cloning was unchanged as a 
result of the new information, whereas in fact their latent value (opinion of cloning) increased. 
The same argument applies at the other end of the scale. Thus, respondents who were on both 
ends of the scale, i.e. “1 = Not at all Likely” and “5 = Very Likely” and who did not change their 
response levels were deleted from the sample.  If kept in the model, these respondents would 
artificially increase the number of  “0” responses.   
For essentially the same reason, the analysis does not consider the magnitude of change 
in the likeliness to consume value.  The full range of potential values for the dependent variable 
is from -4 (for an individual whose scale changes from 5 to 1) to 4 (a change from 1 to 5).  
However, given the confines of the scale, we cannot always identify the desired change in rating 
for an individual whose new value is at either end of the scale – i.e., they may change from a 4 to 
a 5, but if 6 were an option they may have chosen it.  To simplify the analysis, the categorization 
of changes is limited to being either positive, no change, or negative.   
Table 7-1 below shows the proportion of observations remaining in each subsample after 
deleting observations where the response was potentially constrained.  In addition, table 7-1 
includes the percentage of those responses which were potentially constrained.  The total for 
each group will add to 100% across each model specification.  Both France and Ireland each had 
over 30% of respondents which did not change their initial stated likelihood of ‘Not At All 
Likely’ (Option 1) from the initial likeliness question to the second likeliness question (Model 2 
– 1).  The 30% of respondents who are ‘Not at all Likely’ to consume is generally consistent for 
France and Ireland in the Model (3) – (2) and the Model (3) – (1).  China had the largest group of 
respondents who indicated they were ‘Not At All Likely’ to consume cloned product at around 
44% for the first, second, and third models.  These consistent indicators show that the European 
Union countries and China are far less willing to adjust their stated likelihood even if educated.  
The groups which had the largest no change indication of ‘Very Likely to Consume’ 
(Option 5) were AgEcon and Honduras.  For Model (2) – (1), AgEcon indicated 19% and 
Honduras indicated 23%.  AgEcon showed the largest increase of consumers who were not 
willing to change indicated likelihood to consume in the Model (3) – (2) at 35% where Honduras 
indicated an increase to 30%.  The final model resembled the initial Model (2) – (1) where 
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AgEcon indicated 20% and Honduras indicated 22% of respondents which did not change their 
minds in being very likely to consume cloned product.   
The USA, English, and Sociology datasets did show measurable change in those 
consumers who sustained their stated likelihood to consume for ‘Not at All Likely’ (Option 1) 
and ‘Very Likely’ (Option 5).  For each, the percentage in the ‘Very Likely’ (Option 5) from 
Model (2) – (1) and Model (3) – (1) most closely resembled each other, while Model (3) – (2) 
deviated for each.  Interestingly, there was little similarity in the initial “Not at All Likely” 
(Option 1) percentages.  Overall, the ordered logit model was estimated using 66.3% of the 
observations from the full dataset.     
 
Table 7-1: Percentage of Observations Used for the Ordered Logit Model  
  Model (2) ‐ (1)  Model (3) ‐ (2) Model (3) ‐ (1)
  % in 
model 
No Chng 
Option 1 
No Chng 
Option 5 
% in 
model 
No Chng 
Option 1 
No Chng 
Option 5 
% in 
model 
No Chng 
Option 1 
No Chng 
Option 5 
Ag Econ  76.27%  5.08%  18.64% 59.32% 5.08% 35.59% 74.58%  5.08% 20.34%
English  84.78%  13.04%  2.17% 78.26% 8.70% 13.04% 89.13%  8.70% 2.17%
Sociology  80.00%  20.00%  0.00% 76.67% 16.67% 6.67% 83.33%  16.67% 0.00%
USA  80.00%  11.11%  8.89% 69.63% 8.89% 21.48% 81.48%  8.89% 9.63%
Ireland  66.07%  32.14%  1.79% 66.96% 29.46% 3.57% 69.64%  28.57% 1.79%
France  66.87%  31.29%  1.84% 66.87% 30.06% 3.07% 69.94%  28.22% 1.84%
Honduras  62.77%  13.83%  23.40% 59.57% 10.64% 29.79% 63.83%  13.83% 22.34%
China  55.00%  44.29%  0.71% 57.14% 42.86% 0.00% 56.43%  43.57% 0.00%
Total  66.30%  27.48%  6.21% 64.29% 25.47% 10.25% 68.48%  25.47% 6.06%
 
1. Logit Variable 1: Government Approval (2) minus Likeliness to Consume (1) 
 This variable measures the change in response between the first two likeliness to 
consume questions – i.e., from Likeliness to Consume (1) to Government Approval 
(2).  
 The question describing government approval of animal cloning gave consumers new 
information about the safety of cloned products.  Given the new information, 
respondents increased their “likeliness to consume” ratings.  However, not all 
respondents increased their likelihood of consuming between the 1st and 2nd 
assessments.   
 
  
7-85 
 
2. Logit Variable 2: Price Reduction (3)  minus Government Approval (2) 
 This variable measures the change between the third and second likeliness to 
consume question – Price Reduction (3) and Government Approval (2).   
 With the information about a potential 10% price reduction, consumers were given 
another piece of new information regarding cloned products besides the safety.  There 
were observed increases in likeliness to consume levels; however, the increase was 
nominal.  Therefore, this dependent variable will have the least amount of statistically 
significant variables to analyze. 
 
3. Logit Variable 3: Price Reduction (3)  minus Likeliness to Consume (1) 
 This variable measures the change between the third and first likeliness to consume 
question - Price Reduction (3) and Likeliness to Consume (1).   
 There is a total observed increase in likeliness to consume from the original question 
to the third question.  This alone will likely make the model mirror the results using 
the Logit Model (1) variable.  Therefore the hypothesis will be the same and little 
information will be gained from this model.  
 
7.2.2 Independent variables 
The independent variables in the ordered logit model were chosen based on their 
plausibility to potentially influence the observed change in the likelihood of consuming cloned 
product.  The variables included were: 
 
1. Question 4: Perceived Knowledge 
 This question is designed to elicit the perceived knowledge consumers have about 
advanced reproductive technologies.  Answer options include: 1 = Nothing, 2 = Very 
Little, 3 = A Fair Amount, 4 = A Great Deal.  
 It is hypothesized that the more respondents know (or believe they know) about these 
technologies, the more likely they will be to increase their stated likelihood of 
consuming cloned product in response to new information.  The thinking is that the 
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more familiar respondents are with technology, the more accepting they may be of 
information from scientists about product safety.  Thus, a positive sign is expected.   
 
2. Question 5: Likely to Consume (1) 
 This question was designed to find the initial reactions of respondents on their 
likeliness to consume product from cloned animals.  Answer options were on a five 
point Likert scale from 1= Not At All Likely, 3 = Somewhat Likely, and 5= Very 
Likely. 
 Information about product safety or a price decrease would be expected to increase 
reported likelihood of consuming cloned product.  It is expected that the lower the 
initial value for likelihood of consuming, the more likely it will be that the respondent 
will increase that likelihood rating.  Thus the expected sign for the coefficient is 
negative.     
3. Question 6: Reason for Discomfort 
 This question attempts to narrow down the primary reason for discomfort with animal 
cloning.  There were seven possible responses, four of which were used to define 
dummy variables identifying respondents who were primarily concerned about: a) 
cloning being morally wrong, b) cloning’s effect on food safety, c) animal cloning 
leading to human cloning and d) cloning being unsafe for animals.   
 Animal Cloning is Morally Wrong  
The hypothesis for this explanatory variable is if consumers are morally opposed to 
animal cloning they will either decrease or sustain their likeliness to consume cloned 
products. The coefficient is expected to be negative.  
 Unsure of food safety from cloned animals  
The hypothesis for this explanatory variable is that if consumers are concerned with 
the food safety of cloned animals, they should increase their likeliness to consume 
cloned products if given additional information about the safety.  Therefore the 
coefficient on this variable is expected to be positive.  
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 Animal cloning might lead to human cloning  
The hypothesis for this variable is that if consumers are concerned that animal 
cloning is just a slippery slope toward human cloning, than they will decrease or 
maintain their likeliness to consume even if given additional information.  Therefore 
the coefficient is expected to be negative.   
 Unsure that cloning is safe for animals  
The hypothesis for this variable is that if consumers are concerned that animal 
cloning is unsafe for animals, than they will decrease or maintain their likeliness to 
consume even if given additional information, therefore the variable will be negative.  
There is a chance the coefficient will be positive if consumers believe that 
government approval also implies that animal safety is protected.  
 
4. Gender 
 This is a dummy variable for Female = 1.  
 This variable is included to investigate whether females are more or less likely than 
males to change their assessment of cloning in response to new information.  No 
hypothesis is made for the sign of its coefficient.    
 
 
7.3 Ordered Logit Model: Government Approval (2) minus Likeliness to 
Consume (1) 
The first ordered logit model uses as its dependent variable the difference between the 
likeliness levels for Likeliness to Consume (1) and Government Approval (2).  The model 
measures the effects of the explanatory variables on the probability that respondents either 
increase, maintain, or decrease their likelihood of consuming cloned product in response to new 
information about product safety.   
Figure 7-1 gives a breakdown of consumers who decreased, sustained, or increased their 
likeliness to consume rating between the first and second assessments.  Note that the data 
represented in the figure excludes respondents whose evaluation change was potentially 
constrained as explained above. The total number of respondents represented is 427 – or 66.3% 
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of the 644 observations in the earlier OLS models.  As table 7-1 shows, 33.70% (27.48% from 
those who did not change their 1 response plus 6.21% from those who did not change their 5 
response) of the respondents were on the extreme ends of the spectrum and did not change their 
opinions on animal cloning after learning additional information.   
Only 12.88% of respondents decreased their likeliness to consume, indicated by a “-1” 
value.  Conversely, 46.37% increased their likeliness to consume, indicated by a +1 value, and 
40.75% maintained, indicated by a 0 value.  Notably, 20.78% of Chinese respondents decreased 
their likeliness to consume cloned product following the provision of information about 
government approval.  In France, 17.43% of respondents decreased their stated likeliness of 
consuming, whereas in the English class, none decreased their likelihood rating.  There was also 
some variability in terms of the proportion increasing their likelihood of consuming ranging from 
a low of 35.78% in France and China, to a high of almost 70% in the English class.  
 
Figure 7-1: Frequency Chart for Total Change Values of Likeliness Levels, Model (2) – (1)  
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7.3.1 Ordered Logit Results  
Table 8.2 contains the results from the ordered logit model.  Goodness of fit, as indicated by 
Pseudo R-squared shows that the Chinese model had the best overall fit.  Initially, separate 
models were estimated for the AgEcon, English, and Sociology class samples but the ordered 
logit coefficients for the Sociology sample could not be estimated – likely a consequence of the 
limited number of observations.  As a result, the data for the English, Sociology and AgEcon 
classes were combined into one sample, with dummy variables used to represent effects related 
to the different classes.  
The knowtech coefficient is positive, as hypothesized, in four of the five models and 
statistically significant in two.  The positive sign indicates that the more familiar the respondent 
is with animal reproductive technologies, the more likely they are to increase their stated 
likelihood of consuming cloned product in response to the new information about product safety.   
The estimated coefficients on likely1 are negative and statistically significant in each 
respondent group.  This conforms with expectations - it was expected that the lower the initial 
value for likelihood of consuming (likely1), the more likely the respondent would be to increase 
their likelihood rating.  This result suggests that the information about product safety has the 
greatest impact on individuals who were initially skeptical about cloned products.  Importantly, 
this result is not driven by the fact that respondents who initially gave a high rating to their 
likelihood of consuming cloned product were constrained from offering an even higher rating in 
response to the new information, because all such observations are no longer part of the sample.  
What the result indicates is that an individual who initially gave a rating of perhaps 2 to their 
likelihood of consuming cloned product is much more likely to increase that rating than is an 
individual who initially gave a rating of 4.   
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Table 7-2: Ordered Logit Model Results  
  USA  Ireland France Honduras  China
Food Related Issues     
knowtech  0.544837*  0.8308015** 0.0759155 0.2401559  ‐0.155743
likely1  ‐0.9936818***  ‐0.9350056*** ‐1.056762*** ‐1.714988***  ‐2.998934***
Reasons for Concern     
      morallywrong  ‐3.088459***  ‐3.243906*** ‐1.23625** ‐0.8923555  1.448344
      foodsafety  ‐1.48284**  ‐0.0659621 0.0276463 ‐0.3941371  0.4376977
      humancloning  ‐2.619344***  ‐2.485061 ‐0.3917275 1.818788  0.4547694
       animalsafety  ‐2.188432***  ‐0.464802 ‐0.4785274 2.094506  0.5579532
Demographic Info     
female  0.0379731  0.7377869 ‐0.0619967 ‐1.198007*  ‐0.2117327
english  0.7629247   
sociology  ‐0.7397264   
Number of obs  108  74 109 59 76 
Pseudo R2  0.1538  0.159 0.0893 0.2987 0.4698
Log Liklihood  ‐74.953121  ‐60.932754 ‐102.00812 ‐36.986655  ‐42.717051
*,**, and *** indicates statistical significance at the 10%, 5%, and 1% levels. 
 
7.3.1.1 Reason for discomfort with cloning: 
The coefficient on morallywrong is negative in every country except China, and is 
statistically significant in three models.  The negative value indicates that if consumers have 
moral objections to animal cloning, it is probable they will decrease their likeliness to consume 
given new information about government approval.  This is consistent with the hypothesis for 
this variable.  The variable has a positive impact in the Chinese sample, but this may be a 
consequence of data concerns previously noted.    
The foodsafety coefficient was expected to be positive reflecting the idea that if 
consumers are concerned with the food safety of cloned animals, they should increase their 
stated likeliness to consume cloned products when given additional information about product 
safety.  Results do not conform to this expectation, as the coefficient is never significantly 
positive and is in fact negative and significant in the US sample.  The US result indicates that 
those who are concerned with food safety of cloned animals decrease their stated likelihood to 
consume cloned product even if given information about the food safety.  
The coefficients humancloning and animalsafety were expected to be negative, but are 
statistically significant in the expected direction in only one of the five samples.  The estimated 
female coefficient is positive in two models and negative in three, but only statistically 
significant (and negative) in the Honduran sample.   
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Given the patterns in table 7.2 above, the English and Sociology dummy variables show 
positive signs as expected.  Compared to the AgEcon sample, respondents in the English class 
are more likely to increase their stated likelihood of consuming cloned product, while 
respondents in the Sociology class are more likely to reduce their stated likelihood of consuming.  
However, neither dummy variable coefficients are statistically significant.  
 
7.3.2 Marginal Effects 
Arguably the more descriptive analysis from this model is the marginal effects based on 
the directions of change.  Since the dependent variable is categorical with values of “-1”, “0”, 
and “+1”, the marginal effects give the probabilities on the directional change given a one-unit 
change in the independent variable.  The total percentage change for each respondent group will 
equal zero because probabilities must sum to 1 and thus as the probability of being in one 
category increases, the probability of being in another must decrease.  Table 7-3 presents the 
marginal effects.   The discussion will focus on variables that had statistically significant 
coefficients in the ordered logit model.  
First, we consider the knowtech variable, which had the expected positive sign in four of 
the five samples, and was statistically significant in two (USA and Ireland).  In the Irish sample, 
the estimated marginal effects indicate that a one-unit increase in familiarity with technology, 
increases (by 20.6%) the probability that an individual will increase their stated likelihood of 
consuming cloned product,  and reduce by 7.5% and 13.0% respectively the probability that they 
will reduce or maintain the same stated likelihood.   
The likley1 variable had the expected negative sign and was statistically significant in the 
models for all five samples. The marginal effects were most pronounced in the Chinese sample 
where a one-unit reduction in likley1 was associated with a 59% increase in the probability that a 
respondents would increase (as opposed to decrease or maintain) their stated likelihood of 
consuming cloned product.  Collectively the marginal effect on likely1 indicates that individuals 
with higher initial levels of likelihood to purchase were more likely to reduce or maintain their 
evaluation of cloned product than they were to increase it.  
The other variable which had a reasonably consistent effect in the ordered logit model 
was morallywrong.  This variable had negative coefficient estimates in all samples except for 
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China.  In the AgEcon sample, the estimated marginal effect indicates that an individual whose 
primary concern was that cloning was morally wrong was 57% less likely to increase their stated 
likelihood of consuming cloned product, compared to an individual in the baseline category (who 
was not uncomfortable with cloning).  Similar results were found for the other three reasons that 
respondents might object to cloning.  The results indicate that individuals who identify any of the 
four listed concerns as their primary concern with cloning are unlikely to increase their stated 
likelihood of consuming cloned product in response to receiving information from a government 
agency about the safety of cloned products.  However, respondents who are morally opposed to 
the process have the highest probability of decreasing their likeliness to consume given new 
information about product safety.  
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Table 7-3: Marginal Effects from the Ordered Logit Model  
    USA Ireland France Honduras China 
Knowtech  Average Change  8.72% 13.74% 1.15% 3.97% 2.05% 
1 – 4   P [Change ‐1]  ‐1.26% ‐7.55% ‐0.92% ‐0.54% 0.66% 
  P [Change ‐0]  ‐11.82% ‐13.06% ‐0.80% ‐5.42% 2.41% 
  P [Change +1]  13.08% 20.61% 1.72% 5.96% ‐3.07% 
Likely 1  Average Change  15.90% 15.47% 15.96% 28.35% 39.41% 
1 – 5   P [Change ‐1]  2.30% 8.50% 12.79% 3.85% 12.73% 
  P [Change ‐0]  21.56% 14.70% 11.15% 38.67% 46.38% 
  P [Change +1]  ‐23.86% ‐23.20% ‐23.94% ‐42.53% ‐59.12% 
morallywrong  Average Change  37.97% 40.64% 16.24% 13.73% 22.33% 
0‐>1  P [Change ‐1]  28.42% 60.96% 18.84% 2.84% ‐3.81% 
  P [Change ‐0]  28.53% ‐5.89% 5.51% 17.75% ‐29.68% 
  P [Change +1]  ‐56.96% ‐55.07% ‐24.35% ‐20.59% 33.49% 
foodsafety  Average Change  23.07% 1.09% 0.42% 6.47% 5.61% 
0‐>1  P [Change ‐1]  3.95% 0.60% ‐0.33% 0.93% ‐1.96% 
  P [Change ‐0]  30.65% 1.03% ‐0.29% 8.77% ‐6.45% 
  P [Change +1]  ‐34.60% ‐1.64% 0.63% ‐9.70% 8.41% 
humancloning  Average Change  35.98% 31.30% 5.72% 26.14% 6.36% 
0‐>1  P [Change ‐1]  18.16% 45.75% 5.08% ‐2.10% ‐1.69% 
  P [Change ‐0]  35.80% 1.21% 3.51% ‐37.11% ‐7.84% 
  P [Change +1]  ‐53.97% ‐46.95% ‐8.58% 39.21% 9.54% 
animalsafety  Average Change  32.57% 7.70% 6.68% 29.25% 7.62% 
0‐>1  P [Change ‐1]  11.42% 4.57% 6.74% ‐2.39% ‐2.19% 
  P [Change ‐0]  37.43% 6.98% 3.27% ‐41.48% ‐9.24% 
  P [Change +1]  ‐48.85% ‐11.55% ‐10.01% 43.87% 11.44% 
female  Average Change  0.61% 12.08% 0.94% 18.96% 2.73% 
0‐>1  P [Change ‐1]  ‐0.09% ‐6.83% 0.75% 3.21% 0.93% 
  P [Change ‐0]  ‐0.82% ‐11.29% 0.66% 25.24% 3.17% 
  P [Change +1]  0.91% 18.12% ‐1.41% ‐28.45% ‐4.10% 
English  Average Change  11.81%  
0‐>1  P [Change ‐1]  ‐1.63%  
  P [Change ‐0]  ‐16.08%  
  P [Change +1]  17.71%  
Sociology  Average Change  12.08%  
0‐>1  P [Change ‐1]  2.12%  
  P [Change ‐0]  15.99%  
  P [Change +1]  ‐18.11%  
Pr(yx)  P [Change ‐1]  2.37% 10.12% 14.09% 2.30% 4.44% 
  P [Change ‐0]  37.67% 35.53% 51.23% 52.19% 68.55% 
  P [Change +1]  59.96% 54.35% 34.69% 45.51% 27.00% 
 
 
7-94 
 
7.3.3 Ordered Logit Model (2) and Ordered Logit Model (3) 
The work and analysis for the ordered logit model for Price Reduction (3) – Government 
Approval (2) and Price Reduction (3) minus Likeliness to Consume (1) was in fact done for 
completeness of the study.   
The results for Logit Model (2) indicated very low Pseudo R-Squared values and very 
few statistically significant variables.  In fact the only statistically significant variable was 
foodsafety for China.  The poor results are likely due to the very low increase for those 
respondents who were more likely to consume cloned product as seen in Figure 5-6.  For this 
reason, the results will not be analyzed; however, the tables are available in Appendix 10-1.  
The results for Logit Model (3) were consistent with the hypothesis and in fact closely 
mirrored the results from Logit Model (1) – Government Approval (2) minus Likeliness to 
Consume (1).  Due to this, no new information is gained from a separate analysis; however, the 
tables are available in Appendix 10 – 2.  
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8 Conclusion 
The objective of this thesis was to assess consumers’ likelihood of consuming products 
from cloned animals and their progeny.  Since the birth of ‘Dolly the sheep’ in 1996, animal 
cloning has become a highly contentious global political issue that is competing with needed 
efficiencies in a growing production environment.  By examining samples from the US, Europe, 
Asia, and Central America, a current global perspective of consumer attitudes and their likeliness 
to consume cloned product emerges.  The global comparison is especially important to potential 
trade concerns the US meat industry might have once the issue and product materializes on a 
larger scale.  By comparing levels of concern for other food technologies, production practices, 
expressed levels of concern about cloning, and willingness to purchase cloned product, a much 
clearer picture evolves in how consumers will react once the technology has reached the 
marketplace. More specifically this study looked at: a) change in likeliness to consume cloned 
product after being given additional pieces of information about government approvals of food 
safety, b) expressed levels of concern about cloning and their effect on likeliness to consume 
cloned product, c) expressed levels of concern about other food technology issues and their 
effect on likeliness to consume cloned product.  
 
 
8.1 Current Political State 
The primary advantage cloning offers for food production is the ability to exactly 
replicate animals with superior production characteristics.  By duplicating these superior 
breeding animals, cloning extends the longevity of genetically high-quality animals which has 
the potential to enhance overall herd genetics and thus increase overall productivity.  This 
resulting increase in animal productivity has the potential to benefit both producers – through 
lower production costs – and consumers – either through lower retail prices or improved product 
quality and uniformity.  Given the United Nations (2009) estimate that “food production will 
need to double by mid-century to meet demand from a growing world population,” the 
production enhancing benefits of cloning become more appealing.   
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Concurrently however, active and well-organized consumer groups are working to 
implement stringent labeling laws or entire bans on cloning animals, especially for human 
consumption.  These animal cloning opponents aggressively pushed their position citing 
concerns about human health and animal health and welfare, ethical objections to cloning, and 
the potential risks for agro-biodiversity and sustainability.  The controversy has influenced 
several governments to conduct official reviews of the science and its application to the human 
food supply.  Two risk assessments were released in January 2008 by the FDA and the EFSA 
(FDA 2008, EFSA 2010).  Both concluded that it is very unlikely there are any differences 
between products derived from clones and clone offspring and foods derived from 
conventionally bred animals.  However, subsequent to the released assessments, both agencies 
have noted that the ethical concerns related to cloning were not within the purview of the risk 
assessments and must be left to public debate.    
The trade implications from these assessments are substantial.  If legislation banning 
animal cloning or strict domestic and import labeling laws are passed, without being derived 
from adequate and scientifically proven human food and animal welfare risk assessments, it 
could result in WTO intervention.  On July 7, 2010 the European Parliament passed legislation 
which would ban foods derived from clones or their offspring.  In likely response and aversion to 
a potential trade conflict, the European Commission created a separate policy in October 2010 
which implemented a five-year ban on the use of animal cloning for food production but which 
did not ban imports of foods derived from clone offspring.  This ban cited justification based on 
animal welfare grounds and helps to temporarily avoid significant trade issues while Europe 
works to find an adequate political resolution.   
 
 
8.2 Application of Previous Research 
Much research has been conducted on consumer perceptions of biotechnology, but the 
studies during the years immediately before and after the FDA 2008 risk assessment have 
focuses primarily on attitudes toward animal cloning.  Many of these surveys focus on one of 
four areas including: a) level of familiarity with biotechnology and/or cloning, b) likelihood of 
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purchasing/consuming ‘cloned products,’ c) specific concerns about cloning, and d) who 
consumers trust to provide information about the technology.   
Hoban (2001) concluded that not many consumers have a direct connection with 
agriculture and food production which limits their literacy about developments in food 
biotechnology.  However, the more information consumers have about a given food technology, 
the more accepting of the technology they appear to be (Lusk 2008).  Even though it is difficult 
to assess exactly what consumers “know” about an issue, the perceptions consumers have toward 
food products are what influence consumers purchase behavior (Knight 2005).  For cloning 
specifically, this translates to consumer misconception and confusion about its application to 
farming practices (Sosin and Richards 2005) which could affect buying habits.  When asked 
directly, many studies find a one third split between respondents who indicate they would 
purchase cloned product, one third who might consider it given more information, and one third 
who would never purchase (Lusk 2008, Sosin and Richards 2005).  These studies provided the 
basis of the survey which included questions about perceived knowledge, biotechnology 
concerns, and initial reactions to animal cloning.  The results found in this study were generally 
consistent with those found in previous studies.   
Beyond just consumer reactions, this study tried to narrow the focus on why consumers 
indicate discomfort from animal cloning.  In order to create the options, major concerns were 
either replicated from previous surveys or derived from the major positions cloning objectors use 
when communicating to the public and policy makers.  A review of the literature found the most 
commonly cited reasons for discomfort of animal cloning were morality concerns (32%) 
followed by uncertainty about food safety (26%), the fear that animal cloning might lead to 
human cloning (23%), and concerns for animal welfare (14%) (Storey 2006).  The Mellman 
Group (2005) found that religion and ethics tops the list of concerns among consumers who are 
uncomfortable with animal cloning.  For completeness of analysis, other demographic 
information such as religious affiliation and gender where included as well.   
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8.3 Results 
Initial results from this study indicated an overall increase of likeliness to consume after 
being presented with additional pieces of information regarding the FDA and EFSA approvals as 
well as a situation where cloned product would be 10% less expensive.  Concurrently, the basic 
average analysis and the percentage change logit analysis indicated an overall increase in 
likeliness to consume.  This increase can be attributed to the influence of the information about 
product safety and price.  The logit model also signified that the lower the initial value for 
likelihood of consuming (likely1), the more likely the respondent would be to increase their 
likelihood rating after positive information was presented.  This result suggests that the 
information about product safety has the greatest impact on individuals who were initially 
skeptical about cloned products.  From an aggregate standpoint, the total percentage breakdown 
of respondents who indicated they were ‘not at all likely’ to consume, ‘somewhat likely’ to 
consume, and ‘very likely’ to consume were relatively consistent with current literature (Lusk 
2008, Sosin and Richards 2005).  Overall, the ‘not at all likely” category fell from 40% for the 
first question to about 30% in the second and third questions.   
The regression analysis illustrated the effect demographic information, biotechnology 
concerns, and animal cloning concerns might have on purchase intent.   First, consumers who 
indicated negative concerns with advanced food technology, such as hormone use, are 
consistently unlikely to consume cloned products.  This was consistent across all groups.  
Second, the top four listed identified “concerns” including morality, food safety of cloned 
product, potential for human cloning, and animal welfare concerns had consistent negative 
impacts on the models across respondent groups.  The coefficient describing moral concerns 
consistently had the greatest magnitude impact in both the OLS and ordered logit models across 
most groups.  These listed concerns verified that consumers who agreed with the negative 
identifiers were very unlikely to consume cloned product even if educated about the food safety 
issues or price reductions.  Furthermore, the logit analysis showed that there is a high probability 
that consumers who identify with at least one of these concerns will either maintain or decrease 
their likeliness to consume cloned product even if given new information about approval of food 
safety and price reductions. 
The results of the entire analysis were relatively consistent in the overall conclusions.  
While economic analysis expects some deviation, most of the countries followed the same 
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pattern with the exception of China which had known data issues.  This relative consistency 
suggests that once animal cloning reaches a larger market, consumer reactions will likely be the 
same from both US domestic consumers as well as America’s major trade partners in Europe, 
Latin America, and Asia.  Since the results show low initial reaction to animal cloning, 
information and education about the science, its approved food safety, and its potential lower 
market prices will be important in creating consumer acceptance of the technology.  So long as 
the political systems do not create bans or strict labeling which might affect consumer 
perceptions, there is potential for cloned product to be accepted in the marketplace.     
 
 
8.4 Limitations and Recommendations 
Limitations of this dataset were limited responses from each country surveyed and data 
entry concerns for especially the China and Honduras datasets.  In addition, the survey was 
presented to college age students who, especially in Honduras and China, are likely not regular 
purchasers of retail food products and already have higher education levels than many in their 
respective countries.  Many of the students are likely utilizing available cafeteria 
accommodations and have little need to purchase and cook their own food.  With these two 
demographic realities alone, the sample may not be a true picture of current protein buyers even 
if some studies have found students samples to be on par with representative samples (Lusk, et 
al. 2005).  However, these respondents are the demographic which will be potential buyers if 
cloning technology actually emerges as a mainstream production practice.  In addition, the 
survey mainly referred to product derived from ‘animal clones’ and not necessary the ‘progeny 
of animal clones’.  Because of production price however, it is unlikely animal clones will reach 
the marketplace. 
There are several recommendations in applying this study to current and future marketing 
and policy procedures.  Without explicit knowledge of where the political debate will conclude, 
and so long as the production costs stay high, it is likely that animal cloning will only be used for 
specific situations and will not emerge as mainstream livestock production technology.  
However, if the United Nations (2009) estimates on needed production increases materializes, 
and the cost of cloning technology continues to decrease, the economic and productivity benefits 
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of the technology will be become more appealing.  Until then, the economic and political 
benefits of understanding consumer perceptions will be essential to effectively placing the 
product in the marketplace.  We suggest that these perceptions are monitored over time as the 
political and media climate changes toward the technology and in addition find willingness to 
pay for cloned animals versus non cloned animals.  This study will be a part of shaping 
prospective studies and product messaging into the future. 
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10.1 Ordered Logit Model (2): Price Reduction (3) – Government      
Approval (2) 
Because there was not much change between likeliness levels between Price Reduction 
(3) and Government Approval (2), it greatly affected the significance of the ordered logit model 
and made it very hard to gain any new information from the model.  Below are the results from 
the analysis to show that work was done on this model.  
 
Figure 10-1: Frequency Chart for Total Change Values of Likeliness Levels, Model (3) – (2)  
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Table 10-1: Ordered Logit Model Coefficient Results for Logit Model (2) – (1) 
  USA  Ireland France Honduras  China 
Food Related Issues     
knowtech  ‐0.1600267  ‐0.7530452** 0.2661465 ‐0.136781  ‐0.6666715*
likely1  0.3396821  ‐0.427308* 0.0830583 ‐0.1952307  0.1609873
Reason for Concern     
morallywrong  ‐0.2783378  2.17446* 1.14235* 0.0562155  ‐0.3630942
foodsafety  ‐0.0925916  ‐0.3747203 0.3949875 ‐0.8678078  ‐1.476604***
humancloning  1.362185  ‐0.449215 0.0944416 ‐0.2323233  ‐0.343621
animalsafety  0.1600346  0.2036932 0.548949 0.2704362  0.4583864
Demographic Info     
female  0.6642777  ‐0.7380855 ‐0.0169459 0.0591082  ‐0.541748
english  ‐0.4641543 
sociology  0.2429324 
Number of obs  94  75 109 56 79 
Pseudo R2  0.0438  0.0925 0.03 0.0312 0.0933
Log Liklihood  ‐91.759639  ‐72.884179 ‐104.02089 ‐52.157726  ‐69.068897
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Table 10-2: Marginal Effects from Ordered Logit Model (3) – (2) 
    USA Ireland France Honduras China 
Knowtech  Average Change  4.44% 11.79% 3.70% 1.47% 7.21% 
1 – 4  P [Change ‐1]  3.46% 11.99% ‐3.30% 2.21% 8.60% 
  P [Change ‐0]  3.20% 5.70% ‐2.25% ‐0.14% 2.21% 
  P [Change +1]  ‐6.66% ‐17.68% 5.55% ‐2.07% ‐10.81% 
Likely 1  Average Change  1.48% 6.69% 1.15% 2.10% 1.74% 
1 – 5  P [Change ‐1]  1.15% 6.80% ‐1.03% 3.16% ‐2.08% 
  P [Change ‐0]  1.06% 3.23% ‐0.70% ‐0.20% ‐0.53% 
  P [Change +1]  ‐2.22% ‐10.03% 1.73% ‐2.95% 2.61% 
morallywrong  Average Change  21.78% 32.16% 17.08% 0.60% 3.60% 
0‐>1  P [Change ‐1]  ‐11.53% ‐19.95% ‐11.85% ‐0.90% 5.16% 
  P [Change ‐0]  ‐21.14% ‐28.28% ‐13.77% 0.04% 0.25% 
  P [Change +1]  32.67% 48.23% 25.62% 0.86% ‐5.41% 
foodsafety  Average Change  2.55% 5.80% 5.67% 9.69% 17.03% 
0‐>1  P [Change ‐1]  ‐1.99% 6.10% ‐4.60% 14.54% 17.90% 
  P [Change ‐0]  ‐1.84% 2.60% ‐3.90% ‐1.88% 7.64% 
  P [Change +1]  3.83% ‐8.70% 8.50% ‐12.66% ‐25.54% 
humancloning  Average Change  10.90% 6.59% 1.33% 2.66% 3.48% 
0‐>1  P [Change ‐1]  ‐6.90% 8.06% ‐1.15% 3.99% 4.77% 
  P [Change ‐0]  ‐9.45% 1.82% ‐0.84% ‐0.70% 0.45% 
  P [Change +1]  16.35% ‐9.88% 1.99% ‐3.29% ‐5.23% 
animalsafety  Average Change  7.12% 3.22% 8.30% 2.92% 5.14% 
0‐>1  P [Change ‐1]  6.41% ‐3.14% ‐5.66% ‐4.09% ‐5.68% 
  P [Change ‐0]  4.28% ‐1.69% ‐6.79% ‐0.29% ‐2.02% 
  P [Change +1]  ‐10.69% 4.84% 12.46% 4.38% 7.70% 
female  Average Change  3.87% 11.46% 0.24% 0.64% 5.57% 
0‐>1  P [Change ‐1]  ‐3.03% 11.72% 0.21% ‐0.95% 7.43% 
  P [Change ‐0]  ‐2.78% 5.47% 0.14% 0.06% 0.92% 
  P [Change +1]  5.81% ‐17.19% ‐0.35% 0.90% ‐8.35% 
English  Average Change  2.54%  
0‐>1  P [Change ‐1]  2.02%  
  P [Change ‐0]  1.80%  
  P [Change +1]  ‐3.81%  
Sociology  Average Change  5.50%  
0‐>1  P [Change ‐1]  ‐3.98%  
  P [Change ‐0]  ‐4.27%  
  P [Change +1]  8.25%  
Pr(yx)  P [Change ‐1]  14.57% 19.86% 14.49% 20.28% 15.22% 
  P [Change ‐0]  45.72% 42.46% 55.91% 61.15% 64.41% 
  P [Change +1]  39.71% 37.68% 29.60% 18.57% 20.37% 
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10.2 Ordered Logit Model (3): Price Reduction (3) – Likeliness to  Consume (1) 
The difference between Price Reduction (3) and Likeliness to Consume (1) was actually a 
result of the difference between Price Reduction (3) minus Government Approval (2) plus Price 
Government Approval (2) and Likeliness to Consume (1). The greatest magnitude in difference 
came from Government Approval (2) and Likeliness to Consume (1) which affected the model.  
In fact the results mirrored those from  Ordered Logit Model (1) and gave no new information 
worth analyzing.  
 
Figure 10-2: Frequency Chart for Total Change Values of Likeliness Levels, Model (3) –(1) 
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Table 10-3: Ordered Logit Model Coefficient Results for Logit Model (3) – (1) 
USA  Ireland France Honduras  China
Food Related Issues       
knowtech  0.5002639  0.0338419 0.251944 ‐0.01755 ‐0.1206049
likely1  ‐0.8695822***  ‐1.357478*** ‐1.203609*** ‐1.767804***  ‐2.882581***
Reason for Concern       
morallywrong  ‐1.263392  ‐1.083733 ‐0.39996 ‐0.98795 0.7274352
foodsafety  ‐1.537744**  ‐0.4138402 0.535893 ‐0.56452 ‐0.9311406
humancloning  ‐1.753076**  ‐2.418197 ‐0.13933 1.229751  0.2081301
animalsafety  ‐2.347724***  ‐0.3172254 0.294949 1.574938  1.20999*
Demographic Info       
female  0.7009683  0.7075431 0.003176 ‐1.141086*  ‐0.2487018
english  0.5732544 
sociology  0.5962384 
Number of obs  110 78 114 60 78 
Pseudo R2  0.1213  0.1807 0.1069 0.2717 0.4868
Log Liklihood  ‐73.885954  ‐61.256257 ‐100.894 ‐41.9388 ‐41.122659
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Table 10-4: Marginal Effects from Ordered Logit Model (3) – (1) 
    USA  Ireland France Honduras China 
Knowtech  Average Change  6.19% 0.55% 4.07% 0.29% 1.80% 
1 ‐ 4  P [Change ‐1]  ‐2.60% ‐0.32% ‐2.29% 0.08% 0.38% 
  P [Change ‐0]  ‐6.69% ‐0.51% ‐3.80% 0.36% 2.32% 
  P [Change +1]  9.29% 0.82% 6.10% ‐0.43% ‐2.70% 
Likely 1  Average Change  10.77% 22.01% 19.42% 29.16% 43.04% 
1 ‐ 5  P [Change ‐1]  4.51% 12.73% 10.96% 7.92% 9.12% 
  P [Change ‐0]  11.64% 20.28% 18.17% 35.83% 55.44% 
  P [Change +1]  ‐16.15% ‐33.01% ‐29.13% ‐43.75% ‐64.56% 
morallywrong  Average Change  18.86% 17.58% 6.32% 16.04% 11.56% 
0‐>1  P [Change ‐1]  10.66% 14.29% 3.92% 6.26% ‐1.80% 
  P [Change ‐0]  17.63% 12.08% 5.55% 17.80% ‐15.54% 
  P [Change +1]  ‐28.28% ‐26.37% ‐9.48% ‐24.06% 17.34% 
foodsafety  Average Change  19.28% 6.74% 8.76% 9.31% 14.02% 
0‐>1  P [Change ‐1]  8.94% 4.06% ‐4.45% 2.73% 2.84% 
  P [Change ‐0]  19.98% 6.05% ‐8.69% 11.23% 18.20% 
  P [Change +1]  ‐28.91% ‐10.11% 13.13% ‐13.96% ‐21.03% 
humancloning  Average Change  26.44% 32.33% 2.23% 17.49% 3.17% 
0‐>1  P [Change ‐1]  17.11% 44.85% 1.31% ‐3.47% ‐0.62% 
  P [Change ‐0]  22.54% 3.64% 2.04% ‐22.76% ‐4.14% 
  P [Change +1]  ‐39.66% ‐48.49% ‐3.35% 26.23% 4.75% 
animalsafety  Average Change  34.59% 5.19% 4.84% 21.57% 18.50% 
0‐>1  P [Change ‐1]  25.84% 3.15% ‐2.41% ‐4.28% ‐3.43% 
  P [Change ‐0]  26.05% 4.63% ‐4.85% ‐28.08% ‐24.32% 
  P [Change +1]  ‐51.88% ‐7.78% 7.27% 32.35% 27.75% 
female  Average Change  8.58% 11.33% 0.05% 18.49% 3.66% 
0‐>1  P [Change ‐1]  ‐3.63% ‐6.60% ‐0.03% 5.88% 0.82% 
  P [Change ‐0]  ‐9.24% ‐10.39% ‐0.05% 21.85% 4.67% 
  P [Change +1]  12.86% 16.99% 0.08% ‐27.73% ‐5.49% 
English  Average Change  6.83%  
0‐>1  P [Change ‐1]  ‐2.81%  
  P [Change ‐0]  ‐7.42%  
  P [Change +1]  10.24%  
Sociology  Average Change  6.76%  
0‐>1  P [Change ‐1]  ‐2.70%  
  P [Change ‐0]  ‐7.44%  
  P [Change +1]  10.14%  
Pr(yx)  P [Change ‐1]  5.49% 10.48% 10.13% 4.70% 3.27% 
  P [Change ‐0]  19.15% 31.27% 48.80% 40.25% 62.86% 
  P [Change +1]  75.35% 58.25% 41.07% 55.05% 33.87% 
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10.3 Consumer Surveys 
Below is each of the translated surveys.  Included are the English, French, Spanish, and 
Chinese translations. Translations were completed by colleagues in the Kansas State University 
Department of Agricultural Economics including: Dr. Tian Zian, Yue Zheng, Jaeljattin Jean, 
Sandra Contreas, and Quentin Baudouin. 
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10.3.1 English Version Survey 
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10.3.2 French Version Survey 
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10.3.3 Spanish Version Survey  
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10.3.4 Chinese Version Survey 
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10.4 Respondent Open Ended Comments 
 
Respondents were offered the opportunity to write any comments they had about the 
survey or subject matter.  Below are all comments offered by respondents with no spelling or 
grammatical changes.  The comments have been reviewed for correct spelling and where 
appropriate, have been translated into English.  
 
10.4.1 Open Ended Responses: United States 
 It is difficult for a college student to know how to answer on the last page. I answered 
them as if I was at home with my folks on the farm. Thanks. 
 
 Meat grown in a lab seems artificial to me. However if they clone a whole living cow and 
have a whole living cow then that is real beef to be eaten. 
 
 I liked this survey! 
 
 The only reason I would not eat cloned animal meat is because I would think about the 
animal being cloned and it would make me feel sick. The other day I thought about my 
meatloaf being undercooked when it really wasn't but just the thought made me stop 
eating my meatloaf. It is all kind of a mind game with me. 
 
 Interesting survey Sean! The information about cloning is especially interesting. 
 
 I have worked in grocery stores for several years and have seen the behind the scenes 
reality of cutting and selling fresh meat products. People should be just as concerned 
about current meat contamination from improper cutting and handling as about cloning, 
etc. 
 
 To be more specific, maybe ask if the person is a student and living in the dorms. Maybe 
ask them to base their answers off of their parent's household as they are included. 
 
 The other people in my household eat meat. I do not. 
 
 An Environmental Socio student - interesting on the cloning! Unbelievable how 
advanced things have become/are continuing to become. 
 
 Since I am older I have found that the food and Drug admin has approved things in the 
past and then later had to issue warnings due to lack of information from companies that 
manufacture products being released in an attempt to rush getting approval. 
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 I would pay extra money for purchasing foods for my health.  The FDA isn't always right 
and can't be trusted all of the time, especially if their pockets are being lined with money 
from special interest groups, though they claim to be impartial. 
 
10.4.2 Open Ended Responses: Ireland 
 I pay close attention to free range chicken products. I love chicken but am very reluctant 
to buy ready meals, pizzas or take away food with chicken as I prefer to eat free range 
chicken. I pay close attention to weather meat is Irish or not, regarding of the price I will 
pay for Irish products and also free range products. I would love to see labeling on pork 
products that shows what kind of farming practice has taken place, the swine industry 
makes me physically sick when I think of the lives the pigs have under a intensive 
system, I have cut back greatly on pig meat for this reason solely. 
 
 I believe that meat from cloned animals would be perfectly safe.  My objection to cloning 
would be on the basis of a reduction in the gene pool and locally adapted species in the 
long term.  Science has a poor track record accommodating diversity.  And who would 
have the intellectual property right on the clone - the farmer or the breeding company?  
This is a serious and maybe unnecessary implication of such interventions. 
 
 We must take scientific measures in relation to food production or else the world will 
starve. GM is a must for survival. Organic is fine for a small few but it won’t feed the 
world 
 
 In regards to some of your questions the main thing i look for in the buying meat is it 
country of origin and fully traceability. These are in my opinion key to purchases. And i 
would only be in support of cloning if it didn’t destroy the small family farm 
 
 I understand that this survey is about the consumption of cloned animals but personally I 
would be far more concerned about the welfare of the animals as opposed to whether the 
specific animals I consume are cloned or not. Although I know mass producing animals 
is necessary in order to keep up with the demand for consumption, I would be happier to 
pay a higher price for animal products that come from well cared for, healthy animals that 
have a better quality of life rather than if they all have the exact same genetic make up or 
not. I do think cloning animals seems quite an expensive way of producing animals, but 
then I am no expert on the topic. And also I remember hearing that cloned animals have a 
shorter expected life span than their 'original' counter parts, so that may not be in keeping 
with how i feel about animals living a happy healthy life. Though I guess this wouldn't be 
a problem seeing with cloned animals as most animals are on our plates before long 
before we need to worry about them dying of 'natural causes'!! 
 
 I work in the Food Science/Nutrition/Consumer food choice area and therefore I think I 
may have been biased towards some of the answers 
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 It is the DNA which shortens in cloning making the life span of the animal shorter which 
makes me uncomfortable about consuming cloned meat! I prefer to eat meat which is 
'natural', organic and local by preference. There is something about cloning for 
consumption purposes that actually disturbs me 
 
 Will need to do a lot of convincing to get people on board with cloned animal products. 
Cloning brings to mind GM, processing, hormones etc although some of these may not be 
closely related. People want natural, wholesome, organic, unprocessed foods and cloning 
just seems like a step backwards from nature. 
 
 Good luck! 
 
 The question regarding what was my objection to cloning is too narrow, society still 
needs boundaries. Although some people believe in God, some others think they are! I 
can think of many activities in the past which reek of ignorance and impatience, one 
being BSE/CJD. Maybe we should stop conc. on shortcuts to solve the world’s problems 
and initiate the solutions with long term sustainable goals. 
 
 I’m vegetarian that’s why all the answers are negative 
 
 I don't eat much meat, but when I do I prefer to buy free-range or organic, though I am 
tending to eat less. Also if cloned meat was introduced without proper labeling, I would 
definitely stop meat altogether. Same applies to GM produce 
 
 I’m not sure about college graduate was the same as high school but you should change 
to post primary 
 
 "Welcome to gattaca" (movie starring Jude Law)  That's where we are going. Poor future 
generation... 
 
 There should be a text box like this after some of the questions so comments can be left 
as some of the answers are a bit vague 
 
 What’s this about? 
 
 
 
10.4.3 Open Ended Responses: France 
These responses have been translated into English.  For all intensive purposes, the intent 
of the comment has been kept over the literal translation as much as possible. For the sake of 
completeness, the original and English translated versions are included. The English translation 
is in italics.  
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 Ce qui me dérange dans le clonage est davantage le côté éthique j'ai peur qu'après nous 
arrivions à une seule et unique espèce, la plus productive, la race aux plus hauts 
rendements, et que nous perdions toutes les autres races rustiques qui font notre 
richesse... 
o On my side, the problem with cloning is ethic. I’m afraid this will conduct to an only 
one species, the most productive, the highest yield race. And we’ll lose all the other 
rustic races which make the diversity. 
 
 Sur la fin le questionnaire n'est pas très bien fait. En effet, l'enquêteur a oublié de 
mentionner une case "étudiante" qui par conséquent exclut les revenus pour la plupart 
d'entre eux. Mis à part ça j'ai trouvé ce questionnaire intéressant. 
o At the end of the survey it is not very good. Indeed, you should have put a ‘student’ 
mention for the question about revenues. Otherwise the survey was very interesting. 
 
 oui j'ai un petit commentaire, aux questions sur l'identité, il n'y a pas le choix de ne pas 
avoir d'enfant, hors j'en ai pas encore! j'ai répondu par défaut <6 ans. bon courage pour la 
suite 
o I have a comment for the question about identity; there is no choice to have no child, 
but I do not have any! Thus I answered <6. Good luck for next steps 
 
 Le clonage conduit à une uniformisation des races et à une homogénéisation du 
patrimoine génétique du cheptel considéré. Si un jour ceci sort en France?, je ne donne 
pas cher de l'entreprise qui aura le courage de s'être lancée dans cette entreprise.  Je 
rajouterai même que c'est un scandale d'imaginer cela! 
o Cloning conducts to a standardization of races and a homogenization of the 
considered livestock gene pool. What if this happens in France? I doubt the company 
which will have the courage to do that will succeed. In addition, I think it is a scandal 
to imagine that! (Wow, this is a good one!) 
 
 Vous êtes fou les américains!!!!! 
o You american people are crazy!!!!!  
 
 Boncourage! God save America! 
o Good luck! God save America! 
 
 il n'y a pas le prix qui est important dans l'achat de viande carné! il y a aussi et surtout la 
provenance! bonne continuation 
o There is not only the price which is important when purchasing meat! There is also 
the origin, and it is the most important! All the best 
 
 Il m'apparait que le problème du clonage est un point sensible. Je ne me suis pas 
renseigné outre mesure avant votre questionnaire, mes réponses sont donc vraiment 
parfois dues uniquement à mon intuition.   Par contre nous annoncer qu'il va encore 
falloir baisser les prix des éleveurs conventionnels locaux m'attriste profondément. Je ne 
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suis pas fils d'éleveur mais j'apprécierai que nous puissions manger la viande qui provient 
d'à côté de chez moi à un prix raisonnable plutôt qu'une viande ayant traversé l'Atlantique 
et élevée de manière intensive à des prix défiants toute concurrence. Ce n'est pas la 
France qui nécessite de telles innovations; d'autres continents en nécessité profonde de 
produits carnés tels que l'Afrique seraient peut être à cibler.   Merci de prendre en 
considération ce commentaire, Respectueusement, un élève pur pannais. 
o It appears to me that the cloning problem is a sensitive point. I did not enquire about 
this topic before the survey, so my answers are sometimes only due to my intuition. 
However, you tell us that we will again need to decrease conventional local farmer 
prices, and that makes me deeply sad. I do not come from a farm but I’d like to be 
able to eat meat which comes from the local area at a reasonable price instead of 
eating meat which crossed the Atlantic Ocean and was grown intensively at very 
competitive prices. France does not need such innovations; other continents, as 
Africa, might be targeted. Thanks for taking my comment into consideration. 
Sincerely, an ESA Purpan student. 
 
 il faudrait une caractéristique "étudiant" ==> pas de revenus du tout!! 
o You must add a student characteristic => no revenue at all!! 
 
 Le problème lié à cette enquête est qu'en France on ne se sent pas beaucoup concerné par 
le clonage dut fait que l'on en parle pas du tout. 
o The problem with this survey is that in France we do not feel really concerned about 
cloning because nobody talks about it. 
 
 la tradition du bien manger et de l'agriculture à la française ! 
o The good food tradition and the agriculture on the french way!  
 
 Je suis étudiante et n'ai donc pas de revenu. Il n'y a pas de réponse prévoyant ce cas.   
Pour ce qui est de ce que je pense du clonage, je ne suis pas vraiment moralement contre 
(c'est ma réponse dans le questionnaire). Les expériences scientifiques de clonage ne me 
choquent pas mais je trouve contre nature de cloner à grande échelle pour la 
consommation humaine.  De plus je ne savais pas trop comment répondre à la question: 
vous sentez-vous concerné par le prix, le packaging... dans les produits carnés. En effet je 
peux dire que je me sens concerné par le prix par exemple. Je trouve bizard en revanche 
de dire qu'on se sent concerné (ou pas) par les bactéries pathogènes ou le clonage. J'aurais 
plutôt demandé: considérez-vous le clonage, les hormones... comme un danger? 
o I am a student so I do not have any income. There is no answer for this case. About 
cloning, I’m not really against it morally (that’s what I said in the survey). Scientific 
cloning experiments do not shock me, but I feel like it’s not natural to clone at a large 
scale for human consumption. Moreover I did not really know how to answer the 
question: do you feel concerned about the price, packaging… for meat. Indeed, I can 
say I feel concerned about the price for example. But I think it is strange to say to feel 
(or not) concerned about pathogens or cloning. I would rather have asked: Do you 
consider cloning, hormones… as a danger? 
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 Les questions sont étranges et il est difficile d'y répondre car on se sent peu concerné 
(surtout pour l'histoire de clonage qui me parait difficilement envisageable en France) 
o Questions are sometimes strange and difficult to answer because we do not feel really 
concerned (mostly for the cloning history which seems difficult to have in France for 
me) 
 
 c'est bref, facile à répondre, c'est bien! 
o It is short, easy to answer, it is good! 
 
 Les propositions pour les revenus sont bizarres. en effet, nous sommes étudiants, de ce 
fait, nous ne payons pas d'impot pour le moment... 
o The propositions about revenues are strange. Indeed, we are students, thus we do not 
pay taxes for now… 
 
 La seule raison qui pourrait me pousser à être contre le clonage serait que la science 
prenne la place de l'éleveur. 
o The only reason for me to be against cloning would be that the science takes the 
farmer place. 
 
 Je suis étudiant et n'ai donc pas de revenu. Et ce n'est pas parce que des autorités disent 
que la viande cloné est sans danger qu'il faut les prendre au sérieux, on sait trop bien 
comment les lobbyings jouent avec les études... 
o I’m a student and do not have any income. And it is not because authorities say that 
cloning meat is not dangerous that we have to believe them, we know too much how 
lobbies play with studies… 
 
 
10.4.4 Open Ended Responses: Honduras 
These responses have been translated into English.  For all intensive purposes, the intent 
of the comment has been kept over the literal translation as much as possible. For the sake of 
completeness, the original and English translated versions are included. The English translation 
is in italics.  
 Y ya estan en pruebas la carne de animales clonados?? 
o Do we already have meat from cloned animals?  
 
 El consumo de animales clonados no me preocupa por razones morales o religiosas. 
Como productor y consumidor me preocuparia más que sucediera lo mismo que en 
algunas plantaciones frutales, donde practicamente todos los frutales son clonados, que 
una plaga acaba con facilidad con grandes extensiones de terreno. 
o Morality and religion are not the reasons why I am worried about consuming cloned 
animals meat. If a pest can easily affect a large plantation of fruits trees (GMO’s) it 
10-146 
 
could be the possibility something will affect cloned animals? If so, then I would 
worry. 
 
 Espero haber contribuido positivamente a su estudio y ojalá otros colegas se sumen para 
que esta muestra sea válida 
o I hope I have contributed positively to your research. Hopefully other colleagues will 
do help too and your sample will be representative.  
 
 Podria compartir los resultados de la encuesta, Gracias! 
o Could you share the results of the survey? thanks! 
 
 Me gustaría que compartan los resultados de este estudio me parece interesante, saludos. 
josue069@hotmail.com, Nicaragua 
o I would like you to share the results of this study. I think is interesting, Greetings. 
josue069@hotmail.com (Nicaragua) 
 
 Si la clonacion se usa para disminuir el hambre en el mundo, estoy de acuerdo. Caso 
contrario, si se usa para otros fines, es moralmente incorrecto. 
o If cloning is used to reduce hunger in the world, I agree with it. Otherwise, is morally 
wrong. 
 
 excelente encuesta,  saludos 
o Excellent survey. Greetings 
 
 Yo considero que el consumo de carnicos es vital para la vida humana;por la riqueza de 
sus aminoacidos. 
o I consider the meat consumption is very important for human being because is rich in 
its amino acids. 
 
 I think we  need to develop  another word instead of clonation to minimize people to 
think about eat "clonated meal" 
o I think we should use another word instead of cloning, so we avoid the cloned meat 
thought. 
 
 La clonaciòn y ferilizaciòn In Vitro de animales, desde mi punto de vista con llevarìa a 
incrementar la producciòn de alimentos, asì como lo hizo la Revoluciòn Verde en su 
momento, el riego por goteo israelita y como lo està haciendo en la actualidad la 
producciòn bajo ambiente controlado (invernaderos o greenhouses). Lamento mucho que 
en paìses en desarrollo o subdesarrollados, estas tècnicas sean muy caras o poco 
asequibles como para popularizarlas.  Regards  Ivàn Alvarez Viñas 
o From my point of view animals cloning and In Vitro fertilization would lead to 
increased food production. As in the past the Green Revolution and the Israeli drip 
irrigation did, and how is currently doing production by greenhouses. I regret that in 
developing or countries, these techniques are very expensive so aren’t available as 
widely. Regards Ivan Alvarez Viñas. 
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 Pienso que la clonación para obtener reproductores de alto potencial genetico, facilitaria 
llevar esta genetica para el mejoramiento del resto de la poblacion bovina, porcina, 
avicola, etc. No estoy de acuerdo con la clonacion masiva para fines de produccion 
porque reemplaza los procesos evolutivos de las especies en la naturaleza, aumenta el 
riesgo financiero y de salud animal al tener poblaciones con mayor homocigosis y 
vulnerables a pandemias que afectarian a toda la poblacion de animales. 
o I think that cloning for breeding high genetic animals would help to improve the rest 
of the population of cattle, swine, poultry, etc. I do not agree with cloning if the 
purpose is to clone a lot of animals, because it replaces the evolutionary processes of 
species in nature, increases the financial risk and the health risk of having have more 
homozygous. Also increases the pandemics vulnerability. 
 
 Aparentemente,  las dudas sobre los animales clonados y sus resultados como productos 
completamente seguros para la alimentación no han sido del todo aclaradas. Puede ser un 
proceso paso a paso,  pero la gente espera mayor y mejor información,  sin temores! 
o There doubts about cloned animals and the effects of their products. It could be a step 
by step process but people need more information.  
 
 Creo que como consumidores tenemos derecho a saber que consumimos. Quiero saber si 
lo que consumo es clonado o no. Si decido consumirlo me hago responsable de lo que 
consumo. Por tanto es un asunto de preferencias de cada comprador. 
o I think as consumers we are entitled to know what we consume. Let me know if what I 
consume is cloned or not and will be responsible for it. It depends on consumer 
preferences. 
 
 Muy interesante encuesta. Me gustaria saber acerca del motivo de su encuesta ademas 
que empresas estarian realizado este tipo de actiidades tan interesantes. Talves poder 
realizar ese tipo de praticas con fines didacticos en nuestra universidad. 
davids_c1@hotmail.com por si desean enviar información. 
o It is a very interesting survey. I would like to know about the objective of it and also 
who is company is conducting this research. davids_c1@hotmail.com  
 
 EL punto moral es el que me preocupa, la razón del precio, me preocupa los pequenos 
productores que no puedan competir con las compañías que si lo hacen, estaríamos 
eliminando automaticamente al pequeño productos 
o I am worried about the morality issue. I am worried about small producers because 
they cannot compete with Multinational companies that production cost are lower. 
 
 Deberían de colocar el objetivo de la encuesta. Éxitos en su trabajo! 
o You should put the objective of the survey. Success in your work! 
 
 me parece una excelente idea consumir ese tipo de animales ya que asi se puede 
optimizar y mejorar la calidad de los productos al clonar animales ejemplares. 
o I think this is a good idea because the quality can increase.. 
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 sugiero que en la pregunta 7 se reformule una de las opciones y ya uqe le termino 
seguridad alimentaria se refiere a si esa fuente de alimento siempre esta disponible para la 
población 
o I propose to re-formulate Question 7 because the term food security sounds like if the 
meat is going to be available for ever. 
 
 Quiero aclarar algunas cosas, Soy estudiante Universitario.  Con respecto a productos 
transgénicos, yo no considero malo ni mucho menos dañino hasta que me lo comprueben 
científicamente con pruebas científicas. Felicidades a la gente que trabaja con ingeniería 
genética, considero que tecnología transgénica es una herramienta para combatir el 
hambre y es un mecanismo muy útil para la seguridad alimentaria del mundo. 
o I want to clarify some things, I am university student. I don’t think GMO products are 
bad unless scientific prove it. Congratulate the people, who work with genetic 
engineering, I believe that GM technology is a tool to fight hunger and is a very 
useful mechanism for world food security.  
 
 Creo que la clonación es a la vez moralmente incorrecta por i afiliación religiosa, por lo 
cual es la razón primorial por la cual no consumiría prodctos cárnicos de animales 
clonados. 
o I think that cloning is morally and religious incorrect, so that is the reason why I 
won’t consume meat from cloned animals 
 
 no me parecen bien las oportunidades de que nos tomen en cuenta en su investigación 
o I do not find a good opportunity that we are taken into account in your research 
 
 Me parece una excelente idea muy creativa e innovadora el vender carne de animales 
clonados! :) 
o I think an excellent, creative and innovative idea to sell meat from cloned animals! :) 
 
 creo que los temas de OGM son muy interesantes e importantes en nuestros dias, sin 
embargo en lo particular moralmente creo que no estaría tan dispuesto a consumir 
productos de estos a menos que en realidad no se encuentre productos normales y 
tradicionales. Saludos, 
o Nowadays, I think GMOs issues are very interesting and important, but I won’t 
consume them because they are morally incorrect.  
 
 Exitos con el trabajo... 
o Success in your research 
 
 Estoy en 4to año de Zamorano por lo cual indiqué que he completado la secundaria y no 
universidad, al igual que no tengo un salario para poder completar dicha pregunta.    Me 
incomoda el hecho de consumir alimentos derivados de animales clonados, pero quisiera 
aprender un poco más sobre el tema para poder tomar una decisión acertada al momento 
de consumir. 
 I'm in 4th year Zamorano so I indicated that I have completed high school but not 
college. Also, I don’t have wages to complete the question. I am uncomfortable eating 
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meat from cloned animal. However, I would like to learn more about the subject to 
take the right purchase decision. 
 
 
10.4.5 Open Ended Answers: China  
The original Chinese open ended answers will not be provided, only the translations.  
Because the answers were handwritten it is very difficult to transfer them to this document.  
 
 Expecting the appearance of clone food and overspread of that kind of food, decreasing 
the negative effect on the natural environment 
 No comments, but I care about the information of agricultural products 
 Cloning is terrible 
 There is too much saying about clone on a lot of products, I don’t think that is safe. 
 Too hasty. 
 We are all kids, there is no sense for us to talk about that 
 There is no sense to ask us this 
 No Comment (This was mentioned on numerous surveys.) 
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10.5 Animal Cloning Timeline 
 
1885  First Cloning Experiment Inspired by Embryos 
August Weismann, A German zoologist, studied embryonic development where he believed 
embryonic development occurred through diminution, or loss of cells. Wilhelm Roux, Hans 
Dreisch, and Hans Spemann separately each studied Weismann’s ideas and found the one 
nucleus was necessary for embryonic development. Spemann conducted the first ever cloning 
experiment by separating a fertilized cell in the very initial stages of development.  
 
 
1950  Bull Semen successfully frozen 
First successful freezing of bull semen at -79°C for later insemination of cows was 
accomplished.  
 
1952  First Successfully Cloned Tadpole 
Robert Briggs and Thomas King successfully cloned tadpoles by injecting the embryonic nucleus 
from one cell into another. John Gurdon builds on Briggs and Kings study to clone an adult frog 
by injecting adult epithelia cells into a clear nucleus.  
 
 
1981  First Mice Cloned  
Karl Illmensee and Peter Hoppe cloned adult mice using donor embryonic cells injected into 
oocytes and then developed in surrogate female mice.  
 
1986  First Cloned Sheep from Embryonic Cells 
Steen Willadsen cloned both sheep and dairy cows splitting frozen fertilized embryonic cells and 
developing them in surrogate mothers.  
 
 
7/5/1996 Dolly the Sheep is born 
Ian Wilmut and Keith Campbell were successful in producing the first ever organism to be 
cloned using Somatic Cell Nuclear Transfer (SCNT) by injecting donor adult cells into embryos.  
Dolly, a Poll Dorset ewe became an international sensation and lived to give birth to six healthy 
lambs before dying February 14, 2003.  Belief that Dolly’s arthritis was caused by the donor 
animal’s age never was truly confirmed because there were too few clones to compare against at 
the time.  Nonetheless, Dolly’s success prompted international debate on the ethics and efficacy 
of cloning science in both animals and humans.  Many felt there were substantial scientific and 
industry propositions to be made with the new technology.  
 
 
1997  UNESCO signs Human Gene Declaration 
186 member nations of the United Nations Educational, Scientific, and Cultural Organizations 
(UNESCO) sign the Declaration on the Human Genome and Human Right which calls the 
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human genome the “heritage of humanity” while avoiding the prescription of gene or cloning 
therapy (Bonnickson 2001). 
 
Council of Europe bans Genetic Modification of Humans 
The Council of Europe members open the Convention for the Protection of Human Rights and 
the Dignity of the Human Being with Regard to the Application of Biology and Medicine 
(Bioethics Convention) which essentially bans any type of human genetic modification 
(Bonnickson 2001).  
 
3/4/1997 Human Cloning banned in the US 
President Clinton proposed a five year moratorium on federal and privately funded human 
cloning research in the United States. The moratorium titled Prohibition on Federal Funding for 
Cloning of Human Beings led to both House and Senate hearings on the science over the coming 
months.  
 
6/9/1997 Proposed voluntary moratorium on human cloning 
President Clinton proposes legislation that would effectively ban the cloning or the study of 
cloning of humans for at least 5 years. 
 
7/1/1997 Polly is born 
Ian Wilmut and Keith Campbell, the scientists who created Dolly, also created Polly.  Polly, a 
Polled Dorset lamb was cloned from sheep skin cells which were transgenically altered to 
contain human genes.  While this was met with international debate, it is said to have been the 
final goal of the Wilmut team (Panno 2005).  The argument followed that transgenic cloning had 
substantial opportunity to treat a variety of human diseases.  This was confirmed in 2000 by the 
same research team with the successful cloning of sheep containing the human protein alpha 1-
antitrypsin which is used to treat a variety of lung diseases (Wright 2004).  
 
9/1/1997 Scientist sign voluntary moratorium on Human Cloning 
Thousands of biologists and physicians sign a voluntary five-year moratorium on human cloning 
in the United States.  
 
12/5/1997 Richard Seed announces intention to clone human 
Richard Seed, a nuclear physicist, announces intentions to clone a human before federal laws 
could effectively prohibit the process. This statement went directly against the proposed ban by 
President Clinton and forced the United States in a national debate on human cloning which 
prompted legislative bans in numerous states as well as Congressional action.  
 
 
1998  Several Advancements were made in animal cloning 
Several advancements in animal cloning were published in scientific journals.  The University of 
Hawaii cloned dozens of mice validating the science the birth of Dolly.  The Raukura Research 
Center in New Zealand was able to clone the last cow from the rare breed of cattle.  Japanese 
scientist published data showing the successful cloning of eight calves with remarkable success. 
(Wright 2004) 
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1/1/1998 Announcement made to map human genome 
U.S. based Biotechnology firm Perkin-Elmer Corporation announced that, against international 
backlash, it would work with gene sequencing expert J. Craig Venture to privately map the 
human genome.  
 
Nineteen European nations signed a ban on human cloning 
19 out of the 40 European member nations of the Council of Europe signed an agreement which 
required that each nation introduce laws that would effectively prohibit any type of cloning.  This 
effectively started strict regulations in Europe regarding human and animal cloning. The UK and 
Germany both refused on grounds of defending freedom of scientific research and stricter 
existing laws respectfully.  
 
1/20/1998 FDA announces authority over human cloning 
The United States Food and Drug Administration announced that it had sole authority over 
human cloning in the U.S. on grounds it was a form of cellular or genetic therapy.  This forced 
any interest to conduce human cloning to be approved through the FDA first.  
 
 
2001  13 Congressional Bills Introduced on Human Cloning 
13 Bills were introduced to prohibit human cloning in the first session of the 107th Congress 
including H.Res. 214, H.R. 1260, H.R. 1372, H.R. 1608, H.R. 1644, H.R. 2172, H.R. 2608, H.R. 
3495, S. 704, S. 790, S. 1758, and S. 1893. H.R. 2505 with H.Amdt. 284 passed in the House of 
Representatives (see July 16 and 31, 2001). No floor action was taken on the other measures. 
(Wright 2004) 
 
FDA places Voluntary Moratorium on Consumer Ready Cloned Products 
Once cloning became apparent in that it would enter the commercial livestock industry, FDA 
requested a voluntary moratorium that cloned livestock would be kept out of the food supply.  
Livestock producers and scientist agreed.  
 
01/22/2001 UK passes first Legislation Regulating Human Cloning 
The British Government enacted into law the 1990 Human Fertilization and Embryonic 
Regulations (HFER) which later adding to it the Human Reproductive Cloning Bill (1992).  The 
legislation was internationally regarded because it gave flexibility to research while also banning 
the full gestation of cloned human embryos.  There was extensive background work involved as 
well as advisement from 17 organizations which included research facilities, churches, pro-life 
groups, trade unions, and many women’s institutes. (Panno 2005) 
 
03/21/2001 Novel Foods Act (Directive 2001/18/EC 
After years of debate and issuing moratoriums on human cloning, on March 12, 2001 the E.U. 
passed the obligatory Novel Foods Act (Directive 2001/18/EC) whereby all GMO’s are governed 
for commercial release.  Even with this act, cloning was not able to be explicitly included in the 
regulation.  The Novel Foods Act defines GMO’s as any “organism with the exception of human 
beings, in which the genetic material has been altered in a way that does not occur naturally by 
mating and/or natural recombination” (E.U. 2001).    
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07/16/2001 H.R. 2505: Human Cloning Prohibition Act 
Representative David Weldon (R-Florida) and Bark Stupak (D-Michigan) introduce House 
Resolution 2505, the Human Cloning Prohibition Act.  The bill amended Title 18 of the Unites 
States Code in order to prohibit human cloning. It was passed by the House and sent to the 
Senate on August 1, 2001 were it received no further action to this day. (Wright 2004) 
 
11/28/2001 President’s Council on Bioethics 
President Bush issues Executive Order 13237establishing the President’s Council on Bioethics.  
The council was to advise the President on the bioethical issues concerning biomedical science 
and technology. (Wright 2004) 
 
12/14/2001 United Nations General Assembly Takes Up Cloning 
The UN began an international convention against the reproductive cloning of humans.  While 
the debate ventured into all forms of reproductive and therapeutic cloning with the idea that it 
violates human dignity, only a non binding resolution was passed in 2005.  The UN has also 
released a document which contains specific information for countries looking at ruling on 
Human Cloning.  
 
 
2002  4 Congressional Bills Introduced on Human Cloning 
4 bills were introduced in the second session of 107th congress to prohibit human cloning 
including S. 2893, S. 1899, S. 2076, and S. 2439. No floor action was taken on the measures and 
they died at the end of the 107th Congress. (Wright 2004) 
 
Significant leaps were made in Cloning Science 
Significant leaps were made in the science of animal cloning during 2002.  Researchers at 
Advance Cell Technology in Worchester, MA cloned kidney-like organs that were not rejected 
when implanted into recipient cows.  French researchers reported cloning rabbits that would aid 
in human cystic fibrosis studies. Stanford University announced a $120 million institute to study 
stem cell research which included cloning human embryos.  
 
01/28/2002 S. 1899, Human Cloning Prohibition Act of 2001 
Senator Sam Brownback (R-Kansas) introduced a Senate version of the Cloning Prohibition act.  
Even with 30 cosponsors, this bill never made it out of the Senate Judiciary Committee.   
 
02/15/2002 Texas A&M Clones first house pet 
Texas A&M College of Veterinary Medicine announces the cloning of the first cat.  The cat was 
the first household pet to be cloned.  Although the cat looked differently from the donor cat, it 
was in fact an exact genetic replica.  The scientist warned that pet cloning is not reproduction, 
but rather resurrection and that cloned pets will resemble their donors, but will not exactly be 
owners’ old pets.  
 
10/1/2002 FDA sponsors report in preparation for ruling on safety of animal cloning 
According to a National Academy of Science (NAS) panel issued report, there is no evidence 
that food from cloned livestock is unsafe for human consumption although it requires more 
research. The greatest concern is from transgenically cloned animals.  The report issued by the 
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NAS was sponsored by the FDA in preparation to rule on the safety of cloned farm animals and 
other animal-biotechnology products.  
 
12/27/2002 Director of Clonaid announces first human clone 
Briigitte Boiselier, chemist and director of Clonaid a company founded by the religious sect 
Raelians announces a successful human clone was born; however no evidence of confirmation 
was made.  
 
 
2003  10 Congressional Bills Introduced on Human Cloning  
10 bills were introduced in Congress to prohibit human cloning including H.R. 234, H.R. 246, S. 
246, H.R. 534, S. 303, H.R. 801, H.R. 916, H.R. 938, H.R. 534, and S. 1356. Each bill had 
varying determinates and each was met with varying success.  Because cloning had become a 
part of the stem cell controversy, passing bills were very difficult.  
 
02/23/2003 Funding for Cloning Research Prohibited 
FY2003 Consolidated Appropriation Resolution P.L. 108-7 signed into law.  The Appropriation 
Resolution signed into law included a provision originally apart of H.R. 246 which prohibited 
any private funding and only allowed for government funding regarding research that includes 
human cloning that uses human embryos. 
 
02/27/2003 H.R. 534, Human Cloning Prohibition Act Passes House 
Introduced by Representative David Weldon (R-Florida), H.R. 534 was to amend Title 18 of the 
United States Code to prohibit cloning.  The bill was met with controversy, but passed the House 
by a 241-155 vote.  The bill died in the Senate.  
 
05/29/2003 First large Equid Cloned 
University of Idaho and Utah State University announced the first birth a cloned mule. They used 
nuclei cells from a fetus related to a famous racing mule in order to avoid the aging issues found 
in Dolly the sheep.  
 
08/6/2003 First Horse Cloned  
Italian Scientist announced the birth of the first cloned horse.  The donor mare was also the 
surrogate mother. The team had a .04% success rate of developed embryos to harvested eggs.  
 
01/23/2004 Funding for Cloning Research Prohibited 
The FY 2004 Consolidate Omnibus Appropriations Act P.L. 108-199 was signed into law.  The 
appropriation act signed into law included a provision originally part of S.1356 which prohibited 
any private funding and only allowed for government funding regarding research that includes 
human cloning that uses human embryos.  This bill has been repeated and signed into law 1998, 
2001, 2004, 2007.  
 
 
03/08/2005 United Nations General Assembly adopts Declaration on Human Cloning 
After many years of deliberation, the UN adopts a nonbinding declaration on Human Cloning in 
which Member States “were called on to adopt all measures necessary to prohibit all forms of 
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human cloning inasmuch as they are incompatible with human dignity and the protection of 
human life” (United Nations 2005). This declaration did not answer the human cloning debate, 
but at the very least quelled the controversy.  
 
9/26/2005 FDA head resigns, delaying cloning decision 
FRA Head Lester Crawford abruptly resigns.  His resignation, which did not relate to cloning, 
delayed a decision by the FDA on allowing the use of animal cloning in the human food 
industry.  The FDA study had originally been commissioned to the National Academy of 
Sciences in 2002.   
 
10/27/2005 Biotechnology shakes up the industry at the WWFE 
The Worldwide Food Expo (WWFE) took on the controversial issue of animal biotechnology 
including transgenic and cloning. Martina Newell-McGloughlin, director of the University of 
California Systemwide Biotech Research and Education Program, states transgenics and cloning 
could develop high-merit farm animals, duplicate valuable animals used in pharmaceutical 
research, and create a homogeneous population of cells, tissues and even organs that can be 
transferred to organ-failure patients.  She also stated that food-safety concerns held no merit 
because cloned animals are just copies of animals already in the environment.  
 
11/2005 KRC Research Study on Animal Cloning 
Even though Gallup Poll, Inc. had asked the question on moral acceptance of animal cloning, the 
KRC Research Study was the first to focus on what consumers will do once meat and milk from 
cloned animals reach supermarkets. The study found that opinions on animal cloning were still 
being formed and that there was a one third split on buying the product, buying but finding out 
more about the product, and never buying. The study was only lightly covered by the media but 
was followed by numerous other studies. (Sosin and Richards 2005) 
 
11/17/2005 Pew Initiative Survey 
One of the first studies to meet broader media attention, the Pew Initiative Study on Food and 
Biotechnology found that two out of three Americans felt “uncomfortable” with animal cloning 
and about 40% felt food from cloned animals is unsafe.  (The Mellman Group, Inc. 2005) 
 
 
1/4/2006 Six re-cloned calves born in China 
China Agricultural University and Shandong Kelong Animal Husbandry Co confirm that 3 
claves re-cloned from the cells of cloned cattle survived while three died after birth.  These cattle 
were the first animals to be re-cloned from existing clones.   
 
12/28/2006 FDA issues draft documents on the safety of animal clones 
The draft risk assessment found that meat and milk from clones of adult cattle, pigs and goats, 
and their offspring, were as safe to eat as food from conventionally bred animals because they 
were genetic copies of the donor animals. They also stated special labeling was not necessary. 
The initial assessment was the first released from the FDA and was peer-reviewed by a group of 
independent scientific experts in cloning and animal health.  The assessment did propose a risk 
management plan that mitigated animal welfare along with draft guidance to the industry 
because cloning had reached commercial proportions by this time.  The release of this document 
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sparked dramatic controversy over use of cloning for human food. (Food and Drug 
Administration 2006) 
 
2007  Animal Cloning is Met With Significant Controversy 
With the release of FDA’s draft documents stating cloned animals are safe to eat and that it does 
not require special labeling, consumer activist groups and food companies alike weighed in.  
Those who opposed boycotted the science saying consumers had the right to now the science 
used to producer their food and that cloning posed animal welfare issues.  Those who approved 
felt the final study needed to be peer reviewed and extensive, but that cloning was only making 
exact copies of what already existed in nature.  
 
1/12/2007 Major British grocers pledge boycott of meat from cloned animals 
Due to unconfirmed reports that a cloned cow from the U.S. had birthed a calf on a British farm, 
virtually all major British grocery chains pledged a boycott of meat from cloned animals and 
their offspring. While British law prohibits the sale of meat or milk from cloned animals, it 
makes no mention of offspring of clones. Stores like Tesco, Wal-Marts Asada chain, and 
Morisons and Marks & Spencer were among the boycotts. (Hisey 2007) 
 
2/7/2007 Activist Protest Animal Cloning in DC 
Donning cow costumes, many consumer and animal rights activist groups marched in opposition 
to animal cloning in order to attract media attention and create greater congressional opposition 
to the FDA’s draft documents released in December 2006.  Besides consumers right-to-know 
food ingredients, the arguments cloning compromises the welfare of food animals, cloning hurts 
family farmers, and the moral, religious and ethical concerns about cloning were all brought up 
by Ben and Jerry’s Ice Cream Inc. founder Jerry Greenfield.  
 
2/15/2007 Whole Foods and Wild Oats boycott animal cloning  
Whole Foods and Wild Oats are among the first U.S. based companies who released direct 
opposition to animal cloning. Each stated they would ban products from animal clones in their 
stores along with support for labeling which indicates cloning use.  
 
5/3/2007 Scientists support FDA's Approval of food from clones 
200 scientist pledged support of the FDA preliminary approval of animal cloning stating it was 
one of the most rigorous safety reviews ever conducted.  In addition to the pledge, Federation of 
Animal Science Societies ran an ad in the Washington Post showing their support of the science 
and the FDA review process.   
 
10/13/2007 Governor Schwarzenegger Veto’s Food Labeling of Animal Clones 
A bill passed in the California Senate which required all packages containing product from a 
cloned animal was vetoed by Schwarzenegger on grounds that it pre-empted federal law and 
labeling would costly to track. (Schwarzenegger 2007) California was the first state to address 
animal cloning for food use. 
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10/16/2007 AMI takes Pro Active stance in Consumer Education 
American Meat Instituted (AMI) launches a website designed to reach out to consumers by 
creating an online directory concerning biotechnology and especially cloning.  Amid the 
controversy, the AMI felt it was necessary to speak directly to consumers.  
 
12/19/2007 Clone Companies Release Tracking System 
Viagen Inc. and Trans Ova Genetics, the two main U.S. Cloning companies suggest a tracking 
system through an electronic ID tag to each animal cloned through the companies.  Both 
companies are the only to hold patents on cloning in the U.S. (Viagen Inc, TransOva Inc 2007) 
 
 
1/08/2008 FDA Approves Animal Cloning for Human Consumption 
The much anticipated FDA approval for animal cloning was released.  After years of detailed 
study and analysis, the FDA “concluded that meat and milk from clones of cattle, swine, and 
goats, and the offspring of clones from any species traditionally consumed as food, are as safe to 
eat as food from conventionally bred animals” (Food and Drug Administration 2008). The 
release however emphasized that the FDA had no bearing on the ethical issues of animal cloning.  
The approval was met with consumer shock and international controversy from consumer and 
animal activist and trade organizations.  
 
1/11/2008 EFSA Issues Draft Opinion Regarding Animal Cloning 
As commissioned by the E.U. Commission, the European Food Safety Administration (EFSA) 
gave preliminary affirmation to animal cloning for human food. The EFSA declared that while 
there are still uncertainties about the science due to the “small amount of data and studies 
available”, there is “no indication that differences exist in terms of food safety for meat and milk 
of clones and their progeny compared with those from conventionally bred animals.” (European 
Food Safety Authority 2009) 
 
1/15/2008 Numerous Companies announce their stance on Cloning 
Smithfield Foods Inc,Tyson Foods Inc., Kraft Foods Inc, Wal-Mart Stores Inc., PCC Natural 
Markets each announced cloning would not be readily used within their companies.  All 
companies announced they would follow the voluntary moratorium while many commented they 
would continue to monitor the scientific research. (Jargon and Jane 2008) 
 
1/16/2008 EU EGE releases “Ethical aspects of animal cloning for food supply” report 
As commissioned by the EU Commission, the European Group on Ethics in Science and New 
Technologies to the European Commission releases an opinion report on animal cloning.  The 
report made reference to the draft scientific findings of the EFSA (2008) report, the group 
reported “doubts as to whether cloning for food is justified” (EGE 2008). The report 
recommended additional requirements be met including the safety of food products be 
guaranteed as a precondition for marketing; the “five animal freedoms” as recommended by the 
Organization for Animal Health (OIE) be met; EU legislation ensure traceability enforcement for 
all cloned animals and their products; and the import of cloned animals, their offspring, and 
materials derived be conditioned on paper (EGE 2008). 
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Asian Nations Promise to Study Cloning 
Japan, South Korea, and Taiwan promise to study the issue of animal cloning for human food 
use.  While their main concern was food-safety, neither country indicated urgency in the issue. 
 
07/15/2008 EFSA Releases Official Report on Animal Cloning 
The EFSA releases an official scientific opinion on the use of animal cloning and the progeny of 
cloned animals in the human food supply.  The release mirrored their original statement in 
January 2008; however, they reiterate that the EFSA has no bearing on the ethical issue of 
animal cloning and instead refer to the European Commission asking the European Group on 
Ethics in Science and New Technologies to provide an opinion on the ethical aspects of cloning. 
 
9/2/2008 WSJ report shows animal clone offspring has entered the U.S. Food Supply 
An investigative report from the Wall Street Journal (WSJ) shows that the product from the 
offspring of cloned animals has entered the U.S. Food Supply, albeit at miniscule proportions. 
(Zhang and Jargon, Animal Clones' Offspring Are in Food Supply 2008) 
 
 
04/1/2009 Japanese Commission Deems Cloned Livestock Safe to Eat 
In a release by the Japanese Food Safety Commission, cloned cattle and pigs are deemed safe to 
eat.  The release corresponded with the FDA 2008 and EFSA 2008 reports which helped to 
mitigate any potential trade issues. (Japan Food Safety Commission 2009) 
 
 
05/2010 The EFSA Calls for Updated Assessments on Animal Cloning 
In a request from the European Commission to update the current statement on animal cloning, 
the European Food Safety Administration sent a broad request for any scientific studies on 
animal cloning.  This was the start of the 2010 animal cloning debate in Europe.  The decision 
was released in October 2010.  
 
07/07/2010 European Parliament Opens First Reading of Novel Foods Act (2010) 
The Novel Foods Act, among addressing a multitude of safety and ethical issues of new food 
technologies, was introduced in an attempt to ban the sale of foods from cloned animals and their 
offspring. The legislation was sent to the EU legislators for finalization in September. (Novel 
Foods Act 2010) 
 
07/29/2010 New York Times suggests cloned product already in Europe 
New York Times reports a handful of breeders in Switzerland, Britain and possibly other 
countries have imported semen and embryos from cloned animals or their progeny from the 
United States.  In addition they report that while no vendor has publicly acknowledged it, meat 
or dairy products originating from such techniques are believed to be already on supermarket 
shelves. (Kanter 2010) 
 
08/4/10 Briton’s FSA Confirms Cloned Product in Food Supply 
Briton’s Food Standards Agency (FSA) announced confirmation that it found meat from the 
offspring of a cloned cow in the UK food chain.  Stirring extreme controversy in Europe, the 
FSA reiterated the EFSA’s opinion on cloning but that cloned animals are considered Novel 
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Foods and are therefore required to be tracked per the Novel Foods Act 2010. The animals had 
derived from embryos harvested from a cloned cow in the United States (FSA 2007). 
 
9/16/2010 EFSA Backs up its Previous Statement amid Controversy in Europe 
Amid controversy based on the Novel Foods Act and confirmed reports of cloned meat in the 
food supply, the EFSA furthers their confirmation that product from cloned animals do not pose 
a health risk.  The Scientific Committee concurred that no new scientific information had 
recently become available that would require EFSA to reconsider the conclusions and 
recommendations of its previous work in this area. (EFSA 2010) 
 
9/29/2010 H.R. 6325 – Consumer Right to Know Food Labeling Act 
Representative Rosa DeLauro (D-Connecticut) introduces a bill that would mandate that 
bioengineered meat products be labeled accordingly.  It would require the USDA to label 
products of cloned animals if they are intended for consumption. The bill was referred to the 
Committee on Energy and Commerce and House Agriculture. While bills similar such as H.R. 
5577 – Genetically Engineered Food Right to Know Act, this received media attention because it 
addressed cloning directly.  
 
10/6/2010 Cloned steer wins Iowa State Fair Cattle Show 
Doc, a cloned steer whose donor was the previous grand champion steer, won 4-H grand 
champion steer at the Iowa State Fair. The decision sparked controversy not only in the efficacy 
of animal cloning for progeny use, but also the ethics of spending vast sums of money for a 
youth competition. The owners of the steer admitted to entering Doc as means of marketing their 
business. 
 
10/19/2010 European Commission Suspends Animal Cloning for Food Production 
The European Commission proposes a temporary, five year ban on animal cloning for human 
food use. The release was in response to the calls from the European Parliament and Member 
States to launch a specific EU policy on the subject.  However, the ban did not explicitly include 
products derived neither from the progeny of animal clones nor cloning for sport animals. This 
release was met by obvious backlash from many consumer and animal rights activist group in 
both Europe and the United States. 
 
11/10/2010 Parliament Signals Cloning as Top Priorities for EU-US Summit 
Ahead of the EU-US Transatlantic Economic Council summit on November 20th, the European 
Parliament signals differing rules on cloning as well as novel foods and genetically modified 
products will be addressed. (European Parliment 2010) 
 
03/17/2011 EU Commission Rejects European Parliament ban on cloned offspring 
The EU Commission rejects the European Parliaments attempt to ban products derived from 
animal clones.  Citing potential trade retaliation, the EU Commission felt the ban on products 
derived from cloned animals was a ‘de facto’ ban on products from the progeny of cloned 
animals as well.  Because no animal cloning labeling laws currently exist, banning products from 
the progeny of cloned animals would severely limit imports and create trade retaliation from 
trade partners.   
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03/28/2011 European Union and European Parliament Talks Break Down on Animal 
Cloning 
Animal cloning talk between the European Union and the European Parliament break down 
because a compromise on how to treat the offspring of cloned animals could not be reached.  
Therefore the Directive 2001/18/EC - Novel Foods Act which attempted to ban animal clones, 
was actually revoked and now only regulates animal clones.   
 
 
 
